Background  ||| S:24 E:43 ||| NN
We  ||| S:43 E:46 ||| PRP
have  ||| S:46 E:51 ||| VBP
been  ||| S:51 E:56 ||| VBN
interested  ||| S:56 E:67 ||| VBN
in  ||| S:67 E:70 ||| IN
quantitative  ||| S:70 E:83 ||| JJ
analysis  ||| S:83 E:92 ||| NN
of  ||| S:92 E:95 ||| IN
gene  ||| S:95 E:108 ||| NN
expression  ||| S:108 E:119 ||| NN
within  ||| S:119 E:126 ||| IN
single  ||| S:126 E:133 ||| JJ
cells  ||| S:133 E:139 ||| NNS
and  ||| S:139 E:143 ||| CC
the  ||| S:143 E:147 ||| DT
distribution  ||| S:147 E:160 ||| NN
of  ||| S:160 E:163 ||| IN
that  ||| S:163 E:176 ||| DT
expression  ||| S:176 E:187 ||| NN
within  ||| S:187 E:194 ||| IN
populations  ||| S:194 E:206 ||| NNS
of  ||| S:206 E:209 ||| IN
cells  ||| S:209 E:215 ||| NNS
replicating  ||| S:215 E:227 ||| VBG
in  ||| S:227 E:238 ||| IN
culture  ||| S:238 E:246 ||| NN
( ||| S:246 E:247 ||| -LRB-
e.g. ||| S:247 E:251 ||| NNP
, ||| S:251 E:252 ||| ,
)  ||| S:252 E:254 ||| NNP
[  ||| S:254 E:256 ||| -LRB-
1  ||| S:256 E:258 ||| CD
2  ||| S:258 E:260 ||| CD
3  ||| S:260 E:262 ||| CD
]  ||| S:262 E:264 ||| -RRB-
.  ||| S:264 E:266 ||| .
Since  ||| S:266 E:272 ||| IN
the  ||| S:272 E:276 ||| DT
level  ||| S:276 E:282 ||| NN
of  ||| S:282 E:285 ||| IN
any  ||| S:285 E:289 ||| DT
specific  ||| S:289 E:306 ||| JJ
protein  ||| S:306 E:314 ||| NN
within  ||| S:314 E:321 ||| IN
a  ||| S:321 E:323 ||| DT
cell  ||| S:323 E:328 ||| NN
is  ||| S:328 E:331 ||| VBZ
dynamic ||| S:331 E:338 ||| JJ
,  ||| S:338 E:340 ||| ,
and  ||| S:340 E:344 ||| CC
since  ||| S:344 E:350 ||| IN
it  ||| S:350 E:353 ||| PRP
is  ||| S:353 E:356 ||| VBZ
difficult  ||| S:356 E:374 ||| JJ
to  ||| S:374 E:377 ||| TO
describe  ||| S:377 E:386 ||| VB
cells  ||| S:386 E:392 ||| NNS
in  ||| S:392 E:395 ||| IN
tissue  ||| S:395 E:402 ||| NN
culture  ||| S:402 E:410 ||| NN
as  ||| S:410 E:413 ||| IN
"steady  ||| S:413 E:421 ||| CD
state ||| S:421 E:426 ||| NN
"  ||| S:426 E:436 ||| ''
entities ||| S:436 E:444 ||| NNS
,  ||| S:444 E:446 ||| ,
describing  ||| S:446 E:457 ||| VBG
gene  ||| S:457 E:462 ||| NN
expression  ||| S:462 E:473 ||| NN
in  ||| S:473 E:476 ||| IN
cell  ||| S:476 E:481 ||| NN
populations  ||| S:481 E:493 ||| NNS
in  ||| S:493 E:504 ||| IN
quantitative  ||| S:504 E:517 ||| JJ
terms  ||| S:517 E:523 ||| NNS
becomes  ||| S:523 E:531 ||| VBZ
a  ||| S:531 E:533 ||| DT
complex  ||| S:533 E:541 ||| JJ
problem ||| S:541 E:548 ||| NN
.  ||| S:548 E:550 ||| .
Here  ||| S:550 E:555 ||| RB
we  ||| S:555 E:558 ||| PRP
have  ||| S:558 E:571 ||| VBP
explored  ||| S:571 E:580 ||| VBG
the  ||| S:580 E:584 ||| DT
relationship  ||| S:584 E:597 ||| NN
of  ||| S:597 E:600 ||| IN
SV40  ||| S:600 E:605 ||| CD
large  ||| S:605 E:611 ||| JJ
T  ||| S:611 E:613 ||| NN
antigen  ||| S:613 E:621 ||| NN
( ||| S:621 E:622 ||| -LRB-
Tag ||| S:622 E:625 ||| NNP
)  ||| S:625 E:635 ||| -RRB-
expression  ||| S:635 E:646 ||| NN
as  ||| S:646 E:649 ||| IN
a  ||| S:649 E:651 ||| DT
function  ||| S:651 E:660 ||| NN
of  ||| S:660 E:663 ||| IN
cell  ||| S:663 E:668 ||| NN
density  ||| S:668 E:676 ||| NN
and  ||| S:676 E:680 ||| CC
cell  ||| S:680 E:685 ||| NN
cycle  ||| S:685 E:699 ||| NN
duration  ||| S:699 E:708 ||| NN
in  ||| S:708 E:711 ||| IN
clonal  ||| S:711 E:718 ||| JJ
populations  ||| S:718 E:730 ||| NNS
of  ||| S:730 E:733 ||| IN
Tag-immortalized  ||| S:733 E:750 ||| JJ
mouse  ||| S:750 E:764 ||| NN
astrocytes ||| S:764 E:774 ||| NN
.  ||| S:774 E:776 ||| .
These  ||| S:776 E:782 ||| DT
cells  ||| S:782 E:788 ||| NNS
depend  ||| S:788 E:795 ||| VBP
on  ||| S:795 E:798 ||| IN
expression  ||| S:798 E:809 ||| NN
of  ||| S:809 E:812 ||| IN
T  ||| S:812 E:814 ||| NN
antigen  ||| S:814 E:830 ||| NN
for  ||| S:830 E:834 ||| IN
viability ||| S:834 E:843 ||| NN
.  ||| S:843 E:853 ||| .
Expression  ||| S:853 E:864 ||| NN
of  ||| S:864 E:867 ||| IN
Tag  ||| S:867 E:871 ||| NNP
in  ||| S:871 E:874 ||| IN
mouse  ||| S:874 E:880 ||| NN
cells  ||| S:880 E:886 ||| NNS
under  ||| S:886 E:892 ||| IN
selective  ||| S:892 E:910 ||| JJ
conditions  ||| S:910 E:921 ||| NNS
that  ||| S:921 E:926 ||| WDT
do  ||| S:926 E:929 ||| VBP
not  ||| S:929 E:933 ||| RB
require  ||| S:933 E:941 ||| VB
tumorigenic  ||| S:941 E:953 ||| JJ
transformation  ||| S:953 E:976 ||| NN
( ||| S:976 E:977 ||| -LRB-
e.g. ||| S:977 E:981 ||| NNP
,  ||| S:981 E:983 ||| ,
transduction  ||| S:983 E:996 ||| VBG
by  ||| S:996 E:999 ||| IN
retrovirus  ||| S:999 E:1010 ||| NN
and  ||| S:1010 E:1014 ||| CC
selection  ||| S:1014 E:1024 ||| NN
for  ||| S:1024 E:1028 ||| IN
drug  ||| S:1028 E:1041 ||| NN
resistance ||| S:1041 E:1051 ||| NN
)  ||| S:1051 E:1053 ||| -RRB-
produces  ||| S:1053 E:1062 ||| VBZ
immortal  ||| S:1062 E:1071 ||| JJ
cell  ||| S:1071 E:1076 ||| NN
lines  ||| S:1076 E:1082 ||| NNS
with  ||| S:1082 E:1087 ||| IN
limited  ||| S:1087 E:1103 ||| JJ
transformation  ||| S:1103 E:1118 ||| NN
phenotypes  ||| S:1118 E:1129 ||| NNS
[  ||| S:1129 E:1131 ||| -LRB-
4  ||| S:1131 E:1133 ||| CD
5  ||| S:1133 E:1135 ||| CD
]  ||| S:1135 E:1137 ||| -RRB-
.  ||| S:1137 E:1139 ||| .
However ||| S:1139 E:1146 ||| RB
,  ||| S:1146 E:1148 ||| ,
expression  ||| S:1148 E:1159 ||| NN
of  ||| S:1159 E:1170 ||| IN
Tag  ||| S:1170 E:1174 ||| NNP
has  ||| S:1174 E:1178 ||| VBZ
profound  ||| S:1178 E:1187 ||| JJ
effects  ||| S:1187 E:1195 ||| NNS
on  ||| S:1195 E:1198 ||| IN
the  ||| S:1198 E:1202 ||| DT
cell  ||| S:1202 E:1207 ||| NN
cycle ||| S:1207 E:1212 ||| NN
,  ||| S:1212 E:1214 ||| ,
significantly  ||| S:1214 E:1236 ||| RB
reducing  ||| S:1236 E:1245 ||| VBG
cell  ||| S:1245 E:1250 ||| NN
doubling  ||| S:1250 E:1259 ||| NN
time  ||| S:1259 E:1264 ||| NN
and  ||| S:1264 E:1268 ||| CC
increasing  ||| S:1268 E:1279 ||| VBG
saturation  ||| S:1279 E:1298 ||| JJ
density  ||| S:1298 E:1306 ||| NNS
[  ||| S:1306 E:1308 ||| -LRB-
4  ||| S:1308 E:1310 ||| CD
5  ||| S:1310 E:1312 ||| CD
6  ||| S:1312 E:1314 ||| CD
]  ||| S:1314 E:1316 ||| -RRB-
.  ||| S:1316 E:1318 ||| .
These  ||| S:1318 E:1324 ||| DT
direct  ||| S:1324 E:1331 ||| JJ
effects  ||| S:1331 E:1339 ||| NNS
of  ||| S:1339 E:1342 ||| IN
Tag  ||| S:1342 E:1346 ||| NNP
result  ||| S:1346 E:1353 ||| NN
from  ||| S:1353 E:1366 ||| IN
binding  ||| S:1366 E:1374 ||| JJ
and  ||| S:1374 E:1378 ||| CC
inactivation  ||| S:1378 E:1391 ||| NN
of  ||| S:1391 E:1394 ||| IN
the  ||| S:1394 E:1398 ||| DT
retinoblastoma  ||| S:1398 E:1413 ||| NN
family  ||| S:1413 E:1428 ||| NN
proteins  ||| S:1428 E:1437 ||| NNS
( ||| S:1437 E:1438 ||| -LRB-
p130 ||| S:1438 E:1442 ||| NNP
,  ||| S:1442 E:1444 ||| ,
Rb ||| S:1444 E:1446 ||| NNP
,  ||| S:1446 E:1448 ||| ,
p107 ||| S:1448 E:1452 ||| CD
)  ||| S:1452 E:1454 ||| -RRB-
and  ||| S:1454 E:1458 ||| CC
the  ||| S:1458 E:1462 ||| DT
tumor  ||| S:1462 E:1468 ||| NN
suppressor ||| S:1468 E:1478 ||| NN
,  ||| S:1478 E:1480 ||| ,
p53  ||| S:1480 E:1484 ||| NN
[  ||| S:1484 E:1486 ||| -LRB-
7  ||| S:1486 E:1496 ||| CD
8  ||| S:1496 E:1498 ||| CD
9  ||| S:1498 E:1500 ||| CD
]  ||| S:1500 E:1502 ||| -RRB-
.  ||| S:1502 E:1504 ||| .
Tag  ||| S:1504 E:1508 ||| NN
is  ||| S:1508 E:1511 ||| VBZ
rate  ||| S:1511 E:1516 ||| NN
limiting  ||| S:1516 E:1525 ||| VBG
for  ||| S:1525 E:1529 ||| IN
G  ||| S:1529 E:1540 ||| NNP
1  ||| S:1540 E:1542 ||| CD
transit ||| S:1542 E:1549 ||| NN
,  ||| S:1549 E:1551 ||| ,
and  ||| S:1551 E:1555 ||| CC
this  ||| S:1555 E:1560 ||| DT
effect  ||| S:1560 E:1567 ||| NN
( ||| S:1567 E:1568 ||| -LRB-
as  ||| S:1568 E:1571 ||| RB
well  ||| S:1571 E:1576 ||| RB
as  ||| S:1576 E:1587 ||| IN
saturation  ||| S:1587 E:1598 ||| JJ
density  ||| S:1598 E:1606 ||| NN
and  ||| S:1606 E:1610 ||| CC
growth  ||| S:1610 E:1617 ||| NN
in  ||| S:1617 E:1620 ||| IN
soft  ||| S:1620 E:1625 ||| JJ
agar ||| S:1625 E:1629 ||| NN
)  ||| S:1629 E:1631 ||| -RRB-
is  ||| S:1631 E:1634 ||| VBZ
Tag-dose  ||| S:1634 E:1651 ||| JJ
dependent  ||| S:1651 E:1661 ||| JJ
[  ||| S:1661 E:1663 ||| -LRB-
3  ||| S:1663 E:1665 ||| CD
10  ||| S:1665 E:1668 ||| CD
11  ||| S:1668 E:1671 ||| CD
12  ||| S:1671 E:1674 ||| CD
]  ||| S:1674 E:1676 ||| -RRB-
.  ||| S:1676 E:1678 ||| .
Since  ||| S:1678 E:1684 ||| IN
the  ||| S:1684 E:1688 ||| DT
cell  ||| S:1688 E:1693 ||| NN
lines  ||| S:1693 E:1699 ||| NNS
in  ||| S:1699 E:1702 ||| IN
this  ||| S:1702 E:1715 ||| DT
study  ||| S:1715 E:1721 ||| NN
are  ||| S:1721 E:1725 ||| VBP
capable  ||| S:1725 E:1733 ||| JJ
of  ||| S:1733 E:1736 ||| IN
entering  ||| S:1736 E:1745 ||| VBG
a  ||| S:1745 E:1747 ||| DT
quiescent  ||| S:1747 E:1757 ||| JJ
state  ||| S:1757 E:1763 ||| NN
at  ||| S:1763 E:1774 ||| IN
saturation  ||| S:1774 E:1785 ||| JJ
density  ||| S:1785 E:1793 ||| NNS
[  ||| S:1793 E:1795 ||| -LRB-
6  ||| S:1795 E:1797 ||| CD
]  ||| S:1797 E:1799 ||| -RRB-
,  ||| S:1799 E:1801 ||| ,
one  ||| S:1801 E:1805 ||| PRP
might  ||| S:1805 E:1811 ||| MD
expect  ||| S:1811 E:1818 ||| VB
that  ||| S:1818 E:1823 ||| IN
the  ||| S:1823 E:1827 ||| DT
levels  ||| S:1827 E:1842 ||| NNS
of  ||| S:1842 E:1845 ||| IN
Tag  ||| S:1845 E:1849 ||| NNP
would  ||| S:1849 E:1855 ||| MD
decrease  ||| S:1855 E:1864 ||| VB
at  ||| S:1864 E:1867 ||| IN
saturation  ||| S:1867 E:1878 ||| NN
and  ||| S:1878 E:1882 ||| CC
as  ||| S:1882 E:1885 ||| IN
cells  ||| S:1885 E:1899 ||| NNS
progressively  ||| S:1899 E:1913 ||| RB
slow  ||| S:1913 E:1918 ||| VB
down  ||| S:1918 E:1923 ||| RP
as  ||| S:1923 E:1926 ||| IN
a  ||| S:1926 E:1928 ||| DT
function  ||| S:1928 E:1937 ||| NN
of  ||| S:1937 E:1940 ||| IN
cell  ||| S:1940 E:1945 ||| NN
density ||| S:1945 E:1952 ||| NN
.  ||| S:1952 E:1962 ||| .
However ||| S:1962 E:1969 ||| RB
,  ||| S:1969 E:1971 ||| ,
we  ||| S:1971 E:1974 ||| PRP
have  ||| S:1974 E:1979 ||| VBP
previously  ||| S:1979 E:1990 ||| RB
noted  ||| S:1990 E:1996 ||| VBD
that  ||| S:1996 E:2001 ||| IN
the  ||| S:2001 E:2005 ||| DT
Tag  ||| S:2005 E:2009 ||| NNP
increased  ||| S:2009 E:2027 ||| VBD
in  ||| S:2027 E:2030 ||| IN
Tag-transformed  ||| S:2030 E:2046 ||| NNP
NIH  ||| S:2046 E:2050 ||| NNP
3T3  ||| S:2050 E:2054 ||| NNP
cells  ||| S:2054 E:2060 ||| NNS
as  ||| S:2060 E:2063 ||| IN
the  ||| S:2063 E:2067 ||| DT
population  ||| S:2067 E:2078 ||| NN
became  ||| S:2078 E:2093 ||| VBD
more  ||| S:2093 E:2098 ||| RBR
dense  ||| S:2098 E:2104 ||| JJ
and  ||| S:2104 E:2108 ||| CC
the  ||| S:2108 E:2112 ||| DT
cell  ||| S:2112 E:2117 ||| NN
cycle  ||| S:2117 E:2123 ||| NN
time  ||| S:2123 E:2128 ||| NN
increased  ||| S:2128 E:2138 ||| VBN
during  ||| S:2138 E:2153 ||| IN
exponential  ||| S:2153 E:2165 ||| JJ
growth  ||| S:2165 E:2172 ||| NN
[  ||| S:2172 E:2174 ||| -LRB-
11  ||| S:2174 E:2177 ||| CD
]  ||| S:2177 E:2179 ||| -RRB-
.  ||| S:2179 E:2181 ||| .
For  ||| S:2181 E:2185 ||| IN
some  ||| S:2185 E:2190 ||| DT
cell  ||| S:2190 E:2195 ||| NN
types ||| S:2195 E:2200 ||| NNS
,  ||| S:2200 E:2202 ||| ,
like  ||| S:2202 E:2215 ||| IN
fibroblasts  ||| S:2215 E:2227 ||| NN
and  ||| S:2227 E:2231 ||| CC
lymphocytes ||| S:2231 E:2242 ||| NN
,  ||| S:2242 E:2244 ||| ,
G  ||| S:2244 E:2255 ||| NNP
0  ||| S:2255 E:2257 ||| CD
cells  ||| S:2257 E:2263 ||| NNS
have  ||| S:2263 E:2268 ||| VBP
less  ||| S:2268 E:2273 ||| JJR
cell  ||| S:2273 E:2278 ||| NN
mass  ||| S:2278 E:2283 ||| NN
than  ||| S:2283 E:2288 ||| IN
cycling  ||| S:2288 E:2304 ||| JJ
cells ||| S:2304 E:2309 ||| NNS
,  ||| S:2309 E:2311 ||| ,
and  ||| S:2311 E:2315 ||| CC
one  ||| S:2315 E:2319 ||| PRP
might  ||| S:2319 E:2325 ||| MD
expect  ||| S:2325 E:2332 ||| VB
that  ||| S:2332 E:2337 ||| IN
Tag  ||| S:2337 E:2341 ||| NNP
expression  ||| S:2341 E:2352 ||| NN
would  ||| S:2352 E:2366 ||| MD
decrease  ||| S:2366 E:2375 ||| VB
as  ||| S:2375 E:2378 ||| IN
the  ||| S:2378 E:2382 ||| DT
G  ||| S:2382 E:2393 ||| NNP
1  ||| S:2393 E:2395 ||| CD
phase  ||| S:2395 E:2401 ||| NN
of  ||| S:2401 E:2404 ||| IN
the  ||| S:2404 E:2408 ||| DT
cycle  ||| S:2408 E:2414 ||| NN
lengthened  ||| S:2414 E:2425 ||| NNS
and  ||| S:2425 E:2437 ||| CC
cells  ||| S:2437 E:2443 ||| NNS
achieved  ||| S:2443 E:2452 ||| VBN
confluence ||| S:2452 E:2462 ||| NN
.  ||| S:2462 E:2464 ||| .
Since  ||| S:2464 E:2470 ||| IN
Tag  ||| S:2470 E:2474 ||| NNP
did  ||| S:2474 E:2478 ||| VBD
not  ||| S:2478 E:2482 ||| RB
decrease  ||| S:2482 E:2499 ||| VB
simultaneously  ||| S:2499 E:2514 ||| RB
with  ||| S:2514 E:2519 ||| IN
an  ||| S:2519 E:2522 ||| DT
increasing  ||| S:2522 E:2533 ||| VBG
G  ||| S:2533 E:2544 ||| NNP
1  ||| S:2544 E:2546 ||| CD
time ||| S:2546 E:2550 ||| NN
,  ||| S:2550 E:2552 ||| ,
and  ||| S:2552 E:2556 ||| CC
since  ||| S:2556 E:2562 ||| IN
Tag  ||| S:2562 E:2566 ||| NNP
was  ||| S:2566 E:2570 ||| VBD
one  ||| S:2570 E:2574 ||| CD
of  ||| S:2574 E:2577 ||| IN
the  ||| S:2577 E:2581 ||| DT
G  ||| S:2581 E:2592 ||| NNP
1  ||| S:2592 E:2594 ||| CD
rate-limiting  ||| S:2594 E:2608 ||| JJ
molecules ||| S:2608 E:2617 ||| NNS
,  ||| S:2617 E:2619 ||| ,
the  ||| S:2619 E:2623 ||| DT
activity  ||| S:2623 E:2640 ||| NN
of  ||| S:2640 E:2643 ||| IN
Tag  ||| S:2643 E:2647 ||| NNP
must  ||| S:2647 E:2652 ||| MD
have  ||| S:2652 E:2657 ||| VB
been  ||| S:2657 E:2662 ||| VBN
decreasing  ||| S:2662 E:2673 ||| VBG
while  ||| S:2673 E:2679 ||| IN
Tag  ||| S:2679 E:2683 ||| NNP
levels  ||| S:2683 E:2698 ||| NNS
increased ||| S:2698 E:2707 ||| VBD
.  ||| S:2707 E:2709 ||| .
Thus ||| S:2709 E:2713 ||| RB
,  ||| S:2713 E:2715 ||| ,
negative  ||| S:2715 E:2724 ||| JJ
control  ||| S:2724 E:2732 ||| NN
of  ||| S:2732 E:2735 ||| IN
the  ||| S:2735 E:2739 ||| DT
cell  ||| S:2739 E:2744 ||| NN
cycle  ||| S:2744 E:2750 ||| NN
as  ||| S:2750 E:2753 ||| IN
a  ||| S:2753 E:2763 ||| DT
function  ||| S:2763 E:2772 ||| NN
of  ||| S:2772 E:2775 ||| IN
cell  ||| S:2775 E:2780 ||| NN
density  ||| S:2780 E:2788 ||| NN
was  ||| S:2788 E:2792 ||| VBD
dominant  ||| S:2792 E:2801 ||| JJ
to  ||| S:2801 E:2804 ||| TO
the  ||| S:2804 E:2808 ||| DT
activity  ||| S:2808 E:2817 ||| NN
of  ||| S:2817 E:2828 ||| IN
Tag ||| S:2828 E:2831 ||| NNP
.  ||| S:2831 E:2833 ||| .
Though  ||| S:2833 E:2840 ||| IN
the  ||| S:2840 E:2844 ||| DT
Tag-transformed  ||| S:2844 E:2860 ||| JJ
NIH-3T3  ||| S:2860 E:2868 ||| CD
cells  ||| S:2868 E:2874 ||| NNS
could  ||| S:2874 E:2880 ||| MD
not  ||| S:2880 E:2892 ||| RB
maintain  ||| S:2892 E:2901 ||| VB
a  ||| S:2901 E:2903 ||| DT
monolayer  ||| S:2903 E:2913 ||| NN
at  ||| S:2913 E:2916 ||| IN
confluence  ||| S:2916 E:2927 ||| NNS
( ||| S:2927 E:2928 ||| -LRB-
did  ||| S:2928 E:2932 ||| VBD
not  ||| S:2932 E:2936 ||| RB
enter  ||| S:2936 E:2942 ||| VB
G  ||| S:2942 E:2953 ||| NNP
0  ||| S:2953 E:2955 ||| CD
)  ||| S:2955 E:2957 ||| -RRB-
during  ||| S:2957 E:2964 ||| IN
the  ||| S:2964 E:2968 ||| DT
plateau  ||| S:2968 E:2976 ||| NN
phase  ||| S:2976 E:2982 ||| NN
of  ||| S:2982 E:2985 ||| IN
growth ||| S:2985 E:2991 ||| NN
,  ||| S:2991 E:3001 ||| ,
it  ||| S:3001 E:3004 ||| PRP
was  ||| S:3004 E:3008 ||| VBD
expected  ||| S:3008 E:3017 ||| VBN
that  ||| S:3017 E:3022 ||| IN
expression  ||| S:3022 E:3033 ||| NN
would  ||| S:3033 E:3039 ||| MD
eventually  ||| S:3039 E:3050 ||| RB
plateau  ||| S:3050 E:3058 ||| JJ
or  ||| S:3058 E:3069 ||| CC
decrease ||| S:3069 E:3077 ||| NN
.  ||| S:3077 E:3087 ||| .
The  ||| S:3087 E:3091 ||| DT
purpose  ||| S:3091 E:3099 ||| NN
for  ||| S:3099 E:3103 ||| IN
this  ||| S:3103 E:3108 ||| DT
study  ||| S:3108 E:3114 ||| NN
was  ||| S:3114 E:3118 ||| VBD
to  ||| S:3118 E:3121 ||| TO
explore  ||| S:3121 E:3129 ||| VB
further  ||| S:3129 E:3137 ||| RBR
the  ||| S:3137 E:3149 ||| DT
relationship  ||| S:3149 E:3162 ||| NN
between  ||| S:3162 E:3170 ||| IN
Tag  ||| S:3170 E:3174 ||| NNP
expression  ||| S:3174 E:3185 ||| NN
as  ||| S:3185 E:3188 ||| IN
a  ||| S:3188 E:3190 ||| DT
function  ||| S:3190 E:3199 ||| NN
of  ||| S:3199 E:3202 ||| IN
cell  ||| S:3202 E:3215 ||| NN
cycle  ||| S:3215 E:3221 ||| NN
time  ||| S:3221 E:3226 ||| NN
and  ||| S:3226 E:3230 ||| CC
cell  ||| S:3230 E:3235 ||| NN
density ||| S:3235 E:3242 ||| NN
.  ||| S:3242 E:3244 ||| .
We  ||| S:3244 E:3247 ||| PRP
asked  ||| S:3247 E:3253 ||| VBD
whether  ||| S:3253 E:3261 ||| IN
Tag  ||| S:3261 E:3273 ||| NNP
expression  ||| S:3273 E:3284 ||| NN
in  ||| S:3284 E:3287 ||| IN
immortalized  ||| S:3287 E:3300 ||| JJ
mouse  ||| S:3300 E:3306 ||| NN
cells  ||| S:3306 E:3312 ||| NNS
always  ||| S:3312 E:3319 ||| RB
increased  ||| S:3319 E:3329 ||| VBN
as  ||| S:3329 E:3340 ||| IN
a  ||| S:3340 E:3342 ||| DT
function  ||| S:3342 E:3351 ||| NN
of  ||| S:3351 E:3354 ||| IN
G  ||| S:3354 E:3365 ||| NNP
1  ||| S:3365 E:3367 ||| CD
time  ||| S:3367 E:3372 ||| NN
during  ||| S:3372 E:3379 ||| IN
exponential  ||| S:3379 E:3391 ||| JJ
growth  ||| S:3391 E:3398 ||| NN
and  ||| S:3398 E:3410 ||| CC
whether  ||| S:3410 E:3418 ||| IN
levels  ||| S:3418 E:3425 ||| NNS
eventually  ||| S:3425 E:3436 ||| RB
decreased  ||| S:3436 E:3446 ||| VBN
or  ||| S:3446 E:3449 ||| CC
achieved  ||| S:3449 E:3458 ||| VBD
a  ||| S:3458 E:3460 ||| DT
steady  ||| S:3460 E:3475 ||| JJ
state  ||| S:3475 E:3481 ||| NN
level  ||| S:3481 E:3487 ||| NN
at  ||| S:3487 E:3490 ||| IN
high  ||| S:3490 E:3495 ||| JJ
cell  ||| S:3495 E:3500 ||| NN
density ||| S:3500 E:3507 ||| NN
.  ||| S:3507 E:3509 ||| .
The  ||| S:3509 E:3513 ||| DT
advantage  ||| S:3513 E:3523 ||| NN
to  ||| S:3523 E:3526 ||| TO
using  ||| S:3526 E:3540 ||| VBG
astrocyte  ||| S:3540 E:3550 ||| JJ
lines  ||| S:3550 E:3556 ||| NNS
is  ||| S:3556 E:3559 ||| VBZ
that  ||| S:3559 E:3564 ||| DT
many  ||| S:3564 E:3569 ||| JJ
of  ||| S:3569 E:3572 ||| IN
these  ||| S:3572 E:3578 ||| DT
lines  ||| S:3578 E:3584 ||| NNS
can  ||| S:3584 E:3588 ||| MD
maintain  ||| S:3588 E:3597 ||| VB
a  ||| S:3597 E:3607 ||| DT
monolayer  ||| S:3607 E:3617 ||| NN
in  ||| S:3617 E:3620 ||| IN
culture  ||| S:3620 E:3628 ||| NN
for  ||| S:3628 E:3632 ||| IN
long  ||| S:3632 E:3637 ||| JJ
periods  ||| S:3637 E:3645 ||| NNS
of  ||| S:3645 E:3648 ||| IN
time  ||| S:3648 E:3653 ||| NN
[  ||| S:3653 E:3655 ||| -LRB-
6  ||| S:3655 E:3657 ||| CD
]  ||| S:3657 E:3659 ||| -RRB-
.  ||| S:3659 E:3661 ||| .
Since  ||| S:3661 E:3675 ||| IN
Tag  ||| S:3675 E:3679 ||| NNP
levels  ||| S:3679 E:3686 ||| NNS
are  ||| S:3686 E:3690 ||| VBP
significantly  ||| S:3690 E:3704 ||| RB
determined  ||| S:3704 E:3715 ||| VBN
by  ||| S:3715 E:3718 ||| IN
the  ||| S:3718 E:3722 ||| DT
strength  ||| S:3722 E:3731 ||| NN
of  ||| S:3731 E:3742 ||| IN
the  ||| S:3742 E:3746 ||| DT
transcription  ||| S:3746 E:3760 ||| JJ
promoter  ||| S:3760 E:3769 ||| NN
in  ||| S:3769 E:3772 ||| IN
this  ||| S:3772 E:3777 ||| DT
retroviral  ||| S:3777 E:3788 ||| JJ
system  ||| S:3788 E:3795 ||| NN
[  ||| S:3795 E:3797 ||| -LRB-
1  ||| S:3797 E:3799 ||| CD
11  ||| S:3799 E:3810 ||| CD
]  ||| S:3810 E:3812 ||| -RRB-
,  ||| S:3812 E:3814 ||| ,
we  ||| S:3814 E:3817 ||| PRP
examined  ||| S:3817 E:3826 ||| VBD
cell  ||| S:3826 E:3831 ||| NN
lines  ||| S:3831 E:3837 ||| NNS
immortalized  ||| S:3837 E:3850 ||| VBN
by  ||| S:3850 E:3853 ||| IN
Tag  ||| S:3853 E:3857 ||| NNP
transcribed  ||| S:3857 E:3877 ||| NN
from  ||| S:3877 E:3882 ||| IN
two  ||| S:3882 E:3886 ||| CD
different  ||| S:3886 E:3896 ||| JJ
promoters ||| S:3896 E:3905 ||| NNS
.  ||| S:3905 E:3907 ||| .
In  ||| S:3907 E:3910 ||| IN
the  ||| S:3910 E:3914 ||| DT
analysis  ||| S:3914 E:3923 ||| NN
of  ||| S:3923 E:3926 ||| IN
these  ||| S:3926 E:3940 ||| DT
data ||| S:3940 E:3944 ||| NNS
,  ||| S:3944 E:3946 ||| ,
we  ||| S:3946 E:3949 ||| PRP
( ||| S:3949 E:3950 ||| -LRB-
1 ||| S:3950 E:3951 ||| LS
)  ||| S:3951 E:3953 ||| -RRB-
explored  ||| S:3953 E:3962 ||| VBZ
the  ||| S:3962 E:3966 ||| DT
relationship  ||| S:3966 E:3979 ||| NN
between  ||| S:3979 E:3987 ||| IN
expression ||| S:3987 E:3997 ||| NN
,  ||| S:3997 E:4007 ||| ,
G  ||| S:4007 E:4018 ||| NNP
1  ||| S:4018 E:4020 ||| CD
phase  ||| S:4020 E:4026 ||| NN
time ||| S:4026 E:4030 ||| NN
,  ||| S:4030 E:4032 ||| ,
and  ||| S:4032 E:4036 ||| CC
cell  ||| S:4036 E:4041 ||| NN
density ||| S:4041 E:4048 ||| NN
,  ||| S:4048 E:4050 ||| ,
( ||| S:4050 E:4051 ||| -LRB-
2 ||| S:4051 E:4052 ||| LS
)  ||| S:4052 E:4062 ||| -RRB-
asked  ||| S:4062 E:4068 ||| VBD
whether  ||| S:4068 E:4076 ||| IN
the  ||| S:4076 E:4080 ||| DT
transcriptional  ||| S:4080 E:4096 ||| JJ
promoter  ||| S:4096 E:4105 ||| NN
affected  ||| S:4105 E:4114 ||| VBD
those  ||| S:4114 E:4128 ||| DT
relationships ||| S:4128 E:4141 ||| NNS
,  ||| S:4141 E:4143 ||| ,
( ||| S:4143 E:4144 ||| -LRB-
3 ||| S:4144 E:4145 ||| LS
)  ||| S:4145 E:4147 ||| -RRB-
explored  ||| S:4147 E:4156 ||| JJ
analytical  ||| S:4156 E:4167 ||| JJ
methods  ||| S:4167 E:4175 ||| NNS
for  ||| S:4175 E:4187 ||| IN
describing  ||| S:4187 E:4198 ||| VBG
expression  ||| S:4198 E:4209 ||| NN
within  ||| S:4209 E:4216 ||| IN
the  ||| S:4216 E:4220 ||| DT
context  ||| S:4220 E:4228 ||| NN
of  ||| S:4228 E:4231 ||| IN
these  ||| S:4231 E:4245 ||| DT
relationships ||| S:4245 E:4258 ||| NNS
,  ||| S:4258 E:4260 ||| ,
and  ||| S:4260 E:4264 ||| CC
( ||| S:4264 E:4265 ||| -LRB-
4 ||| S:4265 E:4266 ||| LS
)  ||| S:4266 E:4268 ||| -RRB-
asked  ||| S:4268 E:4274 ||| VBD
whether  ||| S:4274 E:4282 ||| IN
the  ||| S:4282 E:4286 ||| DT
"intrinsic  ||| S:4286 E:4305 ||| JJ
expression  ||| S:4305 E:4316 ||| NN
potential ||| S:4316 E:4325 ||| NN
"  ||| S:4325 E:4327 ||| ''
of  ||| S:4327 E:4330 ||| IN
Tag  ||| S:4330 E:4334 ||| NNP
affected  ||| S:4334 E:4343 ||| VBD
Tag  ||| S:4343 E:4347 ||| NNP
expression  ||| S:4347 E:4358 ||| NN
at  ||| S:4358 E:4369 ||| IN
high  ||| S:4369 E:4374 ||| JJ
cell  ||| S:4374 E:4379 ||| NN
density ||| S:4379 E:4386 ||| NN
.  ||| S:4386 E:4388 ||| .
The  ||| S:4388 E:4392 ||| DT
results  ||| S:4392 E:4400 ||| NNS
of  ||| S:4400 E:4403 ||| IN
this  ||| S:4403 E:4408 ||| DT
study  ||| S:4408 E:4414 ||| NN
have  ||| S:4414 E:4419 ||| VBP
practical  ||| S:4419 E:4437 ||| JJ
implications  ||| S:4437 E:4450 ||| NNS
for  ||| S:4450 E:4454 ||| IN
the  ||| S:4454 E:4458 ||| DT
use  ||| S:4458 E:4462 ||| NN
of  ||| S:4462 E:4465 ||| IN
cell  ||| S:4465 E:4470 ||| NN
lines  ||| S:4470 E:4476 ||| NNS
as  ||| S:4476 E:4479 ||| IN
standards  ||| S:4479 E:4489 ||| NNS
in  ||| S:4489 E:4500 ||| IN
quantitative  ||| S:4500 E:4513 ||| JJ
assays  ||| S:4513 E:4520 ||| NN
of  ||| S:4520 E:4523 ||| IN
gene  ||| S:4523 E:4528 ||| NN
expression  ||| S:4528 E:4539 ||| NN
[ ||| S:4539 E:4540 ||| -LRB-
e.g. ||| S:4540 E:4544 ||| NNP
,  ||| S:4544 E:4546 ||| ,
[  ||| S:4546 E:4548 ||| -LRB-
3  ||| S:4548 E:4550 ||| LS
]  ||| S:4550 E:4552 ||| -RRB-
] ||| S:4552 E:4553 ||| -RRB-
.  ||| S:4553 E:4577 ||| .
Results  ||| S:4577 E:4604 ||| NNP
Characterization  ||| S:4604 E:4621 ||| NNP
of  ||| S:4621 E:4624 ||| IN
tkT  ||| S:4624 E:4628 ||| JJ
lines  ||| S:4628 E:4644 ||| NNS
We  ||| S:4644 E:4647 ||| PRP
have  ||| S:4647 E:4652 ||| VBP
previously  ||| S:4652 E:4663 ||| RB
characterized  ||| S:4663 E:4677 ||| VBN
clonal  ||| S:4677 E:4684 ||| JJ
mouse  ||| S:4684 E:4700 ||| NN
astrocyte  ||| S:4700 E:4710 ||| NN
cell  ||| S:4710 E:4715 ||| NN
lines ||| S:4715 E:4720 ||| NNS
,  ||| S:4720 E:4722 ||| ,
immortalized  ||| S:4722 E:4735 ||| VBG
by  ||| S:4735 E:4738 ||| IN
transduction  ||| S:4738 E:4751 ||| NN
of  ||| S:4751 E:4764 ||| IN
SV40  ||| S:4764 E:4769 ||| CD
large  ||| S:4769 E:4775 ||| JJ
T  ||| S:4775 E:4777 ||| NN
antigen  ||| S:4777 E:4785 ||| VBZ
expressed  ||| S:4785 E:4795 ||| VBN
from  ||| S:4795 E:4800 ||| IN
the  ||| S:4800 E:4804 ||| DT
MoMuLV  ||| S:4804 E:4811 ||| JJ
LTR  ||| S:4811 E:4815 ||| NNP
[  ||| S:4815 E:4817 ||| -LRB-
6  ||| S:4817 E:4819 ||| CD
13  ||| S:4819 E:4832 ||| CD
]  ||| S:4832 E:4834 ||| -RRB-
.  ||| S:4834 E:4836 ||| .
Here ||| S:4836 E:4840 ||| RB
,  ||| S:4840 E:4842 ||| ,
we  ||| S:4842 E:4845 ||| PRP
compare  ||| S:4845 E:4853 ||| VBP
variation  ||| S:4853 E:4863 ||| VBN
in  ||| S:4863 E:4866 ||| IN
Tag  ||| S:4866 E:4870 ||| NNP
levels  ||| S:4870 E:4877 ||| NNS
in  ||| S:4877 E:4880 ||| IN
3  ||| S:4880 E:4882 ||| CD
of  ||| S:4882 E:4895 ||| IN
these  ||| S:4895 E:4901 ||| DT
lines  ||| S:4901 E:4907 ||| NNS
and  ||| S:4907 E:4911 ||| CC
3  ||| S:4911 E:4913 ||| CD
additional  ||| S:4913 E:4924 ||| JJ
lines  ||| S:4924 E:4930 ||| NNS
( ||| S:4930 E:4931 ||| -LRB-
termed  ||| S:4931 E:4938 ||| VBN
tkT  ||| S:4938 E:4942 ||| JJ
lines ||| S:4942 E:4947 ||| NNS
) ||| S:4947 E:4948 ||| -RRB-
,  ||| S:4948 E:4960 ||| ,
immortalized  ||| S:4960 E:4973 ||| VBG
with  ||| S:4973 E:4978 ||| IN
Moloney  ||| S:4978 E:4986 ||| NNP
Sarcoma  ||| S:4986 E:4994 ||| NNP
Virus  ||| S:4994 E:5000 ||| NNP
vectors  ||| S:5000 E:5018 ||| VBZ
expressing  ||| S:5018 E:5029 ||| VBG
Tag  ||| S:5029 E:5033 ||| NNP
from  ||| S:5033 E:5038 ||| IN
an  ||| S:5038 E:5041 ||| DT
internal  ||| S:5041 E:5050 ||| JJ
herpes  ||| S:5050 E:5057 ||| FW
thymidine  ||| S:5057 E:5067 ||| FW
kinase  ||| S:5067 E:5084 ||| FW
( ||| S:5084 E:5085 ||| -LRB-
tk ||| S:5085 E:5087 ||| LS
)  ||| S:5087 E:5089 ||| -RRB-
promoter ||| S:5089 E:5097 ||| NN
.  ||| S:5097 E:5099 ||| .
The  ||| S:5099 E:5103 ||| DT
astrocyte  ||| S:5103 E:5113 ||| JJ
lineage  ||| S:5113 E:5121 ||| NN
of  ||| S:5121 E:5124 ||| IN
the  ||| S:5124 E:5128 ||| DT
LTR  ||| S:5128 E:5132 ||| NNP
lines  ||| S:5132 E:5138 ||| NNS
has  ||| S:5138 E:5152 ||| VBZ
been  ||| S:5152 E:5157 ||| VBN
published  ||| S:5157 E:5167 ||| VBN
[  ||| S:5167 E:5169 ||| -LRB-
6  ||| S:5169 E:5171 ||| CD
13  ||| S:5171 E:5174 ||| CD
]  ||| S:5174 E:5176 ||| -RRB-
.  ||| S:5176 E:5178 ||| .
The  ||| S:5178 E:5182 ||| DT
astrocyte  ||| S:5182 E:5192 ||| JJ
lineage  ||| S:5192 E:5200 ||| NN
of  ||| S:5200 E:5203 ||| IN
the  ||| S:5203 E:5217 ||| DT
tkT  ||| S:5217 E:5221 ||| JJ
lines  ||| S:5221 E:5227 ||| NNS
was  ||| S:5227 E:5231 ||| VBD
confirmed  ||| S:5231 E:5241 ||| VBN
by  ||| S:5241 E:5244 ||| IN
the  ||| S:5244 E:5248 ||| DT
presence  ||| S:5248 E:5257 ||| NN
of  ||| S:5257 E:5260 ||| IN
the  ||| S:5260 E:5274 ||| DT
astrocyte-specific  ||| S:5274 E:5293 ||| JJ
intermediate  ||| S:5293 E:5306 ||| JJ
filament  ||| S:5306 E:5315 ||| JJ
protein ||| S:5315 E:5322 ||| NN
,  ||| S:5322 E:5324 ||| ,
GFAP  ||| S:5324 E:5329 ||| NNP
[  ||| S:5329 E:5341 ||| -LRB-
14  ||| S:5341 E:5344 ||| CD
]  ||| S:5344 E:5346 ||| -RRB-
( ||| S:5346 E:5347 ||| -LRB-
Figure  ||| S:5347 E:5354 ||| NNP
1 ||| S:5354 E:5355 ||| CD
) ||| S:5355 E:5356 ||| -RRB-
.  ||| S:5356 E:5358 ||| .
All  ||| S:5358 E:5362 ||| DT
of  ||| S:5362 E:5365 ||| IN
the  ||| S:5365 E:5369 ||| DT
lines  ||| S:5369 E:5375 ||| NNS
contained  ||| S:5375 E:5385 ||| VBD
GFAP ||| S:5385 E:5389 ||| NNP
,  ||| S:5389 E:5391 ||| ,
whereas  ||| S:5391 E:5409 ||| IN
NIH  ||| S:5409 E:5413 ||| NNP
3T3  ||| S:5413 E:5417 ||| NNP
cells  ||| S:5417 E:5423 ||| NNS
treated  ||| S:5423 E:5431 ||| VBN
with  ||| S:5431 E:5436 ||| IN
dibutyryl  ||| S:5436 E:5446 ||| JJ
cAMP  ||| S:5446 E:5451 ||| NN
at  ||| S:5451 E:5454 ||| IN
the  ||| S:5454 E:5458 ||| DT
same  ||| S:5458 E:5473 ||| JJ
level  ||| S:5473 E:5479 ||| NN
as  ||| S:5479 E:5482 ||| IN
the  ||| S:5482 E:5486 ||| DT
astrocyte  ||| S:5486 E:5496 ||| JJ
lines  ||| S:5496 E:5502 ||| NNS
did  ||| S:5502 E:5506 ||| VBD
not ||| S:5506 E:5509 ||| RB
.  ||| S:5509 E:5539 ||| .
Expression  ||| S:5539 E:5550 ||| NN
of  ||| S:5550 E:5553 ||| IN
Tag  ||| S:5553 E:5567 ||| NNP
To  ||| S:5567 E:5570 ||| TO
determine  ||| S:5570 E:5580 ||| VB
the  ||| S:5580 E:5584 ||| DT
Tag  ||| S:5584 E:5588 ||| JJ
expression  ||| S:5588 E:5599 ||| NN
of  ||| S:5599 E:5602 ||| IN
each  ||| S:5602 E:5607 ||| DT
cell  ||| S:5607 E:5612 ||| NN
line  ||| S:5612 E:5617 ||| NN
at  ||| S:5617 E:5620 ||| IN
a  ||| S:5620 E:5632 ||| DT
single  ||| S:5632 E:5639 ||| JJ
density  ||| S:5639 E:5647 ||| NN
and  ||| S:5647 E:5651 ||| CC
validate  ||| S:5651 E:5660 ||| JJ
cytometric  ||| S:5660 E:5671 ||| JJ
measurements ||| S:5671 E:5683 ||| NNS
,  ||| S:5683 E:5695 ||| ,
Western  ||| S:5695 E:5703 ||| JJ
blotting  ||| S:5703 E:5712 ||| NN
was  ||| S:5712 E:5716 ||| VBD
performed  ||| S:5716 E:5726 ||| VBN
on  ||| S:5726 E:5729 ||| IN
all  ||| S:5729 E:5733 ||| DT
cell  ||| S:5733 E:5738 ||| NN
lines  ||| S:5738 E:5744 ||| NNS
and  ||| S:5744 E:5758 ||| CC
compared  ||| S:5758 E:5767 ||| VBN
to  ||| S:5767 E:5770 ||| TO
purified ||| S:5770 E:5778 ||| VB
,  ||| S:5778 E:5780 ||| ,
recombinant  ||| S:5780 E:5792 ||| JJ
Tag  ||| S:5792 E:5796 ||| NNP
( ||| S:5796 E:5797 ||| -LRB-
Figure  ||| S:5797 E:5804 ||| NNP
2A ||| S:5804 E:5806 ||| NNP
) ||| S:5806 E:5807 ||| -RRB-
.  ||| S:5807 E:5819 ||| .
Lysates  ||| S:5819 E:5827 ||| NNP
from  ||| S:5827 E:5832 ||| IN
equal  ||| S:5832 E:5838 ||| JJ
numbers  ||| S:5838 E:5846 ||| NNS
of  ||| S:5846 E:5849 ||| IN
cells  ||| S:5849 E:5855 ||| NNS
were  ||| S:5855 E:5860 ||| VBD
loaded  ||| S:5860 E:5867 ||| VBN
on  ||| S:5867 E:5870 ||| IN
the  ||| S:5870 E:5884 ||| DT
electrophoresis  ||| S:5884 E:5900 ||| JJ
gel  ||| S:5900 E:5904 ||| NN
with  ||| S:5904 E:5909 ||| IN
the  ||| S:5909 E:5913 ||| DT
exception  ||| S:5913 E:5923 ||| NN
of  ||| S:5923 E:5926 ||| IN
P0-13D  ||| S:5926 E:5933 ||| CD
tkT ||| S:5933 E:5936 ||| JJ
# ||| S:5936 E:5937 ||| #
13 ||| S:5937 E:5939 ||| CD
,  ||| S:5939 E:5951 ||| ,
which  ||| S:5951 E:5957 ||| WDT
expressed  ||| S:5957 E:5967 ||| VBD
the  ||| S:5967 E:5971 ||| DT
lowest  ||| S:5971 E:5978 ||| JJS
levels  ||| S:5978 E:5985 ||| NNS
of  ||| S:5985 E:5988 ||| IN
Tag ||| S:5988 E:5991 ||| NNP
.  ||| S:5991 E:5993 ||| .
This  ||| S:5993 E:5998 ||| DT
lysate  ||| S:5998 E:6005 ||| NN
was  ||| S:6005 E:6019 ||| VBD
loaded  ||| S:6019 E:6026 ||| VBN
at  ||| S:6026 E:6029 ||| IN
a  ||| S:6029 E:6031 ||| DT
2-fold  ||| S:6031 E:6038 ||| CD
higher  ||| S:6038 E:6045 ||| JJR
cell  ||| S:6045 E:6050 ||| NN
number ||| S:6050 E:6056 ||| NN
.  ||| S:6056 E:6058 ||| .
Protein  ||| S:6058 E:6066 ||| NN
levels  ||| S:6066 E:6073 ||| NNS
of  ||| S:6073 E:6086 ||| IN
each  ||| S:6086 E:6091 ||| DT
sample  ||| S:6091 E:6098 ||| NN
and  ||| S:6098 E:6102 ||| CC
the  ||| S:6102 E:6106 ||| DT
recombinant  ||| S:6106 E:6118 ||| JJ
Tag  ||| S:6118 E:6122 ||| NNP
were  ||| S:6122 E:6127 ||| VBD
adjusted  ||| S:6127 E:6136 ||| VBN
to  ||| S:6136 E:6149 ||| TO
equality  ||| S:6149 E:6158 ||| VB
by  ||| S:6158 E:6161 ||| IN
the  ||| S:6161 E:6165 ||| DT
addition  ||| S:6165 E:6174 ||| NN
of  ||| S:6174 E:6177 ||| IN
NIH  ||| S:6177 E:6181 ||| NNP
3T3  ||| S:6181 E:6185 ||| NNP
cell  ||| S:6185 E:6190 ||| NN
extract ||| S:6190 E:6197 ||| NN
.  ||| S:6197 E:6199 ||| .
The  ||| S:6199 E:6213 ||| DT
presence  ||| S:6213 E:6222 ||| NN
of  ||| S:6222 E:6225 ||| IN
equal  ||| S:6225 E:6231 ||| JJ
protein  ||| S:6231 E:6239 ||| NN
levels  ||| S:6239 E:6246 ||| NNS
in  ||| S:6246 E:6249 ||| IN
each  ||| S:6249 E:6254 ||| DT
lane  ||| S:6254 E:6259 ||| NN
was  ||| S:6259 E:6273 ||| VBD
confirmed  ||| S:6273 E:6283 ||| VBN
by  ||| S:6283 E:6286 ||| IN
staining  ||| S:6286 E:6295 ||| VBG
the  ||| S:6295 E:6299 ||| DT
blotted  ||| S:6299 E:6307 ||| JJ
gel  ||| S:6307 E:6311 ||| NN
with  ||| S:6311 E:6316 ||| IN
Coomassie  ||| S:6316 E:6326 ||| NNP
blue  ||| S:6326 E:6341 ||| JJ
and  ||| S:6341 E:6345 ||| CC
performing  ||| S:6345 E:6356 ||| VBG
densitometry ||| S:6356 E:6368 ||| NNS
.  ||| S:6368 E:6370 ||| .
The  ||| S:6370 E:6374 ||| DT
protein  ||| S:6374 E:6382 ||| NN
levels  ||| S:6382 E:6389 ||| NNS
were  ||| S:6389 E:6394 ||| VBD
not  ||| S:6394 E:6408 ||| RB
significantly  ||| S:6408 E:6422 ||| RB
different  ||| S:6422 E:6432 ||| JJ
( ||| S:6432 E:6433 ||| -LRB-
coefficient  ||| S:6433 E:6445 ||| NN
of  ||| S:6445 E:6448 ||| IN
variation  ||| S:6448 E:6458 ||| NN
( ||| S:6458 E:6459 ||| -LRB-
CV ||| S:6459 E:6461 ||| NNP
)  ||| S:6461 E:6463 ||| -RRB-
of  ||| S:6463 E:6476 ||| IN
< ||| S:6476 E:6478 ||| SYM
9 ||| S:6478 E:6479 ||| CD
% ||| S:6479 E:6480 ||| NN
) ||| S:6480 E:6481 ||| -RRB-
.  ||| S:6481 E:6483 ||| .
Tag  ||| S:6483 E:6487 ||| NN
in  ||| S:6487 E:6490 ||| IN
the  ||| S:6490 E:6494 ||| DT
cell  ||| S:6494 E:6499 ||| NN
lines  ||| S:6499 E:6505 ||| NNS
migrated  ||| S:6505 E:6514 ||| VBN
at  ||| S:6514 E:6517 ||| IN
the  ||| S:6517 E:6521 ||| DT
correct  ||| S:6521 E:6539 ||| JJ
molecular  ||| S:6539 E:6549 ||| JJ
weight  ||| S:6549 E:6556 ||| NN
and  ||| S:6556 E:6560 ||| CC
cross-reacting  ||| S:6560 E:6575 ||| JJ
bands  ||| S:6575 E:6581 ||| NNS
were  ||| S:6581 E:6586 ||| VBD
not  ||| S:6586 E:6600 ||| RB
detected ||| S:6600 E:6608 ||| VBN
.  ||| S:6608 E:6610 ||| .
When  ||| S:6610 E:6615 ||| WRB
the  ||| S:6615 E:6619 ||| DT
Tag-specific  ||| S:6619 E:6632 ||| JJ
fluorescence  ||| S:6632 E:6645 ||| NNS
( ||| S:6645 E:6646 ||| -LRB-
all  ||| S:6646 E:6650 ||| DT
cell  ||| S:6650 E:6665 ||| NN
cycle  ||| S:6665 E:6671 ||| NN
phase  ||| S:6671 E:6677 ||| NN
fractions ||| S:6677 E:6686 ||| NNS
)  ||| S:6686 E:6688 ||| -RRB-
measured  ||| S:6688 E:6697 ||| VBN
by  ||| S:6697 E:6700 ||| IN
flow  ||| S:6700 E:6705 ||| NN
cytometry  ||| S:6705 E:6715 ||| NNS
was  ||| S:6715 E:6729 ||| VBD
compared  ||| S:6729 E:6738 ||| VBN
to  ||| S:6738 E:6741 ||| TO
the  ||| S:6741 E:6745 ||| DT
intensity  ||| S:6745 E:6755 ||| NN
of  ||| S:6755 E:6758 ||| IN
Western  ||| S:6758 E:6766 ||| JJ
blot  ||| S:6766 E:6771 ||| NNS
bands  ||| S:6771 E:6777 ||| VBP
measured  ||| S:6777 E:6796 ||| VBN
by  ||| S:6796 E:6799 ||| IN
densitometry ||| S:6799 E:6811 ||| NN
,  ||| S:6811 E:6813 ||| ,
the  ||| S:6813 E:6817 ||| DT
two  ||| S:6817 E:6821 ||| CD
measurements  ||| S:6821 E:6834 ||| NNS
showed  ||| S:6834 E:6841 ||| VBD
an  ||| S:6841 E:6854 ||| DT
essentially  ||| S:6854 E:6866 ||| RB
linear  ||| S:6866 E:6873 ||| JJ
relationship  ||| S:6873 E:6886 ||| NN
( ||| S:6886 E:6887 ||| -LRB-
Figure  ||| S:6887 E:6894 ||| NNP
2B ||| S:6894 E:6896 ||| NNP
) ||| S:6896 E:6897 ||| -RRB-
.  ||| S:6897 E:6899 ||| .
Therefore ||| S:6899 E:6908 ||| RB
,  ||| S:6908 E:6920 ||| ,
immunofluorescence  ||| S:6920 E:6939 ||| JJ
flow  ||| S:6939 E:6944 ||| NN
cytometry  ||| S:6944 E:6954 ||| NN
provides  ||| S:6954 E:6963 ||| VBZ
an  ||| S:6963 E:6966 ||| DT
unbiased  ||| S:6966 E:6985 ||| JJ
estimate  ||| S:6985 E:6994 ||| NN
of  ||| S:6994 E:6997 ||| IN
the  ||| S:6997 E:7001 ||| DT
relative  ||| S:7001 E:7010 ||| JJ
levels  ||| S:7010 E:7017 ||| NNS
of  ||| S:7017 E:7020 ||| IN
Tag  ||| S:7020 E:7024 ||| NNP
expression  ||| S:7024 E:7035 ||| NN
for  ||| S:7035 E:7039 ||| IN
the  ||| S:7039 E:7053 ||| DT
range  ||| S:7053 E:7059 ||| NN
of  ||| S:7059 E:7062 ||| IN
measurements  ||| S:7062 E:7075 ||| NNS
presented  ||| S:7075 E:7085 ||| VBN
in  ||| S:7085 E:7088 ||| IN
this  ||| S:7088 E:7093 ||| DT
paper ||| S:7093 E:7098 ||| NN
.  ||| S:7098 E:7128 ||| .
Effect  ||| S:7128 E:7135 ||| NN
of  ||| S:7135 E:7138 ||| IN
cell  ||| S:7138 E:7143 ||| NN
density  ||| S:7143 E:7151 ||| VBZ
related  ||| S:7151 E:7159 ||| VBN
cell  ||| S:7159 E:7164 ||| NN
cycle  ||| S:7164 E:7170 ||| NN
control  ||| S:7170 E:7188 ||| NN
on  ||| S:7188 E:7191 ||| IN
expression  ||| S:7191 E:7202 ||| NN
of  ||| S:7202 E:7205 ||| IN
Tag  ||| S:7205 E:7219 ||| NNP
A  ||| S:7219 E:7221 ||| NNP
priori ||| S:7221 E:7227 ||| FW
,  ||| S:7227 E:7229 ||| ,
one  ||| S:7229 E:7233 ||| PRP
might  ||| S:7233 E:7239 ||| MD
expect  ||| S:7239 E:7246 ||| VB
that  ||| S:7246 E:7251 ||| DT
most  ||| S:7251 E:7256 ||| JJS
cell  ||| S:7256 E:7261 ||| NN
cycle  ||| S:7261 E:7277 ||| NN
related  ||| S:7277 E:7285 ||| VBN
genes  ||| S:7285 E:7291 ||| NNS
will  ||| S:7291 E:7296 ||| MD
be  ||| S:7296 E:7299 ||| VB
less  ||| S:7299 E:7304 ||| RBR
expressed  ||| S:7304 E:7314 ||| VBN
in  ||| S:7314 E:7317 ||| IN
growth  ||| S:7317 E:7324 ||| NN
arrested ||| S:7324 E:7332 ||| VBN
,  ||| S:7332 E:7344 ||| ,
confluent ||| S:7344 E:7353 ||| NN
,  ||| S:7353 E:7355 ||| ,
or  ||| S:7355 E:7358 ||| CC
G  ||| S:7358 E:7371 ||| NNP
0  ||| S:7371 E:7373 ||| CD
cells  ||| S:7373 E:7379 ||| NNS
relative  ||| S:7379 E:7388 ||| JJ
to  ||| S:7388 E:7391 ||| TO
proliferating  ||| S:7391 E:7415 ||| VB
cultures  ||| S:7415 E:7424 ||| JJ
due  ||| S:7424 E:7428 ||| JJ
to  ||| S:7428 E:7431 ||| TO
a  ||| S:7431 E:7433 ||| DT
generalized  ||| S:7433 E:7445 ||| JJ
decrease  ||| S:7445 E:7454 ||| NN
in  ||| S:7454 E:7457 ||| IN
metabolic  ||| S:7457 E:7477 ||| JJ
activity ||| S:7477 E:7485 ||| NN
,  ||| S:7485 E:7487 ||| ,
cell  ||| S:7487 E:7492 ||| NN
protein  ||| S:7492 E:7500 ||| NN
content ||| S:7500 E:7507 ||| NN
,  ||| S:7507 E:7509 ||| ,
and  ||| S:7509 E:7513 ||| CC
cell  ||| S:7513 E:7518 ||| NN
size ||| S:7518 E:7522 ||| NN
.  ||| S:7522 E:7524 ||| .
However ||| S:7524 E:7531 ||| RB
,  ||| S:7531 E:7543 ||| ,
based  ||| S:7543 E:7549 ||| VBN
on  ||| S:7549 E:7552 ||| IN
unpublished  ||| S:7552 E:7564 ||| JJ
observations  ||| S:7564 E:7577 ||| NNS
and  ||| S:7577 E:7581 ||| CC
previous  ||| S:7581 E:7590 ||| JJ
work  ||| S:7590 E:7595 ||| NN
( ||| S:7595 E:7596 ||| -LRB-
see  ||| S:7596 E:7610 ||| VB
Introduction ||| S:7610 E:7622 ||| NNP
, ||| S:7622 E:7623 ||| ,
)  ||| S:7623 E:7625 ||| NNP
[  ||| S:7625 E:7627 ||| -LRB-
11  ||| S:7627 E:7630 ||| CD
]  ||| S:7630 E:7632 ||| -RRB-
,  ||| S:7632 E:7634 ||| ,
we  ||| S:7634 E:7637 ||| PRP
expected  ||| S:7637 E:7646 ||| VBD
that  ||| S:7646 E:7651 ||| IN
the  ||| S:7651 E:7655 ||| DT
Tag  ||| S:7655 E:7669 ||| JJ
expression-cell  ||| S:7669 E:7685 ||| JJ
density  ||| S:7685 E:7693 ||| NN
profiles  ||| S:7693 E:7702 ||| NNS
would  ||| S:7702 E:7708 ||| MD
look  ||| S:7708 E:7713 ||| VB
like  ||| S:7713 E:7718 ||| IN
that  ||| S:7718 E:7723 ||| DT
in  ||| S:7723 E:7736 ||| IN
Figure  ||| S:7736 E:7743 ||| NNP
3 ||| S:7743 E:7744 ||| CD
.  ||| S:7744 E:7746 ||| .
To  ||| S:7746 E:7749 ||| TO
test  ||| S:7749 E:7754 ||| VB
this  ||| S:7754 E:7759 ||| DT
idea ||| S:7759 E:7763 ||| NN
,  ||| S:7763 E:7765 ||| ,
we  ||| S:7765 E:7768 ||| PRP
measured  ||| S:7768 E:7777 ||| VBD
Tag  ||| S:7777 E:7781 ||| NNP
expression  ||| S:7781 E:7802 ||| NN
by  ||| S:7802 E:7805 ||| IN
immunofluorescence  ||| S:7805 E:7824 ||| JJ
flow  ||| S:7824 E:7829 ||| NN
cytometry  ||| S:7829 E:7839 ||| NNS
( ||| S:7839 E:7840 ||| -LRB-
see  ||| S:7840 E:7844 ||| VB
Figure  ||| S:7844 E:7851 ||| NNP
4 ||| S:7851 E:7852 ||| CD
)  ||| S:7852 E:7854 ||| -RRB-
in  ||| S:7854 E:7857 ||| IN
6  ||| S:7857 E:7869 ||| CD
Tag-immortalized  ||| S:7869 E:7886 ||| JJ
mouse  ||| S:7886 E:7892 ||| NN
astrocyte  ||| S:7892 E:7902 ||| NN
lines  ||| S:7902 E:7908 ||| NNS
plated  ||| S:7908 E:7915 ||| VBN
at  ||| S:7915 E:7918 ||| IN
a  ||| S:7918 E:7920 ||| DT
range  ||| S:7920 E:7936 ||| NN
of  ||| S:7936 E:7939 ||| IN
cell  ||| S:7939 E:7944 ||| NN
densities  ||| S:7944 E:7954 ||| NNS
and  ||| S:7954 E:7958 ||| CC
cultured  ||| S:7958 E:7967 ||| NN
for  ||| S:7967 E:7971 ||| IN
2-3  ||| S:7971 E:7975 ||| CD
days  ||| S:7975 E:7980 ||| NNS
as  ||| S:7980 E:7983 ||| IN
previously  ||| S:7983 E:8004 ||| RB
described  ||| S:8004 E:8014 ||| VBN
[  ||| S:8014 E:8016 ||| -LRB-
15  ||| S:8016 E:8019 ||| CD
]  ||| S:8019 E:8021 ||| -RRB-
.  ||| S:8021 E:8023 ||| .
The  ||| S:8023 E:8027 ||| DT
upper  ||| S:8027 E:8033 ||| JJ
densities  ||| S:8033 E:8043 ||| JJ
ensured  ||| S:8043 E:8051 ||| NN
in  ||| S:8051 E:8054 ||| IN
most  ||| S:8054 E:8069 ||| JJS
cases  ||| S:8069 E:8075 ||| NNS
that  ||| S:8075 E:8080 ||| IN
the  ||| S:8080 E:8084 ||| DT
cells  ||| S:8084 E:8090 ||| NNS
would  ||| S:8090 E:8096 ||| MD
be  ||| S:8096 E:8099 ||| VB
in  ||| S:8099 E:8102 ||| IN
either  ||| S:8102 E:8109 ||| RB
the  ||| S:8109 E:8113 ||| DT
"transition ||| S:8113 E:8124 ||| NN
"  ||| S:8124 E:8136 ||| ''
or  ||| S:8136 E:8139 ||| CC
"plateau ||| S:8139 E:8147 ||| NNP
"  ||| S:8147 E:8149 ||| ''
phase  ||| S:8149 E:8155 ||| NN
for  ||| S:8155 E:8159 ||| IN
some  ||| S:8159 E:8164 ||| DT
of  ||| S:8164 E:8167 ||| IN
the  ||| S:8167 E:8171 ||| DT
measurements ||| S:8171 E:8183 ||| NNS
.  ||| S:8183 E:8185 ||| .
Since  ||| S:8185 E:8201 ||| IN
Tag  ||| S:8201 E:8205 ||| NNP
accumulates  ||| S:8205 E:8217 ||| NN
throughout  ||| S:8217 E:8228 ||| IN
the  ||| S:8228 E:8232 ||| DT
cell  ||| S:8232 E:8237 ||| NN
cycle ||| S:8237 E:8242 ||| NN
,  ||| S:8242 E:8244 ||| ,
populations  ||| S:8244 E:8266 ||| NNS
with  ||| S:8266 E:8271 ||| IN
different  ||| S:8271 E:8281 ||| JJ
phase  ||| S:8281 E:8287 ||| NN
fractions  ||| S:8287 E:8297 ||| NNS
will  ||| S:8297 E:8302 ||| MD
have  ||| S:8302 E:8307 ||| VB
different  ||| S:8307 E:8327 ||| JJ
average  ||| S:8327 E:8335 ||| JJ
levels ||| S:8335 E:8341 ||| NNS
,  ||| S:8341 E:8343 ||| ,
therefore ||| S:8343 E:8352 ||| RB
,  ||| S:8352 E:8354 ||| ,
we  ||| S:8354 E:8357 ||| PRP
measured  ||| S:8357 E:8366 ||| VBD
Tag  ||| S:8366 E:8370 ||| NNP
from  ||| S:8370 E:8375 ||| IN
the  ||| S:8375 E:8379 ||| DT
G  ||| S:8379 E:8392 ||| NNP
1  ||| S:8392 E:8394 ||| CD
population  ||| S:8394 E:8405 ||| NN
to  ||| S:8405 E:8408 ||| TO
generate  ||| S:8408 E:8417 ||| VB
measurements  ||| S:8417 E:8440 ||| NNS
independent  ||| S:8440 E:8452 ||| JJ
of  ||| S:8452 E:8455 ||| IN
the  ||| S:8455 E:8459 ||| DT
cell  ||| S:8459 E:8464 ||| NN
cycle  ||| S:8464 E:8470 ||| NN
phase  ||| S:8470 E:8476 ||| NN
fraction  ||| S:8476 E:8485 ||| NN
distribution  ||| S:8485 E:8508 ||| NN
as  ||| S:8508 E:8511 ||| IN
previously  ||| S:8511 E:8522 ||| RB
described  ||| S:8522 E:8532 ||| VBN
[  ||| S:8532 E:8534 ||| -LRB-
3  ||| S:8534 E:8536 ||| LS
]  ||| S:8536 E:8538 ||| -RRB-
.  ||| S:8538 E:8550 ||| .
Figure  ||| S:8550 E:8557 ||| NN
5Ashows  ||| S:8557 E:8565 ||| VBZ
the  ||| S:8565 E:8569 ||| DT
relationship  ||| S:8569 E:8582 ||| NN
of  ||| S:8582 E:8585 ||| IN
final  ||| S:8585 E:8591 ||| JJ
cell  ||| S:8591 E:8596 ||| NN
number  ||| S:8596 E:8613 ||| NN
to  ||| S:8613 E:8616 ||| TO
initial  ||| S:8616 E:8624 ||| JJ
cell  ||| S:8624 E:8629 ||| NN
number  ||| S:8629 E:8636 ||| NN
for  ||| S:8636 E:8640 ||| IN
two  ||| S:8640 E:8644 ||| CD
combined  ||| S:8644 E:8653 ||| JJ
experiments  ||| S:8653 E:8665 ||| NNS
from  ||| S:8665 E:8680 ||| IN
one  ||| S:8680 E:8684 ||| CD
cell  ||| S:8684 E:8689 ||| NN
line ||| S:8689 E:8693 ||| NN
.  ||| S:8693 E:8695 ||| .
Plots  ||| S:8695 E:8701 ||| NNS
like  ||| S:8701 E:8706 ||| IN
this  ||| S:8706 E:8711 ||| DT
were  ||| S:8711 E:8716 ||| VBD
used  ||| S:8716 E:8721 ||| VBN
to  ||| S:8721 E:8724 ||| TO
determine  ||| S:8724 E:8734 ||| VB
the  ||| S:8734 E:8748 ||| DT
samples  ||| S:8748 E:8756 ||| NNS
that  ||| S:8756 E:8761 ||| WDT
represented  ||| S:8761 E:8773 ||| VBD
the  ||| S:8773 E:8777 ||| DT
exponential  ||| S:8777 E:8789 ||| JJ
portion  ||| S:8789 E:8797 ||| NN
of  ||| S:8797 E:8800 ||| IN
a  ||| S:8800 E:8812 ||| DT
growth  ||| S:8812 E:8819 ||| NN
curve ||| S:8819 E:8824 ||| NN
.  ||| S:8824 E:8826 ||| .
The  ||| S:8826 E:8830 ||| DT
slope  ||| S:8830 E:8836 ||| NN
of  ||| S:8836 E:8839 ||| IN
a  ||| S:8839 E:8841 ||| DT
straight  ||| S:8841 E:8850 ||| JJ
line  ||| S:8850 E:8855 ||| NN
was  ||| S:8855 E:8859 ||| VBD
calculated  ||| S:8859 E:8880 ||| VBN
and  ||| S:8880 E:8884 ||| CC
samples  ||| S:8884 E:8892 ||| NNS
were  ||| S:8892 E:8897 ||| VBD
chosen  ||| S:8897 E:8904 ||| VBN
for  ||| S:8904 E:8908 ||| IN
inclusion  ||| S:8908 E:8918 ||| NN
when  ||| S:8918 E:8923 ||| WRB
the  ||| S:8923 E:8927 ||| DT
slope  ||| S:8927 E:8933 ||| NN
was  ||| S:8933 E:8947 ||| VBD
either  ||| S:8947 E:8954 ||| DT
maximal  ||| S:8954 E:8962 ||| NN
or  ||| S:8962 E:8965 ||| CC
>  ||| S:8965 E:8967 ||| CD
2.0  ||| S:8967 E:8971 ||| CD
when  ||| S:8971 E:8976 ||| WRB
sufficient  ||| S:8976 E:8987 ||| JJ
data  ||| S:8987 E:8992 ||| NNS
could  ||| S:8992 E:8998 ||| MD
not  ||| S:8998 E:9012 ||| RB
be  ||| S:9012 E:9015 ||| VB
obtained  ||| S:9015 E:9024 ||| VBN
by  ||| S:9024 E:9027 ||| IN
maximization ||| S:9027 E:9039 ||| NN
.  ||| S:9039 E:9041 ||| .
The  ||| S:9041 E:9045 ||| DT
% ||| S:9045 E:9046 ||| NN
G  ||| S:9046 E:9059 ||| NNP
1  ||| S:9059 E:9061 ||| CD
curves  ||| S:9061 E:9068 ||| NNS
( ||| S:9068 E:9069 ||| -LRB-
5B ||| S:9069 E:9071 ||| NNP
)  ||| S:9071 E:9073 ||| -RRB-
were  ||| S:9073 E:9078 ||| VBD
used  ||| S:9078 E:9083 ||| VBN
as  ||| S:9083 E:9086 ||| IN
a  ||| S:9086 E:9088 ||| DT
secondary  ||| S:9088 E:9108 ||| JJ
guide  ||| S:9108 E:9114 ||| NN
to  ||| S:9114 E:9117 ||| TO
selecting  ||| S:9117 E:9127 ||| VB
the  ||| S:9127 E:9131 ||| DT
exponential  ||| S:9131 E:9143 ||| JJ
data ||| S:9143 E:9147 ||| NNS
.  ||| S:9147 E:9149 ||| .
Figure  ||| S:9149 E:9156 ||| NN
5Bshows  ||| S:9156 E:9174 ||| NN
that  ||| S:9174 E:9179 ||| IN
the  ||| S:9179 E:9183 ||| DT
G  ||| S:9183 E:9196 ||| NNP
1  ||| S:9196 E:9198 ||| CD
fraction  ||| S:9198 E:9207 ||| NN
increased  ||| S:9207 E:9217 ||| VBN
as  ||| S:9217 E:9220 ||| IN
a  ||| S:9220 E:9222 ||| DT
function  ||| S:9222 E:9231 ||| NN
of  ||| S:9231 E:9244 ||| IN
final  ||| S:9244 E:9250 ||| JJ
cell  ||| S:9250 E:9255 ||| NN
density  ||| S:9255 E:9263 ||| NN
but  ||| S:9263 E:9267 ||| CC
that  ||| S:9267 E:9272 ||| DT
more  ||| S:9272 E:9277 ||| RBR
dense  ||| S:9277 E:9283 ||| JJ
cells  ||| S:9283 E:9289 ||| NNS
arrested  ||| S:9289 E:9308 ||| VBN
with  ||| S:9308 E:9313 ||| IN
a  ||| S:9313 E:9315 ||| DT
significant  ||| S:9315 E:9327 ||| JJ
fraction  ||| S:9327 E:9336 ||| NN
of  ||| S:9336 E:9339 ||| IN
S ||| S:9339 E:9340 ||| NNP
,  ||| S:9340 E:9342 ||| ,
G  ||| S:9342 E:9355 ||| NNP
2  ||| S:9355 E:9357 ||| CD
,  ||| S:9357 E:9359 ||| ,
and  ||| S:9359 E:9363 ||| CC
M  ||| S:9363 E:9365 ||| NNP
cells ||| S:9365 E:9370 ||| NNS
.  ||| S:9370 E:9372 ||| .
The  ||| S:9372 E:9376 ||| DT
increase  ||| S:9376 E:9385 ||| NN
in  ||| S:9385 E:9388 ||| IN
the  ||| S:9388 E:9392 ||| DT
G  ||| S:9392 E:9415 ||| NNP
1  ||| S:9415 E:9417 ||| CD
fraction  ||| S:9417 E:9426 ||| NN
was  ||| S:9426 E:9430 ||| VBD
expected  ||| S:9430 E:9439 ||| VBN
as  ||| S:9439 E:9442 ||| IN
we  ||| S:9442 E:9445 ||| PRP
have  ||| S:9445 E:9460 ||| VBP
demonstrated  ||| S:9460 E:9473 ||| VBN
in  ||| S:9473 E:9476 ||| IN
several  ||| S:9476 E:9484 ||| JJ
cell  ||| S:9484 E:9489 ||| NN
systems  ||| S:9489 E:9497 ||| NNS
that  ||| S:9497 E:9502 ||| IN
the  ||| S:9502 E:9506 ||| DT
G  ||| S:9506 E:9519 ||| NNP
1  ||| S:9519 E:9521 ||| CD
cell  ||| S:9521 E:9526 ||| NN
cycle  ||| S:9526 E:9532 ||| NN
phase  ||| S:9532 E:9538 ||| NN
increases  ||| S:9538 E:9548 ||| NNS
in  ||| S:9548 E:9551 ||| IN
length  ||| S:9551 E:9568 ||| NN
and  ||| S:9568 E:9572 ||| CC
frequency  ||| S:9572 E:9582 ||| NN
during  ||| S:9582 E:9589 ||| IN
exponential  ||| S:9589 E:9601 ||| JJ
growth  ||| S:9601 E:9608 ||| NN
as  ||| S:9608 E:9611 ||| IN
a  ||| S:9611 E:9613 ||| DT
function  ||| S:9613 E:9622 ||| NN
of  ||| S:9622 E:9635 ||| IN
cell  ||| S:9635 E:9640 ||| NN
density  ||| S:9640 E:9648 ||| NNS
[  ||| S:9648 E:9650 ||| -LRB-
11  ||| S:9650 E:9653 ||| CD
15  ||| S:9653 E:9656 ||| CD
16  ||| S:9656 E:9659 ||| CD
]  ||| S:9659 E:9661 ||| -RRB-
.  ||| S:9661 E:9663 ||| .
This  ||| S:9663 E:9668 ||| DT
change  ||| S:9668 E:9675 ||| NN
in  ||| S:9675 E:9678 ||| IN
G  ||| S:9678 E:9691 ||| NNP
1  ||| S:9691 E:9693 ||| CD
can  ||| S:9693 E:9697 ||| MD
be  ||| S:9697 E:9700 ||| VB
demonstrated  ||| S:9700 E:9713 ||| VBN
either  ||| S:9713 E:9720 ||| RB
by  ||| S:9720 E:9733 ||| IN
successive  ||| S:9733 E:9744 ||| JJ
harvests  ||| S:9744 E:9753 ||| NN
from  ||| S:9753 E:9758 ||| IN
cells  ||| S:9758 E:9764 ||| NNS
plated  ||| S:9764 E:9771 ||| VBN
at  ||| S:9771 E:9774 ||| IN
a  ||| S:9774 E:9776 ||| DT
single  ||| S:9776 E:9783 ||| JJ
density  ||| S:9783 E:9801 ||| NN
or  ||| S:9801 E:9804 ||| CC
by  ||| S:9804 E:9807 ||| IN
plating  ||| S:9807 E:9815 ||| JJ
cells  ||| S:9815 E:9821 ||| NNS
at  ||| S:9821 E:9824 ||| IN
different  ||| S:9824 E:9834 ||| JJ
densities  ||| S:9834 E:9844 ||| NN
and  ||| S:9844 E:9848 ||| CC
harvesting  ||| S:9848 E:9869 ||| JJ
simultaneously  ||| S:9869 E:9884 ||| NNS
( ||| S:9884 E:9885 ||| -LRB-
as  ||| S:9885 E:9888 ||| RB
in  ||| S:9888 E:9891 ||| IN
this  ||| S:9891 E:9896 ||| DT
study ||| S:9896 E:9901 ||| NN
) ||| S:9901 E:9902 ||| -RRB-
.  ||| S:9902 E:9904 ||| .
The  ||| S:9904 E:9908 ||| DT
presence  ||| S:9908 E:9917 ||| NN
of  ||| S:9917 E:9920 ||| IN
S  ||| S:9920 E:9932 ||| NNP
phase  ||| S:9932 E:9938 ||| NN
at  ||| S:9938 E:9941 ||| IN
confluence  ||| S:9941 E:9952 ||| NN
is  ||| S:9952 E:9955 ||| VBZ
typical  ||| S:9955 E:9963 ||| JJ
of  ||| S:9963 E:9966 ||| IN
transformed  ||| S:9966 E:9978 ||| JJ
cells ||| S:9978 E:9983 ||| NNS
.  ||| S:9983 E:9995 ||| .
Figure  ||| S:9995 E:10002 ||| NN
5 ||| S:10002 E:10003 ||| CD
( ||| S:10003 E:10004 ||| -LRB-
C ||| S:10004 E:10005 ||| NNP
,  ||| S:10005 E:10007 ||| ,
D ||| S:10007 E:10008 ||| NNP
)  ||| S:10008 E:10010 ||| -RRB-
shows  ||| S:10010 E:10016 ||| VBZ
the  ||| S:10016 E:10020 ||| DT
expression  ||| S:10020 E:10031 ||| NN
profiles  ||| S:10031 E:10040 ||| NNS
for  ||| S:10040 E:10044 ||| IN
Tag  ||| S:10044 E:10058 ||| NNP
versus  ||| S:10058 E:10065 ||| CC
% ||| S:10065 E:10066 ||| NN
G  ||| S:10066 E:10079 ||| NNP
1  ||| S:10079 E:10081 ||| CD
( ||| S:10081 E:10082 ||| -LRB-
C ||| S:10082 E:10083 ||| NNP
)  ||| S:10083 E:10085 ||| -RRB-
and  ||| S:10085 E:10089 ||| CC
final  ||| S:10089 E:10095 ||| JJ
cell  ||| S:10095 E:10100 ||| NN
density  ||| S:10100 E:10108 ||| NNS
( ||| S:10108 E:10109 ||| -LRB-
D ||| S:10109 E:10110 ||| NNP
) ||| S:10110 E:10111 ||| -RRB-
.  ||| S:10111 E:10113 ||| .
The  ||| S:10113 E:10127 ||| DT
exponential  ||| S:10127 E:10139 ||| JJ
region  ||| S:10139 E:10146 ||| NN
defines  ||| S:10146 E:10154 ||| VBZ
the  ||| S:10154 E:10158 ||| DT
data  ||| S:10158 E:10163 ||| NNS
used  ||| S:10163 E:10168 ||| VBN
for  ||| S:10168 E:10172 ||| IN
regression  ||| S:10172 E:10193 ||| JJ
measurements ||| S:10193 E:10205 ||| NNS
.  ||| S:10205 E:10207 ||| .
Tag  ||| S:10207 E:10211 ||| JJ
expression  ||| S:10211 E:10222 ||| NN
at  ||| S:10222 E:10225 ||| IN
terminal  ||| S:10225 E:10234 ||| NN
cell  ||| S:10234 E:10239 ||| NN
density ||| S:10239 E:10246 ||| NN
,  ||| S:10246 E:10258 ||| ,
"Final  ||| S:10258 E:10265 ||| NNP
Tag ||| S:10265 E:10268 ||| NNP
" ||| S:10268 E:10269 ||| ''
,  ||| S:10269 E:10271 ||| ,
was  ||| S:10271 E:10275 ||| VBD
determined  ||| S:10275 E:10286 ||| VBN
by  ||| S:10286 E:10289 ||| IN
the  ||| S:10289 E:10293 ||| DT
average  ||| S:10293 E:10301 ||| NN
of  ||| S:10301 E:10304 ||| IN
the  ||| S:10304 E:10308 ||| DT
final  ||| S:10308 E:10324 ||| JJ
two  ||| S:10324 E:10328 ||| CD
samples  ||| S:10328 E:10336 ||| NNS
( ||| S:10336 E:10337 ||| -LRB-
arrow ||| S:10337 E:10342 ||| LS
) ||| S:10342 E:10343 ||| -RRB-
.  ||| S:10343 E:10355 ||| .
To  ||| S:10355 E:10358 ||| TO
evaluate  ||| S:10358 E:10367 ||| VB
expression ||| S:10367 E:10377 ||| NN
,  ||| S:10377 E:10379 ||| ,
Tag  ||| S:10379 E:10383 ||| NNP
measurements  ||| S:10383 E:10396 ||| NNS
for  ||| S:10396 E:10400 ||| IN
samples  ||| S:10400 E:10418 ||| NNS
in  ||| S:10418 E:10421 ||| IN
exponential  ||| S:10421 E:10433 ||| JJ
growth  ||| S:10433 E:10440 ||| NN
( ||| S:10440 E:10441 ||| -LRB-
see  ||| S:10441 E:10445 ||| VB
above  ||| S:10445 E:10451 ||| IN
criteria ||| S:10451 E:10459 ||| NNS
)  ||| S:10459 E:10461 ||| -RRB-
were  ||| S:10461 E:10466 ||| VBD
subjected  ||| S:10466 E:10486 ||| VBN
to  ||| S:10486 E:10489 ||| TO
linear  ||| S:10489 E:10496 ||| VB
regression  ||| S:10496 E:10507 ||| VBN
on  ||| S:10507 E:10510 ||| IN
final  ||| S:10510 E:10516 ||| JJ
cell  ||| S:10516 E:10521 ||| NN
density  ||| S:10521 E:10529 ||| NN
to  ||| S:10529 E:10532 ||| TO
generate  ||| S:10532 E:10541 ||| VB
an  ||| S:10541 E:10554 ||| DT
intercept  ||| S:10554 E:10564 ||| NN
representing  ||| S:10564 E:10577 ||| VBG
the  ||| S:10577 E:10581 ||| DT
Tag  ||| S:10581 E:10585 ||| JJ
level  ||| S:10585 E:10591 ||| NN
at  ||| S:10591 E:10594 ||| IN
a  ||| S:10594 E:10596 ||| DT
hypothetical  ||| S:10596 E:10619 ||| JJ
zero  ||| S:10619 E:10624 ||| CD
cell  ||| S:10624 E:10629 ||| NN
density ||| S:10629 E:10636 ||| NN
.  ||| S:10636 E:10638 ||| .
This  ||| S:10638 E:10643 ||| DT
value  ||| S:10643 E:10649 ||| NN
for  ||| S:10649 E:10653 ||| IN
each  ||| S:10653 E:10658 ||| DT
experiment  ||| S:10658 E:10669 ||| NN
was  ||| S:10669 E:10683 ||| VBD
used  ||| S:10683 E:10688 ||| VBN
to  ||| S:10688 E:10691 ||| TO
normalize  ||| S:10691 E:10701 ||| VB
data  ||| S:10701 E:10706 ||| NNS
for  ||| S:10706 E:10710 ||| IN
each  ||| S:10710 E:10715 ||| DT
data  ||| S:10715 E:10720 ||| NNS
set  ||| S:10720 E:10724 ||| VBN
to  ||| S:10724 E:10727 ||| TO
a  ||| S:10727 E:10729 ||| DT
zero  ||| S:10729 E:10734 ||| CD
cell  ||| S:10734 E:10749 ||| NN
density  ||| S:10749 E:10757 ||| NN
value  ||| S:10757 E:10763 ||| NN
of  ||| S:10763 E:10766 ||| IN
100  ||| S:10766 E:10770 ||| CD
and  ||| S:10770 E:10774 ||| CC
thus  ||| S:10774 E:10779 ||| RB
correct  ||| S:10779 E:10787 ||| VB
for  ||| S:10787 E:10791 ||| IN
differences  ||| S:10791 E:10803 ||| NNS
in  ||| S:10803 E:10816 ||| IN
fluorescence  ||| S:10816 E:10829 ||| JJ
measurements  ||| S:10829 E:10842 ||| NNS
obtained  ||| S:10842 E:10851 ||| VBN
in  ||| S:10851 E:10854 ||| IN
multiple  ||| S:10854 E:10873 ||| JJ
experiments ||| S:10873 E:10884 ||| NNS
,  ||| S:10884 E:10886 ||| ,
and  ||| S:10886 E:10890 ||| CC
additionally ||| S:10890 E:10902 ||| RB
,  ||| S:10902 E:10904 ||| ,
scale  ||| S:10904 E:10910 ||| VBG
the  ||| S:10910 E:10914 ||| DT
data  ||| S:10914 E:10919 ||| NNS
to  ||| S:10919 E:10922 ||| TO
be  ||| S:10922 E:10935 ||| VB
independent  ||| S:10935 E:10947 ||| JJ
of  ||| S:10947 E:10950 ||| IN
cell  ||| S:10950 E:10955 ||| NN
line  ||| S:10955 E:10960 ||| NN
specific  ||| S:10960 E:10969 ||| JJ
expression  ||| S:10969 E:10980 ||| NN
levels ||| S:10980 E:10986 ||| NNS
.  ||| S:10986 E:10988 ||| .
The  ||| S:10988 E:11002 ||| DT
normalized  ||| S:11002 E:11013 ||| JJ
data  ||| S:11013 E:11018 ||| NNS
were  ||| S:11018 E:11023 ||| VBD
then  ||| S:11023 E:11028 ||| RB
combined  ||| S:11028 E:11037 ||| VBN
for  ||| S:11037 E:11041 ||| IN
replicate  ||| S:11041 E:11051 ||| NN
or  ||| S:11051 E:11064 ||| CC
triplicate  ||| S:11064 E:11075 ||| JJ
experiments  ||| S:11075 E:11087 ||| NNS
and  ||| S:11087 E:11091 ||| CC
subjected  ||| S:11091 E:11101 ||| VBN
to  ||| S:11101 E:11104 ||| TO
linear  ||| S:11104 E:11111 ||| VB
regression  ||| S:11111 E:11132 ||| VBN
on  ||| S:11132 E:11135 ||| IN
the  ||| S:11135 E:11139 ||| DT
fraction  ||| S:11139 E:11148 ||| NN
of  ||| S:11148 E:11151 ||| IN
G  ||| S:11151 E:11164 ||| NNP
1  ||| S:11164 E:11166 ||| CD
cells  ||| S:11166 E:11172 ||| NNS
and  ||| S:11172 E:11176 ||| CC
final  ||| S:11176 E:11182 ||| JJ
cell  ||| S:11182 E:11187 ||| NN
densities ||| S:11187 E:11196 ||| NN
.  ||| S:11196 E:11198 ||| .
Data  ||| S:11198 E:11213 ||| NNS
for  ||| S:11213 E:11217 ||| IN
two  ||| S:11217 E:11221 ||| CD
cell  ||| S:11221 E:11226 ||| NN
lines  ||| S:11226 E:11232 ||| NNS
are  ||| S:11232 E:11236 ||| VBP
shown  ||| S:11236 E:11242 ||| VBN
in  ||| S:11242 E:11245 ||| IN
Figure  ||| S:11245 E:11252 ||| NNP
6 ||| S:11252 E:11253 ||| CD
.  ||| S:11253 E:11255 ||| .
For  ||| S:11255 E:11259 ||| IN
all  ||| S:11259 E:11263 ||| DT
cell  ||| S:11263 E:11278 ||| NN
lines ||| S:11278 E:11283 ||| NNS
,  ||| S:11283 E:11285 ||| ,
the  ||| S:11285 E:11289 ||| DT
slope  ||| S:11289 E:11295 ||| NN
and  ||| S:11295 E:11299 ||| CC
SE  ||| S:11299 E:11302 ||| NNP
of  ||| S:11302 E:11305 ||| IN
the  ||| S:11305 E:11309 ||| DT
slope  ||| S:11309 E:11315 ||| NN
were  ||| S:11315 E:11320 ||| VBD
calculated  ||| S:11320 E:11331 ||| VBN
and  ||| S:11331 E:11345 ||| CC
plotted  ||| S:11345 E:11353 ||| NN
in  ||| S:11353 E:11356 ||| IN
Figure  ||| S:11356 E:11363 ||| NNP
7 ||| S:11363 E:11364 ||| CD
.  ||| S:11364 E:11366 ||| .
In  ||| S:11366 E:11369 ||| IN
one  ||| S:11369 E:11373 ||| CD
of  ||| S:11373 E:11376 ||| IN
the  ||| S:11376 E:11380 ||| DT
cell  ||| S:11380 E:11385 ||| NN
lines ||| S:11385 E:11390 ||| NNS
,  ||| S:11390 E:11392 ||| ,
the  ||| S:11392 E:11396 ||| DT
slopes  ||| S:11396 E:11413 ||| NNS
for  ||| S:11413 E:11417 ||| IN
Tag  ||| S:11417 E:11421 ||| NNP
versus  ||| S:11421 E:11428 ||| CC
both  ||| S:11428 E:11433 ||| DT
G  ||| S:11433 E:11446 ||| NNP
1  ||| S:11446 E:11448 ||| CD
and  ||| S:11448 E:11452 ||| CC
cell  ||| S:11452 E:11457 ||| NN
density  ||| S:11457 E:11465 ||| NN
were  ||| S:11465 E:11470 ||| VBD
not  ||| S:11470 E:11484 ||| RB
significantly  ||| S:11484 E:11498 ||| RB
different  ||| S:11498 E:11508 ||| JJ
from  ||| S:11508 E:11513 ||| IN
zero ||| S:11513 E:11517 ||| CD
.  ||| S:11517 E:11519 ||| .
For  ||| S:11519 E:11523 ||| IN
another  ||| S:11523 E:11531 ||| DT
line ||| S:11531 E:11535 ||| NN
,  ||| S:11535 E:11537 ||| ,
the  ||| S:11537 E:11551 ||| DT
slopes  ||| S:11551 E:11558 ||| NNS
had  ||| S:11558 E:11562 ||| VBD
significant  ||| S:11562 E:11574 ||| JJ
positive  ||| S:11574 E:11583 ||| JJ
values ||| S:11583 E:11589 ||| NNS
,  ||| S:11589 E:11591 ||| ,
and  ||| S:11591 E:11595 ||| CC
in  ||| S:11595 E:11598 ||| IN
the  ||| S:11598 E:11612 ||| DT
remaining  ||| S:11612 E:11622 ||| JJ
4  ||| S:11622 E:11624 ||| CD
lines  ||| S:11624 E:11630 ||| NNS
both  ||| S:11630 E:11635 ||| DT
slopes  ||| S:11635 E:11642 ||| NNS
were  ||| S:11642 E:11647 ||| VBD
negative  ||| S:11647 E:11656 ||| JJ
and  ||| S:11656 E:11670 ||| CC
significant ||| S:11670 E:11681 ||| JJ
.  ||| S:11681 E:11683 ||| .
Figure  ||| S:11683 E:11690 ||| NN
6shows  ||| S:11690 E:11697 ||| CD
data  ||| S:11697 E:11702 ||| NNS
for  ||| S:11702 E:11706 ||| IN
the  ||| S:11706 E:11710 ||| DT
cell  ||| S:11710 E:11715 ||| NN
line  ||| S:11715 E:11720 ||| NN
that  ||| S:11720 E:11735 ||| WDT
did  ||| S:11735 E:11739 ||| VBD
not  ||| S:11739 E:11743 ||| RB
differ  ||| S:11743 E:11750 ||| VB
from  ||| S:11750 E:11755 ||| IN
zero  ||| S:11755 E:11760 ||| CD
and  ||| S:11760 E:11764 ||| CC
a  ||| S:11764 E:11766 ||| DT
representative  ||| S:11766 E:11781 ||| JJ
line  ||| S:11781 E:11786 ||| NN
with  ||| S:11786 E:11801 ||| IN
negative  ||| S:11801 E:11810 ||| JJ
slopes ||| S:11810 E:11816 ||| NNS
.  ||| S:11816 E:11818 ||| .
The  ||| S:11818 E:11822 ||| DT
two  ||| S:11822 E:11826 ||| CD
cell  ||| S:11826 E:11831 ||| NN
lines  ||| S:11831 E:11837 ||| NNS
that  ||| S:11837 E:11842 ||| WDT
did  ||| S:11842 E:11846 ||| VBD
not  ||| S:11846 E:11850 ||| RB
display  ||| S:11850 E:11868 ||| VB
a  ||| S:11868 E:11870 ||| DT
decrease  ||| S:11870 E:11879 ||| NN
in  ||| S:11879 E:11882 ||| IN
Tag  ||| S:11882 E:11886 ||| NNP
during  ||| S:11886 E:11893 ||| IN
exponential  ||| S:11893 E:11905 ||| JJ
growth  ||| S:11905 E:11912 ||| NN
were  ||| S:11912 E:11927 ||| VBD
transformed  ||| S:11927 E:11939 ||| VBN
with  ||| S:11939 E:11944 ||| IN
retroviruses  ||| S:11944 E:11957 ||| NNS
utilizing  ||| S:11957 E:11967 ||| VBP
the  ||| S:11967 E:11971 ||| DT
retroviral  ||| S:11971 E:11992 ||| JJ
LTR ||| S:11992 E:11995 ||| NNP
.  ||| S:11995 E:11997 ||| .
Three  ||| S:11997 E:12003 ||| CD
of  ||| S:12003 E:12006 ||| IN
the  ||| S:12006 E:12010 ||| DT
cell  ||| S:12010 E:12015 ||| NN
lines  ||| S:12015 E:12021 ||| NNS
that  ||| S:12021 E:12026 ||| WDT
showed  ||| S:12026 E:12033 ||| VBD
a  ||| S:12033 E:12035 ||| DT
significant  ||| S:12035 E:12057 ||| JJ
decrease  ||| S:12057 E:12066 ||| NN
in  ||| S:12066 E:12069 ||| IN
Tag  ||| S:12069 E:12073 ||| NNP
during  ||| S:12073 E:12080 ||| IN
exponential  ||| S:12080 E:12092 ||| JJ
growth  ||| S:12092 E:12099 ||| NN
utilized  ||| S:12099 E:12118 ||| NNS
retroviruses  ||| S:12118 E:12131 ||| VBP
encoding  ||| S:12131 E:12140 ||| JJ
transcription  ||| S:12140 E:12154 ||| NN
of  ||| S:12154 E:12157 ||| IN
Tag  ||| S:12157 E:12161 ||| NNP
from  ||| S:12161 E:12166 ||| IN
the  ||| S:12166 E:12170 ||| DT
htk  ||| S:12170 E:12184 ||| JJ
promoter ||| S:12184 E:12192 ||| NN
,  ||| S:12192 E:12194 ||| ,
which  ||| S:12194 E:12200 ||| WDT
can  ||| S:12200 E:12204 ||| MD
be  ||| S:12204 E:12207 ||| VB
a  ||| S:12207 E:12209 ||| DT
weak  ||| S:12209 E:12214 ||| JJ
promoter  ||| S:12214 E:12223 ||| NN
in  ||| S:12223 E:12226 ||| IN
mouse  ||| S:12226 E:12232 ||| NN
cells  ||| S:12232 E:12238 ||| NNS
[  ||| S:12238 E:12240 ||| -LRB-
1  ||| S:12240 E:12252 ||| CD
11  ||| S:12252 E:12255 ||| CD
]  ||| S:12255 E:12257 ||| -RRB-
but  ||| S:12257 E:12261 ||| CC
subject  ||| S:12261 E:12269 ||| JJ
to  ||| S:12269 E:12272 ||| TO
cell  ||| S:12272 E:12277 ||| NN
line  ||| S:12277 E:12282 ||| NN
specific  ||| S:12282 E:12291 ||| JJ
effects  ||| S:12291 E:12299 ||| NNS
( ||| S:12299 E:12300 ||| -LRB-
see  ||| S:12300 E:12314 ||| VB
discussion ||| S:12314 E:12324 ||| NN
) ||| S:12324 E:12325 ||| -RRB-
.  ||| S:12325 E:12327 ||| .
One  ||| S:12327 E:12331 ||| CD
of  ||| S:12331 E:12334 ||| IN
the  ||| S:12334 E:12338 ||| DT
cell  ||| S:12338 E:12343 ||| NN
lines  ||| S:12343 E:12349 ||| NNS
showing  ||| S:12349 E:12357 ||| VBG
a  ||| S:12357 E:12359 ||| DT
significant  ||| S:12359 E:12381 ||| JJ
decrease  ||| S:12381 E:12390 ||| NN
in  ||| S:12390 E:12393 ||| IN
Tag  ||| S:12393 E:12397 ||| NNP
expression  ||| S:12397 E:12408 ||| NN
was  ||| S:12408 E:12412 ||| VBD
K1-30  ||| S:12412 E:12418 ||| CD
which  ||| S:12418 E:12424 ||| WDT
encoded  ||| S:12424 E:12432 ||| VBZ
an  ||| S:12432 E:12445 ||| DT
Rb-binding  ||| S:12445 E:12456 ||| JJ
defective  ||| S:12456 E:12466 ||| JJ
mutant  ||| S:12466 E:12473 ||| JJ
Tag  ||| S:12473 E:12477 ||| JJ
transcribed  ||| S:12477 E:12489 ||| NN
from  ||| S:12489 E:12494 ||| IN
the  ||| S:12494 E:12508 ||| DT
retroviral  ||| S:12508 E:12519 ||| JJ
LTR  ||| S:12519 E:12523 ||| NNP
[  ||| S:12523 E:12525 ||| -LRB-
6  ||| S:12525 E:12527 ||| CD
]  ||| S:12527 E:12529 ||| -RRB-
.  ||| S:12529 E:12559 ||| .
Serum  ||| S:12559 E:12565 ||| JJ
levels  ||| S:12565 E:12572 ||| NNS
do  ||| S:12572 E:12575 ||| VBP
not  ||| S:12575 E:12579 ||| RB
affect  ||| S:12579 E:12586 ||| VB
Tag  ||| S:12586 E:12590 ||| JJ
expression  ||| S:12590 E:12611 ||| NN
It  ||| S:12611 E:12614 ||| PRP
is  ||| S:12614 E:12617 ||| VBZ
possible  ||| S:12617 E:12626 ||| JJ
that  ||| S:12626 E:12631 ||| IN
Tag  ||| S:12631 E:12635 ||| NNP
expression  ||| S:12635 E:12646 ||| NN
could  ||| S:12646 E:12652 ||| MD
be  ||| S:12652 E:12655 ||| VB
regulated  ||| S:12655 E:12675 ||| VBN
by  ||| S:12675 E:12678 ||| IN
factors  ||| S:12678 E:12686 ||| NNS
in  ||| S:12686 E:12689 ||| IN
serum ||| S:12689 E:12694 ||| NN
,  ||| S:12694 E:12696 ||| ,
and  ||| S:12696 E:12700 ||| CC
that  ||| S:12700 E:12705 ||| IN
these  ||| S:12705 E:12711 ||| DT
factors  ||| S:12711 E:12719 ||| NNS
could  ||| S:12719 E:12725 ||| MD
be  ||| S:12725 E:12738 ||| VB
progressively  ||| S:12738 E:12752 ||| RB
depleted  ||| S:12752 E:12761 ||| VBN
at  ||| S:12761 E:12764 ||| IN
increasing  ||| S:12764 E:12775 ||| VBG
cell  ||| S:12775 E:12780 ||| NN
numbers ||| S:12780 E:12787 ||| NNS
.  ||| S:12787 E:12789 ||| .
To  ||| S:12789 E:12802 ||| TO
test  ||| S:12802 E:12807 ||| VB
this ||| S:12807 E:12811 ||| DT
,  ||| S:12811 E:12813 ||| ,
the  ||| S:12813 E:12817 ||| DT
cell  ||| S:12817 E:12822 ||| NN
line  ||| S:12822 E:12827 ||| NN
in  ||| S:12827 E:12830 ||| IN
which  ||| S:12830 E:12836 ||| WDT
Tag  ||| S:12836 E:12840 ||| NNP
control  ||| S:12840 E:12848 ||| NN
was  ||| S:12848 E:12852 ||| VBD
most  ||| S:12852 E:12867 ||| RBS
sensitive  ||| S:12867 E:12877 ||| JJ
to  ||| S:12877 E:12880 ||| TO
density ||| S:12880 E:12887 ||| VB
,  ||| S:12887 E:12889 ||| ,
P0-3D  ||| S:12889 E:12895 ||| CD
tkT ||| S:12895 E:12898 ||| JJ
# ||| S:12898 E:12899 ||| #
5 ||| S:12899 E:12900 ||| CD
,  ||| S:12900 E:12902 ||| ,
was  ||| S:12902 E:12906 ||| VBD
grown  ||| S:12906 E:12912 ||| VBN
for  ||| S:12912 E:12916 ||| IN
3  ||| S:12916 E:12918 ||| CD
days  ||| S:12918 E:12933 ||| NNS
starting  ||| S:12933 E:12942 ||| VBG
at  ||| S:12942 E:12945 ||| IN
an  ||| S:12945 E:12948 ||| DT
intermediate  ||| S:12948 E:12961 ||| JJ
density  ||| S:12961 E:12969 ||| NN
of  ||| S:12969 E:12972 ||| IN
10  ||| S:12972 E:12975 ||| CD
6cells  ||| S:12975 E:12982 ||| CD
per  ||| S:12982 E:12986 ||| IN
10  ||| S:12986 E:12999 ||| CD
cm  ||| S:12999 E:13002 ||| JJ
plate  ||| S:13002 E:13008 ||| NN
with  ||| S:13008 E:13013 ||| IN
varying  ||| S:13013 E:13021 ||| VBG
concentrations  ||| S:13021 E:13036 ||| NNS
of  ||| S:13036 E:13039 ||| IN
serum  ||| S:13039 E:13045 ||| NNS
ranging  ||| S:13045 E:13063 ||| VBG
from  ||| S:13063 E:13068 ||| IN
2.5-10 ||| S:13068 E:13074 ||| CD
% ||| S:13074 E:13075 ||| NN
.  ||| S:13075 E:13077 ||| .
Tag  ||| S:13077 E:13081 ||| JJ
level  ||| S:13081 E:13087 ||| NN
as  ||| S:13087 E:13090 ||| IN
well  ||| S:13090 E:13095 ||| RB
as  ||| S:13095 E:13098 ||| IN
% ||| S:13098 E:13099 ||| NN
G  ||| S:13099 E:13112 ||| NNP
1  ||| S:13112 E:13114 ||| CD
was  ||| S:13114 E:13118 ||| VBD
equivalent  ||| S:13118 E:13129 ||| NN
at  ||| S:13129 E:13132 ||| IN
all  ||| S:13132 E:13136 ||| DT
serum  ||| S:13136 E:13142 ||| JJ
levels  ||| S:13142 E:13159 ||| NNS
( ||| S:13159 E:13160 ||| -LRB-
Table  ||| S:13160 E:13166 ||| NNP
2 ||| S:13166 E:13167 ||| CD
) ||| S:13167 E:13168 ||| -RRB-
.  ||| S:13168 E:13170 ||| .
Since ||| S:13170 E:13175 ||| IN
,  ||| S:13175 E:13177 ||| ,
there  ||| S:13177 E:13183 ||| EX
is  ||| S:13183 E:13186 ||| VBZ
significantly  ||| S:13186 E:13200 ||| RB
less  ||| S:13200 E:13205 ||| RBR
serum ||| S:13205 E:13210 ||| JJ
/ ||| S:13210 E:13211 ||| CD
cell  ||| S:13211 E:13226 ||| NN
in  ||| S:13226 E:13229 ||| IN
2.5 ||| S:13229 E:13232 ||| CD
%  ||| S:13232 E:13234 ||| NN
serum  ||| S:13234 E:13240 ||| NN
samples ||| S:13240 E:13247 ||| NNS
,  ||| S:13247 E:13249 ||| ,
we  ||| S:13249 E:13252 ||| PRP
conclude  ||| S:13252 E:13261 ||| VBP
that  ||| S:13261 E:13266 ||| IN
factors  ||| S:13266 E:13274 ||| NNS
in  ||| S:13274 E:13277 ||| IN
serum ||| S:13277 E:13282 ||| NN
,  ||| S:13282 E:13294 ||| ,
at  ||| S:13294 E:13297 ||| IN
concentrations  ||| S:13297 E:13312 ||| NNS
that  ||| S:13312 E:13317 ||| WDT
maintain  ||| S:13317 E:13326 ||| VBP
exponential  ||| S:13326 E:13338 ||| JJ
growth ||| S:13338 E:13344 ||| NN
,  ||| S:13344 E:13346 ||| ,
do  ||| S:13346 E:13359 ||| VBP
not  ||| S:13359 E:13363 ||| RB
regulate  ||| S:13363 E:13372 ||| VB
Tag  ||| S:13372 E:13376 ||| JJ
levels  ||| S:13376 E:13383 ||| NNS
in  ||| S:13383 E:13386 ||| IN
these  ||| S:13386 E:13392 ||| DT
cell  ||| S:13392 E:13397 ||| NN
lines ||| S:13397 E:13402 ||| NNS
.  ||| S:13402 E:13432 ||| .
Characterization  ||| S:13432 E:13449 ||| NN
of  ||| S:13449 E:13452 ||| IN
density  ||| S:13452 E:13460 ||| NN
and  ||| S:13460 E:13464 ||| CC
growth  ||| S:13464 E:13471 ||| NN
phase  ||| S:13471 E:13487 ||| NN
effects  ||| S:13487 E:13495 ||| NNS
on  ||| S:13495 E:13498 ||| IN
Tag  ||| S:13498 E:13525 ||| NNP
Tag  ||| S:13525 E:13529 ||| NNP
expression  ||| S:13529 E:13540 ||| NN
at  ||| S:13540 E:13543 ||| IN
high  ||| S:13543 E:13548 ||| JJ
cell  ||| S:13548 E:13553 ||| NN
density  ||| S:13553 E:13573 ||| NN
For  ||| S:13573 E:13577 ||| IN
each  ||| S:13577 E:13582 ||| DT
cell  ||| S:13582 E:13587 ||| NN
line ||| S:13587 E:13591 ||| NN
,  ||| S:13591 E:13593 ||| ,
the  ||| S:13593 E:13597 ||| DT
levels  ||| S:13597 E:13604 ||| NNS
of  ||| S:13604 E:13607 ||| IN
Tag  ||| S:13607 E:13611 ||| NNP
at  ||| S:13611 E:13614 ||| IN
high  ||| S:13614 E:13619 ||| JJ
cell  ||| S:13619 E:13636 ||| NN
density  ||| S:13636 E:13644 ||| NNS
( ||| S:13644 E:13645 ||| -LRB-
either  ||| S:13645 E:13652 ||| DT
transition  ||| S:13652 E:13663 ||| NN
or  ||| S:13663 E:13666 ||| CC
plateau  ||| S:13666 E:13674 ||| JJ
phase ||| S:13674 E:13679 ||| NN
)  ||| S:13679 E:13681 ||| -RRB-
were  ||| S:13681 E:13698 ||| VBD
significantly  ||| S:13698 E:13712 ||| RB
lower  ||| S:13712 E:13718 ||| JJR
than  ||| S:13718 E:13723 ||| IN
during  ||| S:13723 E:13730 ||| IN
exponential  ||| S:13730 E:13742 ||| JJ
growth ||| S:13742 E:13748 ||| NN
.  ||| S:13748 E:13762 ||| .
This  ||| S:13762 E:13767 ||| DT
level  ||| S:13767 E:13773 ||| NN
ranged  ||| S:13773 E:13780 ||| VBD
from  ||| S:13780 E:13785 ||| IN
a  ||| S:13785 E:13787 ||| DT
12-63 ||| S:13787 E:13792 ||| JJ
%  ||| S:13792 E:13794 ||| NN
decrease  ||| S:13794 E:13803 ||| NN
compared  ||| S:13803 E:13812 ||| VBN
to  ||| S:13812 E:13827 ||| TO
the  ||| S:13827 E:13831 ||| DT
hypothetical  ||| S:13831 E:13844 ||| JJ
Tag  ||| S:13844 E:13848 ||| JJ
level  ||| S:13848 E:13854 ||| NN
of  ||| S:13854 E:13857 ||| IN
100  ||| S:13857 E:13861 ||| CD
( ||| S:13861 E:13862 ||| -LRB-
normalized ||| S:13862 E:13872 ||| LS
)  ||| S:13872 E:13874 ||| -RRB-
at  ||| S:13874 E:13877 ||| IN
0  ||| S:13877 E:13891 ||| CD
cell  ||| S:13891 E:13896 ||| NN
density  ||| S:13896 E:13904 ||| NNS
( ||| S:13904 E:13905 ||| -LRB-
Table  ||| S:13905 E:13911 ||| NNP
1 ||| S:13911 E:13912 ||| CD
) ||| S:13912 E:13913 ||| -RRB-
.  ||| S:13913 E:13949 ||| .
Tag  ||| S:13949 E:13953 ||| JJ
expression  ||| S:13953 E:13964 ||| NN
at  ||| S:13964 E:13967 ||| IN
zero  ||| S:13967 E:13972 ||| CD
and  ||| S:13972 E:13976 ||| CC
late  ||| S:13976 E:13981 ||| JJ
cell  ||| S:13981 E:13998 ||| NN
densities  ||| S:13998 E:14020 ||| NN
Figure  ||| S:14020 E:14027 ||| NN
8Ashows  ||| S:14027 E:14035 ||| VBZ
the  ||| S:14035 E:14039 ||| DT
correlation  ||| S:14039 E:14051 ||| JJ
plot  ||| S:14051 E:14056 ||| NN
for  ||| S:14056 E:14060 ||| IN
the  ||| S:14060 E:14076 ||| DT
objective ||| S:14076 E:14085 ||| NN
,  ||| S:14085 E:14087 ||| ,
"expression  ||| S:14087 E:14099 ||| CD
potential ||| S:14099 E:14108 ||| JJ
"  ||| S:14108 E:14110 ||| ``
intercept  ||| S:14110 E:14120 ||| JJ
measurement  ||| S:14120 E:14144 ||| NN
at  ||| S:14144 E:14147 ||| IN
zero  ||| S:14147 E:14152 ||| CD
cell  ||| S:14152 E:14157 ||| NN
density  ||| S:14157 E:14165 ||| NNS
( ||| S:14165 E:14166 ||| -LRB-
defined  ||| S:14166 E:14174 ||| VBN
above ||| S:14174 E:14179 ||| IN
)  ||| S:14179 E:14181 ||| -RRB-
and  ||| S:14181 E:14185 ||| CC
Tag  ||| S:14185 E:14189 ||| NNP
measured  ||| S:14189 E:14210 ||| VBD
from  ||| S:14210 E:14215 ||| IN
Western  ||| S:14215 E:14223 ||| JJ
blots  ||| S:14223 E:14229 ||| NN
in  ||| S:14229 E:14232 ||| IN
Figure  ||| S:14232 E:14239 ||| NNP
2 ||| S:14239 E:14240 ||| CD
.  ||| S:14240 E:14242 ||| .
The  ||| S:14242 E:14246 ||| DT
Western  ||| S:14246 E:14254 ||| JJ
blot  ||| S:14254 E:14259 ||| JJ
data  ||| S:14259 E:14276 ||| NNS
represent  ||| S:14276 E:14286 ||| VBP
a  ||| S:14286 E:14288 ||| DT
sampling  ||| S:14288 E:14297 ||| NN
of  ||| S:14297 E:14300 ||| IN
Tag  ||| S:14300 E:14304 ||| NNP
expression  ||| S:14304 E:14315 ||| NN
on  ||| S:14315 E:14318 ||| IN
growing  ||| S:14318 E:14338 ||| VBG
cultures ||| S:14338 E:14346 ||| NNS
,  ||| S:14346 E:14348 ||| ,
in  ||| S:14348 E:14351 ||| IN
late  ||| S:14351 E:14356 ||| JJ
exponential  ||| S:14356 E:14368 ||| JJ
growth ||| S:14368 E:14374 ||| NN
,  ||| S:14374 E:14376 ||| ,
and  ||| S:14376 E:14380 ||| CC
thus  ||| S:14380 E:14385 ||| RB
might  ||| S:14385 E:14403 ||| MD
reflect  ||| S:14403 E:14411 ||| VB
the  ||| S:14411 E:14415 ||| DT
average ||| S:14415 E:14422 ||| NN
,  ||| S:14422 E:14424 ||| ,
qualitative  ||| S:14424 E:14436 ||| JJ
experiment ||| S:14436 E:14446 ||| NN
.  ||| S:14446 E:14448 ||| .
The  ||| S:14448 E:14464 ||| DT
overall  ||| S:14464 E:14472 ||| JJ
agreement  ||| S:14472 E:14482 ||| NN
with  ||| S:14482 E:14487 ||| IN
the  ||| S:14487 E:14491 ||| DT
intercept  ||| S:14491 E:14501 ||| JJ
measurement  ||| S:14501 E:14525 ||| NN
supports  ||| S:14525 E:14534 ||| VBZ
the  ||| S:14534 E:14538 ||| DT
use  ||| S:14538 E:14542 ||| NN
of  ||| S:14542 E:14545 ||| IN
this  ||| S:14545 E:14550 ||| DT
objective  ||| S:14550 E:14560 ||| NN
means  ||| S:14560 E:14566 ||| VBZ
to  ||| S:14566 E:14569 ||| TO
determine  ||| S:14569 E:14591 ||| VB
expression  ||| S:14591 E:14602 ||| NN
potential ||| S:14602 E:14611 ||| NN
,  ||| S:14611 E:14613 ||| ,
i.e. ||| S:14613 E:14617 ||| FW
,  ||| S:14617 E:14619 ||| ,
expression  ||| S:14619 E:14630 ||| NN
that  ||| S:14630 E:14635 ||| WDT
is  ||| S:14635 E:14650 ||| VBZ
independent  ||| S:14650 E:14662 ||| JJ
of  ||| S:14662 E:14665 ||| IN
population  ||| S:14665 E:14676 ||| NN
growth ||| S:14676 E:14682 ||| NN
/ ||| S:14682 E:14683 ||| CD
density  ||| S:14683 E:14691 ||| CD
effects ||| S:14691 E:14698 ||| NNS
,  ||| S:14698 E:14700 ||| ,
in  ||| S:14700 E:14715 ||| IN
quantitative  ||| S:14715 E:14728 ||| JJ
analysis ||| S:14728 E:14736 ||| NN
.  ||| S:14736 E:14738 ||| .
The  ||| S:14738 E:14742 ||| DT
R  ||| S:14742 E:14744 ||| NN
2value  ||| S:14744 E:14751 ||| NN
for  ||| S:14751 E:14755 ||| IN
the  ||| S:14755 E:14759 ||| DT
regression  ||| S:14759 E:14782 ||| NN
is  ||| S:14782 E:14785 ||| VBZ
79 ||| S:14785 E:14787 ||| CD
% ||| S:14787 E:14788 ||| NN
.  ||| S:14788 E:14790 ||| .
The  ||| S:14790 E:14794 ||| DT
single  ||| S:14794 E:14801 ||| JJ
outlier  ||| S:14801 E:14809 ||| NN
represents  ||| S:14809 E:14820 ||| VBZ
P0-17D ||| S:14820 E:14826 ||| RB
# ||| S:14826 E:14827 ||| #
8  ||| S:14827 E:14829 ||| CD
which  ||| S:14829 E:14835 ||| WDT
is  ||| S:14835 E:14850 ||| VBZ
the  ||| S:14850 E:14854 ||| DT
only  ||| S:14854 E:14859 ||| JJ
cell  ||| S:14859 E:14864 ||| NN
line  ||| S:14864 E:14869 ||| NN
that  ||| S:14869 E:14874 ||| WDT
showed  ||| S:14874 E:14881 ||| VBD
an  ||| S:14881 E:14884 ||| DT
increase  ||| S:14884 E:14893 ||| NN
in  ||| S:14893 E:14896 ||| IN
Tag  ||| S:14896 E:14912 ||| NNP
during  ||| S:14912 E:14919 ||| IN
exponential  ||| S:14919 E:14931 ||| JJ
growth  ||| S:14931 E:14938 ||| NN
and  ||| S:14938 E:14942 ||| CC
so  ||| S:14942 E:14945 ||| RB
would  ||| S:14945 E:14951 ||| MD
not  ||| S:14951 E:14955 ||| RB
be  ||| S:14955 E:14958 ||| VB
expected  ||| S:14958 E:14979 ||| VBN
to  ||| S:14979 E:14982 ||| TO
fit  ||| S:14982 E:14986 ||| VB
the  ||| S:14986 E:14990 ||| DT
regression  ||| S:14990 E:15001 ||| NN
as  ||| S:15001 E:15004 ||| IN
well ||| S:15004 E:15008 ||| RB
.  ||| S:15008 E:15010 ||| .
If  ||| S:15010 E:15013 ||| IN
P0-17D ||| S:15013 E:15019 ||| RB
# ||| S:15019 E:15020 ||| #
8  ||| S:15020 E:15022 ||| CD
is  ||| S:15022 E:15025 ||| VBZ
removed ||| S:15025 E:15032 ||| VBN
,  ||| S:15032 E:15046 ||| ,
the  ||| S:15046 E:15050 ||| DT
R  ||| S:15050 E:15052 ||| NN
2is  ||| S:15052 E:15056 ||| CD
97 ||| S:15056 E:15058 ||| CD
% ||| S:15058 E:15059 ||| NN
.  ||| S:15059 E:15095 ||| .
Relationship  ||| S:15095 E:15108 ||| NN
of  ||| S:15108 E:15111 ||| IN
Tag  ||| S:15111 E:15115 ||| NNP
expression  ||| S:15115 E:15126 ||| NN
as  ||| S:15126 E:15129 ||| IN
a  ||| S:15129 E:15131 ||| DT
function  ||| S:15131 E:15140 ||| NN
of  ||| S:15140 E:15155 ||| IN
cell  ||| S:15155 E:15160 ||| NN
density  ||| S:15160 E:15168 ||| NN
and  ||| S:15168 E:15172 ||| CC
G  ||| S:15172 E:15174 ||| NNP
1phase  ||| S:15174 E:15181 ||| NNP
time  ||| S:15181 E:15198 ||| NN
An  ||| S:15198 E:15201 ||| DT
increase  ||| S:15201 E:15210 ||| NN
in  ||| S:15210 E:15213 ||| IN
the  ||| S:15213 E:15217 ||| DT
fraction  ||| S:15217 E:15226 ||| NN
of  ||| S:15226 E:15229 ||| IN
G  ||| S:15229 E:15244 ||| NNP
1  ||| S:15244 E:15246 ||| CD
cells  ||| S:15246 E:15252 ||| NNS
as  ||| S:15252 E:15255 ||| IN
a  ||| S:15255 E:15257 ||| DT
linear  ||| S:15257 E:15264 ||| JJ
function  ||| S:15264 E:15273 ||| NN
of  ||| S:15273 E:15276 ||| IN
cell  ||| S:15276 E:15293 ||| NN
density  ||| S:15293 E:15301 ||| NN
is  ||| S:15301 E:15304 ||| VBZ
a  ||| S:15304 E:15306 ||| DT
common  ||| S:15306 E:15313 ||| JJ
observation  ||| S:15313 E:15325 ||| NN
in  ||| S:15325 E:15328 ||| IN
this  ||| S:15328 E:15333 ||| DT
laboratory  ||| S:15333 E:15356 ||| NN
[ ||| S:15356 E:15357 ||| -LRB-
e.g. ||| S:15357 E:15361 ||| NNP
,  ||| S:15361 E:15363 ||| ,
Figure  ||| S:15363 E:15370 ||| NNP
4B ||| S:15370 E:15372 ||| NNP
,  ||| S:15372 E:15374 ||| ,
[  ||| S:15374 E:15376 ||| -LRB-
11  ||| S:15376 E:15379 ||| CD
15  ||| S:15379 E:15382 ||| CD
16  ||| S:15382 E:15385 ||| CD
]  ||| S:15385 E:15387 ||| CD
] ||| S:15387 E:15388 ||| -RRB-
.  ||| S:15388 E:15390 ||| .
Figure  ||| S:15390 E:15397 ||| NN
8Bshows  ||| S:15397 E:15405 ||| NN
that  ||| S:15405 E:15422 ||| IN
there  ||| S:15422 E:15428 ||| EX
is  ||| S:15428 E:15431 ||| VBZ
a  ||| S:15431 E:15433 ||| DT
correlated  ||| S:15433 E:15444 ||| JJ
relationship  ||| S:15444 E:15457 ||| NN
between  ||| S:15457 E:15465 ||| IN
the  ||| S:15465 E:15469 ||| DT
slopes ||| S:15469 E:15475 ||| NNS
,  ||| S:15475 E:15489 ||| ,
i.e. ||| S:15489 E:15493 ||| FW
,  ||| S:15493 E:15495 ||| ,
changes  ||| S:15495 E:15503 ||| NNS
in  ||| S:15503 E:15506 ||| IN
Tag  ||| S:15506 E:15510 ||| NNP
concentration  ||| S:15510 E:15524 ||| NN
as  ||| S:15524 E:15527 ||| IN
a  ||| S:15527 E:15529 ||| DT
function  ||| S:15529 E:15538 ||| NN
of  ||| S:15538 E:15541 ||| IN
G  ||| S:15541 E:15556 ||| NNP
1  ||| S:15556 E:15558 ||| CD
phase  ||| S:15558 E:15564 ||| NN
time  ||| S:15564 E:15569 ||| NN
is  ||| S:15569 E:15572 ||| VBZ
correlated  ||| S:15572 E:15583 ||| VBN
with  ||| S:15583 E:15600 ||| IN
changes  ||| S:15600 E:15608 ||| NNS
in  ||| S:15608 E:15611 ||| IN
Tag  ||| S:15611 E:15615 ||| NNP
as  ||| S:15615 E:15618 ||| IN
a  ||| S:15618 E:15620 ||| DT
function  ||| S:15620 E:15629 ||| NN
of  ||| S:15629 E:15632 ||| IN
cell  ||| S:15632 E:15637 ||| NN
density ||| S:15637 E:15644 ||| NN
.  ||| S:15644 E:15680 ||| .
Relationship  ||| S:15680 E:15693 ||| NN
between  ||| S:15693 E:15701 ||| IN
final  ||| S:15701 E:15707 ||| JJ
Tag  ||| S:15707 E:15711 ||| NNP
and  ||| S:15711 E:15715 ||| CC
the  ||| S:15715 E:15719 ||| DT
expression  ||| S:15719 E:15742 ||| NN
profile  ||| S:15742 E:15750 ||| NN
for  ||| S:15750 E:15754 ||| IN
G  ||| S:15754 E:15756 ||| NNP
1  ||| S:15756 E:15770 ||| CD
Figure  ||| S:15770 E:15777 ||| NN
8Cshows  ||| S:15777 E:15785 ||| NN
that  ||| S:15785 E:15790 ||| IN
there  ||| S:15790 E:15796 ||| EX
is  ||| S:15796 E:15799 ||| VBZ
a  ||| S:15799 E:15801 ||| DT
significant  ||| S:15801 E:15825 ||| JJ
correlation  ||| S:15825 E:15837 ||| NN
between  ||| S:15837 E:15845 ||| IN
the  ||| S:15845 E:15849 ||| DT
rate  ||| S:15849 E:15854 ||| NN
of  ||| S:15854 E:15857 ||| IN
change  ||| S:15857 E:15864 ||| NN
of  ||| S:15864 E:15867 ||| IN
T  ||| S:15867 E:15869 ||| NN
antigen  ||| S:15869 E:15877 ||| NN
as  ||| S:15877 E:15892 ||| IN
a  ||| S:15892 E:15894 ||| DT
function  ||| S:15894 E:15903 ||| NN
of  ||| S:15903 E:15906 ||| IN
cell  ||| S:15906 E:15911 ||| NN
cycle  ||| S:15911 E:15917 ||| NN
time  ||| S:15917 E:15922 ||| NN
and  ||| S:15922 E:15926 ||| CC
the  ||| S:15926 E:15930 ||| DT
end-point  ||| S:15930 E:15952 ||| JJ
expression  ||| S:15952 E:15963 ||| NN
level  ||| S:15963 E:15969 ||| NN
determined  ||| S:15969 E:15980 ||| VBN
at  ||| S:15980 E:15983 ||| IN
or  ||| S:15983 E:15986 ||| CC
near  ||| S:15986 E:15991 ||| IN
a  ||| S:15991 E:15993 ||| DT
plateau  ||| S:15993 E:16001 ||| NN
phase  ||| S:16001 E:16019 ||| NN
in  ||| S:16019 E:16022 ||| IN
these  ||| S:16022 E:16028 ||| DT
experiments ||| S:16028 E:16039 ||| NNS
.  ||| S:16039 E:16041 ||| .
Therefore ||| S:16041 E:16050 ||| RB
,  ||| S:16050 E:16052 ||| ,
the  ||| S:16052 E:16056 ||| DT
levels  ||| S:16056 E:16063 ||| NNS
at  ||| S:16063 E:16078 ||| IN
confluence  ||| S:16078 E:16089 ||| NN
or  ||| S:16089 E:16092 ||| CC
plateau  ||| S:16092 E:16100 ||| NN
can  ||| S:16100 E:16104 ||| MD
be  ||| S:16104 E:16107 ||| VB
predicted  ||| S:16107 E:16117 ||| VBN
by  ||| S:16117 E:16120 ||| IN
the  ||| S:16120 E:16124 ||| DT
direction  ||| S:16124 E:16146 ||| NN
and  ||| S:16146 E:16150 ||| CC
rate  ||| S:16150 E:16155 ||| NN
of  ||| S:16155 E:16158 ||| IN
change  ||| S:16158 E:16165 ||| NN
during  ||| S:16165 E:16172 ||| IN
exponential  ||| S:16172 E:16184 ||| JJ
growth ||| S:16184 E:16190 ||| NN
.  ||| S:16190 E:16192 ||| .
Figure  ||| S:16192 E:16211 ||| NN
8Dshows  ||| S:16211 E:16219 ||| NN
that  ||| S:16219 E:16224 ||| IN
the  ||| S:16224 E:16228 ||| DT
same  ||| S:16228 E:16233 ||| JJ
relationship  ||| S:16233 E:16246 ||| NN
holds  ||| S:16246 E:16252 ||| VBZ
true  ||| S:16252 E:16257 ||| JJ
for  ||| S:16257 E:16261 ||| IN
cell  ||| S:16261 E:16278 ||| NN
density ||| S:16278 E:16285 ||| NN
,  ||| S:16285 E:16287 ||| ,
as  ||| S:16287 E:16290 ||| RB
would  ||| S:16290 E:16296 ||| MD
be  ||| S:16296 E:16299 ||| VB
expected  ||| S:16299 E:16308 ||| VBN
from  ||| S:16308 E:16313 ||| IN
Figure  ||| S:16313 E:16320 ||| NNP
8B ||| S:16320 E:16322 ||| NNP
.  ||| S:16322 E:16358 ||| .
Control  ||| S:16358 E:16366 ||| NN
of  ||| S:16366 E:16369 ||| IN
Tag  ||| S:16369 E:16373 ||| NNP
expression  ||| S:16373 E:16384 ||| NN
during  ||| S:16384 E:16391 ||| IN
exponential  ||| S:16391 E:16415 ||| JJ
growth  ||| S:16415 E:16422 ||| NN
is  ||| S:16422 E:16425 ||| VBZ
independent  ||| S:16425 E:16437 ||| JJ
of  ||| S:16437 E:16440 ||| IN
the  ||| S:16440 E:16444 ||| DT
intrinsic  ||| S:16444 E:16454 ||| JJ
expression  ||| S:16454 E:16477 ||| NN
potential  ||| S:16477 E:16499 ||| JJ
Figures  ||| S:16499 E:16507 ||| NNS
8Eand  ||| S:16507 E:16513 ||| CD
8Fshow  ||| S:16513 E:16520 ||| CD
the  ||| S:16520 E:16524 ||| DT
regression  ||| S:16524 E:16535 ||| NN
of  ||| S:16535 E:16538 ||| IN
average  ||| S:16538 E:16546 ||| JJ
Tag  ||| S:16546 E:16562 ||| JJ
expression  ||| S:16562 E:16573 ||| NN
( ||| S:16573 E:16574 ||| -LRB-
Western  ||| S:16574 E:16582 ||| JJ
blot  ||| S:16582 E:16587 ||| NN
in  ||| S:16587 E:16590 ||| IN
Figure  ||| S:16590 E:16597 ||| NNP
2 ||| S:16597 E:16598 ||| CD
)  ||| S:16598 E:16600 ||| -RRB-
on  ||| S:16600 E:16603 ||| IN
the  ||| S:16603 E:16607 ||| DT
G  ||| S:16607 E:16622 ||| NNP
1  ||| S:16622 E:16624 ||| CD
and  ||| S:16624 E:16628 ||| CC
cell  ||| S:16628 E:16633 ||| NN
density  ||| S:16633 E:16641 ||| NN
slopes ||| S:16641 E:16647 ||| NNS
.  ||| S:16647 E:16661 ||| .
Regression  ||| S:16661 E:16672 ||| NNP
of  ||| S:16672 E:16675 ||| IN
data  ||| S:16675 E:16680 ||| NNS
for  ||| S:16680 E:16684 ||| IN
the  ||| S:16684 E:16688 ||| DT
intercept  ||| S:16688 E:16698 ||| JJ
calculations  ||| S:16698 E:16723 ||| NNS
( ||| S:16723 E:16724 ||| -LRB-
e.g. ||| S:16724 E:16728 ||| NNP
,  ||| S:16728 E:16730 ||| ,
as  ||| S:16730 E:16733 ||| RB
in  ||| S:16733 E:16736 ||| IN
Figure  ||| S:16736 E:16743 ||| NNP
8A ||| S:16743 E:16745 ||| NNP
)  ||| S:16745 E:16747 ||| -RRB-
gave  ||| S:16747 E:16752 ||| VBD
a  ||| S:16752 E:16754 ||| DT
similar  ||| S:16754 E:16762 ||| JJ
plot ||| S:16762 E:16766 ||| NN
.  ||| S:16766 E:16768 ||| .
There  ||| S:16768 E:16786 ||| EX
appears  ||| S:16786 E:16794 ||| VBZ
to  ||| S:16794 E:16797 ||| TO
be  ||| S:16797 E:16800 ||| VB
no  ||| S:16800 E:16803 ||| DT
relationship  ||| S:16803 E:16816 ||| NN
between  ||| S:16816 E:16824 ||| IN
the  ||| S:16824 E:16828 ||| DT
intrinsic  ||| S:16828 E:16850 ||| JJ
expression  ||| S:16850 E:16861 ||| NN
"strength ||| S:16861 E:16870 ||| NN
"  ||| S:16870 E:16872 ||| ''
or  ||| S:16872 E:16875 ||| CC
potential  ||| S:16875 E:16885 ||| JJ
and  ||| S:16885 E:16889 ||| CC
change  ||| S:16889 E:16896 ||| NN
in  ||| S:16896 E:16899 ||| IN
Tag  ||| S:16899 E:16915 ||| NNP
expression  ||| S:16915 E:16926 ||| NN
as  ||| S:16926 E:16929 ||| IN
a  ||| S:16929 E:16931 ||| DT
function  ||| S:16931 E:16940 ||| NN
of  ||| S:16940 E:16943 ||| IN
G  ||| S:16943 E:16958 ||| NNP
1  ||| S:16958 E:16960 ||| CD
phase  ||| S:16960 E:16966 ||| NN
fraction  ||| S:16966 E:16975 ||| NN
( ||| S:16975 E:16976 ||| -LRB-
time ||| S:16976 E:16980 ||| NN
)  ||| S:16980 E:16982 ||| -RRB-
or  ||| S:16982 E:16985 ||| CC
cell  ||| S:16985 E:17002 ||| NN
density ||| S:17002 E:17009 ||| NN
,  ||| S:17009 E:17011 ||| ,
i.e. ||| S:17011 E:17015 ||| FW
,  ||| S:17015 E:17017 ||| ,
growth  ||| S:17017 E:17024 ||| NN
related  ||| S:17024 E:17032 ||| VBN
control  ||| S:17032 E:17040 ||| NN
of  ||| S:17040 E:17043 ||| IN
Tag  ||| S:17043 E:17059 ||| NNP
expression ||| S:17059 E:17069 ||| NN
.  ||| S:17069 E:17113 ||| .
Discussion  ||| S:17113 E:17132 ||| NN
There  ||| S:17132 E:17138 ||| EX
is  ||| S:17138 E:17141 ||| VBZ
good  ||| S:17141 E:17146 ||| JJ
evidence  ||| S:17146 E:17155 ||| NN
that  ||| S:17155 E:17160 ||| IN
quantitative  ||| S:17160 E:17173 ||| JJ
changes  ||| S:17173 E:17181 ||| NNS
in  ||| S:17181 E:17184 ||| IN
gene  ||| S:17184 E:17197 ||| NN
expression  ||| S:17197 E:17208 ||| NNS
are  ||| S:17208 E:17212 ||| VBP
important  ||| S:17212 E:17222 ||| JJ
for  ||| S:17222 E:17226 ||| IN
some  ||| S:17226 E:17231 ||| DT
regulatory  ||| S:17231 E:17242 ||| JJ
genes ||| S:17242 E:17247 ||| NNS
.  ||| S:17247 E:17249 ||| .
For  ||| S:17249 E:17261 ||| IN
example ||| S:17261 E:17268 ||| NN
,  ||| S:17268 E:17270 ||| ,
periodic  ||| S:17270 E:17279 ||| JJ
quantitative  ||| S:17279 E:17292 ||| JJ
changes  ||| S:17292 E:17300 ||| NNS
in  ||| S:17300 E:17303 ||| IN
the  ||| S:17303 E:17307 ||| DT
levels  ||| S:17307 E:17314 ||| NNS
of  ||| S:17314 E:17325 ||| IN
cyclin  ||| S:17325 E:17332 ||| JJ
proteins  ||| S:17332 E:17341 ||| NNS
that  ||| S:17341 E:17346 ||| IN
activate  ||| S:17346 E:17355 ||| FW
cyclin  ||| S:17355 E:17362 ||| FW
dependent  ||| S:17362 E:17380 ||| FW
serine ||| S:17380 E:17386 ||| FW
/ ||| S:17386 E:17387 ||| FW
threonine  ||| S:17387 E:17397 ||| FW
kinases  ||| S:17397 E:17405 ||| FW
( ||| S:17405 E:17406 ||| -LRB-
cdk ||| S:17406 E:17409 ||| NN
's ||| S:17409 E:17411 ||| POS
)  ||| S:17411 E:17413 ||| -RRB-
appear  ||| S:17413 E:17420 ||| VBP
to  ||| S:17420 E:17423 ||| TO
be  ||| S:17423 E:17426 ||| VB
the  ||| S:17426 E:17430 ||| DT
"core ||| S:17430 E:17435 ||| NN
"  ||| S:17435 E:17445 ||| ''
cell  ||| S:17445 E:17450 ||| NN
cycle  ||| S:17450 E:17456 ||| NN
machinery  ||| S:17456 E:17466 ||| NN
in  ||| S:17466 E:17469 ||| IN
mammalian  ||| S:17469 E:17479 ||| JJ
cells ||| S:17479 E:17484 ||| NNS
.  ||| S:17484 E:17486 ||| .
In  ||| S:17486 E:17489 ||| IN
this  ||| S:17489 E:17494 ||| DT
case ||| S:17494 E:17498 ||| NN
,  ||| S:17498 E:17508 ||| ,
cyclin  ||| S:17508 E:17515 ||| JJ
molecular  ||| S:17515 E:17525 ||| JJ
concentration  ||| S:17525 E:17539 ||| NN
is  ||| S:17539 E:17542 ||| VBZ
directly  ||| S:17542 E:17551 ||| RB
related  ||| S:17551 E:17559 ||| VBN
to  ||| S:17559 E:17562 ||| TO
cdk  ||| S:17562 E:17574 ||| VB
activity  ||| S:17574 E:17583 ||| NN
and  ||| S:17583 E:17587 ||| CC
activity  ||| S:17587 E:17596 ||| NN
is  ||| S:17596 E:17599 ||| VBZ
directly  ||| S:17599 E:17608 ||| RB
related  ||| S:17608 E:17616 ||| VBN
to  ||| S:17616 E:17619 ||| TO
cell  ||| S:17619 E:17624 ||| NN
cycle  ||| S:17624 E:17638 ||| NN
transition  ||| S:17638 E:17649 ||| NN
rates  ||| S:17649 E:17655 ||| NNS
[  ||| S:17655 E:17657 ||| -LRB-
17  ||| S:17657 E:17660 ||| CD
]  ||| S:17660 E:17662 ||| -RRB-
.  ||| S:17662 E:17664 ||| .
When  ||| S:17664 E:17669 ||| WRB
regulatory  ||| S:17669 E:17680 ||| JJ
proteins  ||| S:17680 E:17689 ||| NNS
affect  ||| S:17689 E:17704 ||| VBP
cell  ||| S:17704 E:17709 ||| NN
processes  ||| S:17709 E:17719 ||| VBZ
involved  ||| S:17719 E:17728 ||| VBN
in  ||| S:17728 E:17731 ||| IN
disease ||| S:17731 E:17738 ||| NN
,  ||| S:17738 E:17740 ||| ,
measurement  ||| S:17740 E:17752 ||| NN
of  ||| S:17752 E:17763 ||| IN
molecular  ||| S:17763 E:17773 ||| JJ
concentration  ||| S:17773 E:17787 ||| NN
takes  ||| S:17787 E:17793 ||| VBZ
on  ||| S:17793 E:17796 ||| IN
added  ||| S:17796 E:17802 ||| JJ
importance ||| S:17802 E:17812 ||| NN
.  ||| S:17812 E:17814 ||| .
For  ||| S:17814 E:17826 ||| IN
example ||| S:17826 E:17833 ||| NN
,  ||| S:17833 E:17835 ||| ,
the  ||| S:17835 E:17839 ||| DT
expression  ||| S:17839 E:17850 ||| NN
of  ||| S:17850 E:17853 ||| IN
a  ||| S:17853 E:17855 ||| DT
number  ||| S:17855 E:17862 ||| NN
of  ||| S:17862 E:17865 ||| IN
oncogenes ||| S:17865 E:17874 ||| NNS
,  ||| S:17874 E:17884 ||| ,
proto-oncogenes ||| S:17884 E:17899 ||| NNP
,  ||| S:17899 E:17901 ||| ,
and  ||| S:17901 E:17905 ||| CC
reduced  ||| S:17905 E:17913 ||| VBN
or  ||| S:17913 E:17916 ||| CC
absence  ||| S:17916 E:17924 ||| NN
of  ||| S:17924 E:17927 ||| IN
expression  ||| S:17927 E:17938 ||| NN
of  ||| S:17938 E:17949 ||| IN
recessive  ||| S:17949 E:17959 ||| JJ
oncogenes  ||| S:17959 E:17969 ||| NN
has  ||| S:17969 E:17973 ||| VBZ
been  ||| S:17973 E:17978 ||| VBN
postulated  ||| S:17978 E:17989 ||| VBN
to  ||| S:17989 E:17992 ||| TO
provide  ||| S:17992 E:18008 ||| VB
diagnostic  ||| S:18008 E:18019 ||| JJ
and ||| S:18019 E:18022 ||| CC
/ ||| S:18022 E:18023 ||| NNP
or  ||| S:18023 E:18026 ||| CC
prognostic  ||| S:18026 E:18037 ||| JJ
information  ||| S:18037 E:18049 ||| NN
in  ||| S:18049 E:18052 ||| IN
human  ||| S:18052 E:18058 ||| JJ
cancers  ||| S:18058 E:18074 ||| NNS
[ ||| S:18074 E:18075 ||| -LRB-
e.g. ||| S:18075 E:18079 ||| NNP
,  ||| S:18079 E:18081 ||| ,
[  ||| S:18081 E:18083 ||| -LRB-
18  ||| S:18083 E:18086 ||| CD
19  ||| S:18086 E:18089 ||| CD
20  ||| S:18089 E:18092 ||| CD
]  ||| S:18092 E:18094 ||| CD
] ||| S:18094 E:18095 ||| -RRB-
.  ||| S:18095 E:18097 ||| .
Currently ||| S:18097 E:18106 ||| RB
,  ||| S:18106 E:18108 ||| ,
cancer  ||| S:18108 E:18115 ||| NN
gene  ||| S:18115 E:18120 ||| NN
expression  ||| S:18120 E:18139 ||| NN
research  ||| S:18139 E:18148 ||| NN
is  ||| S:18148 E:18151 ||| VBZ
seldom  ||| S:18151 E:18158 ||| RB
done  ||| S:18158 E:18163 ||| VBN
in  ||| S:18163 E:18166 ||| IN
a  ||| S:18166 E:18168 ||| DT
rigorously  ||| S:18168 E:18179 ||| JJ
quantitative  ||| S:18179 E:18200 ||| JJ
manner ||| S:18200 E:18206 ||| NN
,  ||| S:18206 E:18208 ||| ,
which  ||| S:18208 E:18214 ||| WDT
may  ||| S:18214 E:18218 ||| MD
contribute  ||| S:18218 E:18229 ||| VB
to  ||| S:18229 E:18232 ||| TO
the  ||| S:18232 E:18236 ||| DT
sometimes  ||| S:18236 E:18246 ||| RB
conflicting  ||| S:18246 E:18266 ||| JJ
results  ||| S:18266 E:18274 ||| NNS
[  ||| S:18274 E:18276 ||| -LRB-
21  ||| S:18276 E:18279 ||| CD
]  ||| S:18279 E:18281 ||| -RRB-
.  ||| S:18281 E:18283 ||| .
Much  ||| S:18283 E:18288 ||| JJ
evidence  ||| S:18288 E:18297 ||| NN
leads  ||| S:18297 E:18303 ||| VBZ
to  ||| S:18303 E:18306 ||| TO
the  ||| S:18306 E:18310 ||| DT
conclusion  ||| S:18310 E:18321 ||| NN
that  ||| S:18321 E:18334 ||| IN
the  ||| S:18334 E:18338 ||| DT
tumorigenic  ||| S:18338 E:18350 ||| JJ
phenotype  ||| S:18350 E:18360 ||| NN
of  ||| S:18360 E:18363 ||| IN
mammalian  ||| S:18363 E:18373 ||| JJ
cells  ||| S:18373 E:18379 ||| NNS
is  ||| S:18379 E:18382 ||| VBZ
markedly  ||| S:18382 E:18399 ||| RB
affected  ||| S:18399 E:18408 ||| VBN
by  ||| S:18408 E:18411 ||| IN
quantitative  ||| S:18411 E:18424 ||| JJ
changes  ||| S:18424 E:18432 ||| NNS
in  ||| S:18432 E:18435 ||| IN
expression  ||| S:18435 E:18446 ||| NN
of  ||| S:18446 E:18457 ||| IN
regulatory  ||| S:18457 E:18468 ||| JJ
genes ||| S:18468 E:18473 ||| NNS
.  ||| S:18473 E:18475 ||| .
In  ||| S:18475 E:18478 ||| IN
experimental  ||| S:18478 E:18491 ||| JJ
systems ||| S:18491 E:18498 ||| NNS
,  ||| S:18498 E:18500 ||| ,
small  ||| S:18500 E:18506 ||| JJ
shifts  ||| S:18506 E:18513 ||| NNS
in  ||| S:18513 E:18524 ||| IN
expression  ||| S:18524 E:18535 ||| NN
can  ||| S:18535 E:18539 ||| MD
have  ||| S:18539 E:18544 ||| VB
profound  ||| S:18544 E:18553 ||| JJ
consequences ||| S:18553 E:18565 ||| NNS
.  ||| S:18565 E:18567 ||| .
For  ||| S:18567 E:18571 ||| IN
instance ||| S:18571 E:18579 ||| NN
,  ||| S:18579 E:18581 ||| ,
in  ||| S:18581 E:18592 ||| IN
NIH  ||| S:18592 E:18596 ||| NNP
3T3  ||| S:18596 E:18600 ||| NNP
cells ||| S:18600 E:18605 ||| NNS
,  ||| S:18605 E:18607 ||| ,
expression  ||| S:18607 E:18618 ||| NN
of  ||| S:18618 E:18621 ||| IN
SV40  ||| S:18621 E:18626 ||| CD
large  ||| S:18626 E:18632 ||| JJ
T  ||| S:18632 E:18634 ||| NN
antigen  ||| S:18634 E:18642 ||| NN
( ||| S:18642 E:18643 ||| -LRB-
Tag ||| S:18643 E:18646 ||| NNP
)  ||| S:18646 E:18648 ||| -RRB-
at  ||| S:18648 E:18659 ||| IN
high  ||| S:18659 E:18664 ||| JJ
levels  ||| S:18664 E:18671 ||| NNS
( ||| S:18671 E:18672 ||| -LRB-
~2  ||| S:18672 E:18675 ||| CD
  ||| S:18675 E:18677 ||| CD
10  ||| S:18677 E:18680 ||| CD
6molecules  ||| S:18680 E:18691 ||| CD
per  ||| S:18691 E:18695 ||| IN
G  ||| S:18695 E:18706 ||| NNP
1  ||| S:18706 E:18708 ||| CD
cell ||| S:18708 E:18712 ||| NN
)  ||| S:18712 E:18714 ||| -RRB-
decreases  ||| S:18714 E:18724 ||| VBZ
the  ||| S:18724 E:18728 ||| DT
G  ||| S:18728 E:18739 ||| NNP
1  ||| S:18739 E:18741 ||| CD
phase  ||| S:18741 E:18747 ||| NN
time  ||| S:18747 E:18752 ||| NN
by  ||| S:18752 E:18755 ||| IN
~18 ||| S:18755 E:18758 ||| CD
%  ||| S:18758 E:18760 ||| NN
[  ||| S:18760 E:18762 ||| -LRB-
3  ||| S:18762 E:18764 ||| CD
11  ||| S:18764 E:18767 ||| CD
]  ||| S:18767 E:18769 ||| -RRB-
.  ||| S:18769 E:18771 ||| .
However ||| S:18771 E:18778 ||| RB
,  ||| S:18778 E:18788 ||| ,
~43 ||| S:18788 E:18791 ||| CD
%  ||| S:18791 E:18793 ||| NN
of  ||| S:18793 E:18796 ||| IN
this  ||| S:18796 E:18801 ||| DT
effect  ||| S:18801 E:18808 ||| NN
can  ||| S:18808 E:18812 ||| MD
be  ||| S:18812 E:18815 ||| VB
accounted  ||| S:18815 E:18825 ||| VBN
for  ||| S:18825 E:18829 ||| IN
with  ||| S:18829 E:18834 ||| IN
the  ||| S:18834 E:18838 ||| DT
initial  ||| S:18838 E:18854 ||| JJ
expression  ||| S:18854 E:18865 ||| NN
of  ||| S:18865 E:18868 ||| IN
~  ||| S:18868 E:18870 ||| CD
6000-14,000  ||| S:18870 E:18882 ||| CD
molecules  ||| S:18882 E:18892 ||| NNS
per  ||| S:18892 E:18896 ||| IN
G  ||| S:18896 E:18907 ||| NNP
1  ||| S:18907 E:18909 ||| CD
cell  ||| S:18909 E:18914 ||| NN
and  ||| S:18914 E:18918 ||| CC
~87 ||| S:18918 E:18921 ||| CD
%  ||| S:18921 E:18923 ||| NN
can  ||| S:18923 E:18927 ||| MD
be  ||| S:18927 E:18930 ||| VB
accounted  ||| S:18930 E:18940 ||| VBN
for  ||| S:18940 E:18944 ||| IN
by  ||| S:18944 E:18955 ||| IN
expression  ||| S:18955 E:18966 ||| NN
of  ||| S:18966 E:18969 ||| IN
~  ||| S:18969 E:18971 ||| CD
103,000-133,000  ||| S:18971 E:18987 ||| CD
molecules  ||| S:18987 E:18997 ||| NNS
[  ||| S:18997 E:18999 ||| -LRB-
3  ||| S:18999 E:19001 ||| CD
11  ||| S:19001 E:19004 ||| CD
]  ||| S:19004 E:19006 ||| -RRB-
.  ||| S:19006 E:19016 ||| .
Previously ||| S:19016 E:19026 ||| RB
,  ||| S:19026 E:19028 ||| ,
we  ||| S:19028 E:19031 ||| PRP
measured  ||| S:19031 E:19040 ||| VBD
the  ||| S:19040 E:19044 ||| DT
relative  ||| S:19044 E:19053 ||| JJ
dose  ||| S:19053 E:19058 ||| NN
response  ||| S:19058 E:19067 ||| NN
for  ||| S:19067 E:19071 ||| IN
G  ||| S:19071 E:19090 ||| NNP
1  ||| S:19090 E:19092 ||| CD
transit  ||| S:19092 E:19100 ||| NN
for  ||| S:19100 E:19104 ||| IN
SV40  ||| S:19104 E:19109 ||| CD
Large  ||| S:19109 E:19115 ||| JJ
T  ||| S:19115 E:19117 ||| NN
antigen  ||| S:19117 E:19133 ||| VBZ
expressed  ||| S:19133 E:19143 ||| VBN
in  ||| S:19143 E:19146 ||| IN
NIH  ||| S:19146 E:19150 ||| NNP
3T3  ||| S:19150 E:19154 ||| NNP
cells ||| S:19154 E:19159 ||| NNS
.  ||| S:19159 E:19161 ||| .
In  ||| S:19161 E:19164 ||| IN
this  ||| S:19164 E:19169 ||| DT
work ||| S:19169 E:19173 ||| NN
,  ||| S:19173 E:19175 ||| ,
the  ||| S:19175 E:19179 ||| DT
levels  ||| S:19179 E:19186 ||| NNS
of  ||| S:19186 E:19189 ||| IN
Tag  ||| S:19189 E:19201 ||| NNP
in  ||| S:19201 E:19204 ||| IN
G  ||| S:19204 E:19215 ||| NNP
1  ||| S:19215 E:19217 ||| CD
increased  ||| S:19217 E:19227 ||| VBD
18 ||| S:19227 E:19229 ||| CD
%  ||| S:19229 E:19231 ||| NN
during  ||| S:19231 E:19238 ||| IN
exponential  ||| S:19238 E:19258 ||| JJ
population  ||| S:19258 E:19269 ||| NN
growth  ||| S:19269 E:19276 ||| NN
as  ||| S:19276 E:19279 ||| IN
the  ||| S:19279 E:19283 ||| DT
length  ||| S:19283 E:19290 ||| NN
of  ||| S:19290 E:19293 ||| IN
G  ||| S:19293 E:19304 ||| NNP
1  ||| S:19304 E:19306 ||| CD
was  ||| S:19306 E:19310 ||| VBD
increasing  ||| S:19310 E:19321 ||| VBG
[  ||| S:19321 E:19323 ||| -LRB-
11  ||| S:19323 E:19326 ||| CD
]  ||| S:19326 E:19328 ||| -RRB-
.  ||| S:19328 E:19330 ||| .
Since  ||| S:19330 E:19336 ||| IN
Tag  ||| S:19336 E:19340 ||| NNP
is  ||| S:19340 E:19351 ||| VBZ
rate-limiting  ||| S:19351 E:19365 ||| JJ
for  ||| S:19365 E:19369 ||| IN
G  ||| S:19369 E:19380 ||| NNP
1  ||| S:19380 E:19382 ||| CD
transit  ||| S:19382 E:19390 ||| NN
in  ||| S:19390 E:19393 ||| IN
these  ||| S:19393 E:19399 ||| DT
cells ||| S:19399 E:19404 ||| NNS
,  ||| S:19404 E:19406 ||| ,
the  ||| S:19406 E:19410 ||| DT
increase  ||| S:19410 E:19427 ||| NN
in  ||| S:19427 E:19430 ||| IN
transit  ||| S:19430 E:19438 ||| JJ
time  ||| S:19438 E:19443 ||| NN
as  ||| S:19443 E:19446 ||| IN
a  ||| S:19446 E:19448 ||| DT
function  ||| S:19448 E:19457 ||| NN
of  ||| S:19457 E:19460 ||| IN
G  ||| S:19460 E:19471 ||| NNP
1  ||| S:19471 E:19473 ||| CD
Tag  ||| S:19473 E:19477 ||| JJ
concentration  ||| S:19477 E:19491 ||| NN
represented  ||| S:19491 E:19503 ||| VBD
an  ||| S:19503 E:19514 ||| DT
apparent  ||| S:19514 E:19523 ||| JJ
paradox  ||| S:19523 E:19531 ||| NN
that  ||| S:19531 E:19536 ||| WDT
is  ||| S:19536 E:19539 ||| VBZ
resolved  ||| S:19539 E:19548 ||| VBN
( ||| S:19548 E:19549 ||| -LRB-
in  ||| S:19549 E:19552 ||| IN
the  ||| S:19552 E:19556 ||| DT
simplest  ||| S:19556 E:19565 ||| NN
and  ||| S:19565 E:19577 ||| CC
obvious  ||| S:19577 E:19585 ||| JJ
manner ||| S:19585 E:19591 ||| NN
)  ||| S:19591 E:19593 ||| -RRB-
by  ||| S:19593 E:19596 ||| IN
stating  ||| S:19596 E:19604 ||| VBG
that  ||| S:19604 E:19609 ||| IN
additional  ||| S:19609 E:19620 ||| JJ
rate-limiting  ||| S:19620 E:19642 ||| JJ
entities  ||| S:19642 E:19651 ||| NNS
operate  ||| S:19651 E:19659 ||| VBP
to  ||| S:19659 E:19662 ||| TO
set  ||| S:19662 E:19666 ||| VB
the  ||| S:19666 E:19670 ||| DT
G  ||| S:19670 E:19681 ||| NNP
1  ||| S:19681 E:19683 ||| CD
transit  ||| S:19683 E:19691 ||| NN
time ||| S:19691 E:19695 ||| NN
.  ||| S:19695 E:19697 ||| .
One  ||| S:19697 E:19701 ||| PRP
easily  ||| S:19701 E:19708 ||| RB
measured  ||| S:19708 E:19717 ||| VBN
and  ||| S:19717 E:19729 ||| CC
pervasive  ||| S:19729 E:19739 ||| JJ
entity  ||| S:19739 E:19746 ||| NN
that  ||| S:19746 E:19751 ||| WDT
regulates  ||| S:19751 E:19761 ||| VBZ
G  ||| S:19761 E:19772 ||| NNP
1  ||| S:19772 E:19774 ||| CD
phase  ||| S:19774 E:19780 ||| NN
time  ||| S:19780 E:19785 ||| NN
is  ||| S:19785 E:19788 ||| VBZ
cell  ||| S:19788 E:19793 ||| NN
density ||| S:19793 E:19800 ||| NN
,  ||| S:19800 E:19802 ||| ,
which  ||| S:19802 E:19808 ||| WDT
is  ||| S:19808 E:19819 ||| VBZ
taken  ||| S:19819 E:19825 ||| VBN
as  ||| S:19825 E:19828 ||| IN
a  ||| S:19828 E:19830 ||| DT
surrogate  ||| S:19830 E:19840 ||| NN
for  ||| S:19840 E:19844 ||| IN
cell-cell  ||| S:19844 E:19854 ||| JJ
contact ||| S:19854 E:19861 ||| NN
.  ||| S:19861 E:19863 ||| .
This  ||| S:19863 E:19868 ||| DT
effect  ||| S:19868 E:19875 ||| NN
can  ||| S:19875 E:19887 ||| MD
be  ||| S:19887 E:19890 ||| VB
separated  ||| S:19890 E:19900 ||| JJ
analytically  ||| S:19900 E:19913 ||| NN
from  ||| S:19913 E:19918 ||| IN
growth  ||| S:19918 E:19925 ||| NN
factor  ||| S:19925 E:19932 ||| NN
concentration  ||| S:19932 E:19954 ||| NN
[  ||| S:19954 E:19956 ||| -LRB-
15  ||| S:19956 E:19959 ||| CD
16  ||| S:19959 E:19962 ||| CD
]  ||| S:19962 E:19964 ||| -RRB-
and  ||| S:19964 E:19968 ||| CC
therefore ||| S:19968 E:19977 ||| RB
,  ||| S:19977 E:19979 ||| ,
appears  ||| S:19979 E:19987 ||| VBZ
to  ||| S:19987 E:19990 ||| TO
measure  ||| S:19990 E:19998 ||| VB
independent  ||| S:19998 E:20018 ||| JJ
cell  ||| S:20018 E:20023 ||| NN
cycle  ||| S:20023 E:20029 ||| NN
regulatory  ||| S:20029 E:20040 ||| JJ
mechanisms ||| S:20040 E:20050 ||| NNS
.  ||| S:20050 E:20052 ||| .
Our  ||| S:20052 E:20056 ||| PRP$
work  ||| S:20056 E:20061 ||| NN
[  ||| S:20061 E:20063 ||| -LRB-
6  ||| S:20063 E:20065 ||| CD
11  ||| S:20065 E:20068 ||| CD
]  ||| S:20068 E:20070 ||| -RRB-
and  ||| S:20070 E:20082 ||| CC
most  ||| S:20082 E:20087 ||| RBS
other  ||| S:20087 E:20093 ||| JJ
work  ||| S:20093 E:20098 ||| NN
indicates  ||| S:20098 E:20108 ||| VBZ
that  ||| S:20108 E:20113 ||| IN
the  ||| S:20113 E:20117 ||| DT
cell  ||| S:20117 E:20122 ||| NN
density  ||| S:20122 E:20130 ||| VBZ
dependent  ||| S:20130 E:20148 ||| JJ
mechanisms  ||| S:20148 E:20159 ||| NNS
that  ||| S:20159 E:20164 ||| WDT
negatively  ||| S:20164 E:20175 ||| RB
regulate  ||| S:20175 E:20184 ||| VB
cell  ||| S:20184 E:20189 ||| NN
proliferation  ||| S:20189 E:20203 ||| NNS
are  ||| S:20203 E:20215 ||| VBP
dominant  ||| S:20215 E:20224 ||| JJ
to  ||| S:20224 E:20227 ||| TO
Tag ||| S:20227 E:20230 ||| NNP
.  ||| S:20230 E:20232 ||| .
Indeed  ||| S:20232 E:20239 ||| RB
this  ||| S:20239 E:20244 ||| DT
may  ||| S:20244 E:20248 ||| MD
be  ||| S:20248 E:20251 ||| VB
universal  ||| S:20251 E:20261 ||| JJ
for  ||| S:20261 E:20273 ||| IN
oncogenes ||| S:20273 E:20282 ||| NNS
,  ||| S:20282 E:20284 ||| ,
since  ||| S:20284 E:20290 ||| IN
we  ||| S:20290 E:20293 ||| PRP
are  ||| S:20293 E:20297 ||| VBP
not  ||| S:20297 E:20301 ||| RB
aware  ||| S:20301 E:20307 ||| JJ
of  ||| S:20307 E:20310 ||| IN
instances  ||| S:20310 E:20320 ||| NNS
when  ||| S:20320 E:20333 ||| WRB
anchorage  ||| S:20333 E:20343 ||| JJ
dependent  ||| S:20343 E:20353 ||| JJ
cells  ||| S:20353 E:20359 ||| NNS
fail  ||| S:20359 E:20364 ||| VBP
to  ||| S:20364 E:20367 ||| TO
enter  ||| S:20367 E:20373 ||| VB
a  ||| S:20373 E:20375 ||| DT
plateau  ||| S:20375 E:20383 ||| NN
phase  ||| S:20383 E:20389 ||| NN
in  ||| S:20389 E:20400 ||| IN
tissue  ||| S:20400 E:20407 ||| NN
culture ||| S:20407 E:20414 ||| NN
.  ||| S:20414 E:20424 ||| .
The  ||| S:20424 E:20428 ||| DT
study  ||| S:20428 E:20434 ||| NN
presented  ||| S:20434 E:20444 ||| VBN
in  ||| S:20444 E:20447 ||| IN
this  ||| S:20447 E:20452 ||| DT
paper  ||| S:20452 E:20458 ||| NN
represents  ||| S:20458 E:20469 ||| VBZ
further  ||| S:20469 E:20485 ||| JJ
investigation  ||| S:20485 E:20499 ||| NN
into  ||| S:20499 E:20504 ||| IN
the  ||| S:20504 E:20508 ||| DT
effect  ||| S:20508 E:20515 ||| NN
of  ||| S:20515 E:20518 ||| IN
cell  ||| S:20518 E:20523 ||| NN
density  ||| S:20523 E:20531 ||| NN
on  ||| S:20531 E:20534 ||| IN
gene  ||| S:20534 E:20547 ||| NN
expression ||| S:20547 E:20557 ||| NN
.  ||| S:20557 E:20559 ||| .
Cell  ||| S:20559 E:20564 ||| NN
lines  ||| S:20564 E:20570 ||| NNS
were  ||| S:20570 E:20575 ||| VBD
created  ||| S:20575 E:20583 ||| VBN
by  ||| S:20583 E:20586 ||| IN
incorporation  ||| S:20586 E:20600 ||| NN
of  ||| S:20600 E:20611 ||| IN
retroviral  ||| S:20611 E:20622 ||| JJ
vectors  ||| S:20622 E:20630 ||| NN
into  ||| S:20630 E:20635 ||| IN
the  ||| S:20635 E:20639 ||| DT
genome  ||| S:20639 E:20646 ||| NN
and  ||| S:20646 E:20650 ||| CC
expression  ||| S:20650 E:20661 ||| NN
of  ||| S:20661 E:20664 ||| IN
Tag  ||| S:20664 E:20676 ||| NNP
from  ||| S:20676 E:20681 ||| IN
either  ||| S:20681 E:20688 ||| RB
the  ||| S:20688 E:20692 ||| DT
retroviral  ||| S:20692 E:20703 ||| JJ
LTR  ||| S:20703 E:20707 ||| NNP
( ||| S:20707 E:20708 ||| -LRB-
considered  ||| S:20708 E:20719 ||| VBN
to  ||| S:20719 E:20722 ||| TO
be  ||| S:20722 E:20725 ||| VB
a  ||| S:20725 E:20727 ||| DT
strong  ||| S:20727 E:20742 ||| JJ
promoter ||| S:20742 E:20750 ||| NN
)  ||| S:20750 E:20752 ||| -RRB-
or  ||| S:20752 E:20755 ||| CC
the  ||| S:20755 E:20759 ||| DT
herpes  ||| S:20759 E:20766 ||| JJ
virus  ||| S:20766 E:20772 ||| NN
thymidine  ||| S:20772 E:20782 ||| VBZ
kinase  ||| S:20782 E:20789 ||| JJ
promoter ||| S:20789 E:20797 ||| NN
,  ||| S:20797 E:20807 ||| ,
internal  ||| S:20807 E:20816 ||| JJ
to  ||| S:20816 E:20819 ||| TO
the  ||| S:20819 E:20823 ||| DT
viral  ||| S:20823 E:20829 ||| JJ
LTR  ||| S:20829 E:20833 ||| NNP
[  ||| S:20833 E:20835 ||| -LRB-
1  ||| S:20835 E:20837 ||| LS
]  ||| S:20837 E:20839 ||| -RRB-
.  ||| S:20839 E:20841 ||| .
In  ||| S:20841 E:20844 ||| IN
our  ||| S:20844 E:20848 ||| PRP$
established  ||| S:20848 E:20860 ||| JJ
NIH  ||| S:20860 E:20872 ||| NNP
3T3  ||| S:20872 E:20876 ||| NNP
cell  ||| S:20876 E:20881 ||| NN
line ||| S:20881 E:20885 ||| NN
,  ||| S:20885 E:20887 ||| ,
Tag  ||| S:20887 E:20891 ||| NNP
is  ||| S:20891 E:20894 ||| VBZ
expressed  ||| S:20894 E:20904 ||| VBN
from  ||| S:20904 E:20909 ||| IN
the  ||| S:20909 E:20913 ||| DT
htk  ||| S:20913 E:20917 ||| JJ
promoter  ||| S:20917 E:20926 ||| NN
at  ||| S:20926 E:20937 ||| IN
considerably  ||| S:20937 E:20950 ||| RB
lower  ||| S:20950 E:20956 ||| JJR
levels  ||| S:20956 E:20963 ||| NNS
than  ||| S:20963 E:20968 ||| IN
from  ||| S:20968 E:20973 ||| IN
the  ||| S:20973 E:20977 ||| DT
LTR  ||| S:20977 E:20981 ||| NNP
for  ||| S:20981 E:20985 ||| IN
a  ||| S:20985 E:20995 ||| DT
considerable  ||| S:20995 E:21008 ||| JJ
time  ||| S:21008 E:21013 ||| NN
after  ||| S:21013 E:21019 ||| IN
transduction  ||| S:21019 E:21032 ||| NNS
[ ||| S:21032 E:21033 ||| -LRB-
unpublished  ||| S:21033 E:21053 ||| JJ
observations ||| S:21053 E:21065 ||| NNS
,  ||| S:21065 E:21067 ||| ,
and  ||| S:21067 E:21071 ||| CC
[  ||| S:21071 E:21073 ||| -LRB-
11  ||| S:21073 E:21076 ||| CD
]  ||| S:21076 E:21078 ||| CD
] ||| S:21078 E:21079 ||| -RRB-
.  ||| S:21079 E:21081 ||| .
However ||| S:21081 E:21088 ||| RB
,  ||| S:21088 E:21090 ||| ,
when  ||| S:21090 E:21095 ||| WRB
a  ||| S:21095 E:21097 ||| DT
large  ||| S:21097 E:21103 ||| JJ
number  ||| S:21103 E:21110 ||| NN
of  ||| S:21110 E:21121 ||| IN
htk-Tag  ||| S:21121 E:21129 ||| JJ
astrocyte  ||| S:21129 E:21139 ||| JJ
clones  ||| S:21139 E:21146 ||| NNS
were  ||| S:21146 E:21151 ||| VBD
checked  ||| S:21151 E:21159 ||| VBN
100  ||| S:21159 E:21163 ||| CD
days  ||| S:21163 E:21168 ||| NNS
after  ||| S:21168 E:21182 ||| IN
creation ||| S:21182 E:21190 ||| NN
,  ||| S:21190 E:21192 ||| ,
the  ||| S:21192 E:21196 ||| DT
expression  ||| S:21196 E:21207 ||| NN
levels  ||| S:21207 E:21214 ||| NNS
displayed  ||| S:21214 E:21224 ||| VBD
a  ||| S:21224 E:21226 ||| DT
very  ||| S:21226 E:21231 ||| RB
large  ||| S:21231 E:21245 ||| JJ
range ||| S:21245 E:21250 ||| NN
,  ||| S:21250 E:21252 ||| ,
and  ||| S:21252 E:21256 ||| CC
thus  ||| S:21256 E:21261 ||| RB
we  ||| S:21261 E:21264 ||| PRP
expect  ||| S:21264 E:21271 ||| VBP
that  ||| S:21271 E:21276 ||| IN
this  ||| S:21276 E:21281 ||| DT
weak  ||| S:21281 E:21286 ||| JJ
promoter  ||| S:21286 E:21295 ||| NN
is  ||| S:21295 E:21306 ||| VBZ
subject  ||| S:21306 E:21314 ||| JJ
to  ||| S:21314 E:21317 ||| TO
positional  ||| S:21317 E:21328 ||| VB
effects  ||| S:21328 E:21336 ||| NNS
on  ||| S:21336 E:21339 ||| IN
transcription  ||| S:21339 E:21353 ||| NN
or  ||| S:21353 E:21364 ||| CC
mutational  ||| S:21364 E:21375 ||| JJ
events  ||| S:21375 E:21382 ||| NNS
that  ||| S:21382 E:21387 ||| WDT
affect  ||| S:21387 E:21394 ||| VBP
gene  ||| S:21394 E:21399 ||| NN
expression  ||| S:21399 E:21410 ||| NN
( ||| S:21410 E:21411 ||| -LRB-
unpublished  ||| S:21411 E:21431 ||| JJ
data ||| S:21431 E:21435 ||| NNS
) ||| S:21435 E:21436 ||| -RRB-
.  ||| S:21436 E:21438 ||| .
Polyclonal  ||| S:21438 E:21449 ||| JJ
populations  ||| S:21449 E:21461 ||| NNS
produced  ||| S:21461 E:21470 ||| VBN
by  ||| S:21470 E:21473 ||| IN
transduction  ||| S:21473 E:21486 ||| NN
of  ||| S:21486 E:21497 ||| IN
htk-Tag  ||| S:21497 E:21505 ||| JJ
vectors  ||| S:21505 E:21513 ||| NN
that  ||| S:21513 E:21518 ||| WDT
were  ||| S:21518 E:21523 ||| VBD
passaged  ||| S:21523 E:21532 ||| VBN
without  ||| S:21532 E:21540 ||| IN
selection ||| S:21540 E:21549 ||| NN
,  ||| S:21549 E:21559 ||| ,
displayed  ||| S:21559 E:21569 ||| VBN
expression  ||| S:21569 E:21580 ||| NN
levels  ||| S:21580 E:21587 ||| NNS
equivalent  ||| S:21587 E:21598 ||| NN
to  ||| S:21598 E:21601 ||| TO
or  ||| S:21601 E:21604 ||| CC
higher  ||| S:21604 E:21611 ||| JJR
than  ||| S:21611 E:21624 ||| IN
LTR-Tag  ||| S:21624 E:21632 ||| JJ
cell  ||| S:21632 E:21637 ||| NN
lines  ||| S:21637 E:21643 ||| NNS
( ||| S:21643 E:21644 ||| -LRB-
Frisa  ||| S:21644 E:21650 ||| NNP
and  ||| S:21650 E:21654 ||| CC
Jacobberger ||| S:21654 E:21665 ||| NNP
,  ||| S:21665 E:21667 ||| ,
unpublished  ||| S:21667 E:21687 ||| JJ
data ||| S:21687 E:21691 ||| NNS
) ||| S:21691 E:21692 ||| -RRB-
.  ||| S:21692 E:21694 ||| .
This  ||| S:21694 E:21699 ||| DT
selection  ||| S:21699 E:21709 ||| NN
for  ||| S:21709 E:21713 ||| IN
increased  ||| S:21713 E:21723 ||| JJ
Tag  ||| S:21723 E:21727 ||| JJ
expression  ||| S:21727 E:21738 ||| NN
makes  ||| S:21738 E:21752 ||| VBZ
sense  ||| S:21752 E:21758 ||| NN
given  ||| S:21758 E:21764 ||| VBN
the  ||| S:21764 E:21768 ||| DT
low  ||| S:21768 E:21772 ||| JJ
growth  ||| S:21772 E:21779 ||| NN
rate  ||| S:21779 E:21784 ||| NN
of  ||| S:21784 E:21787 ||| IN
primary  ||| S:21787 E:21795 ||| JJ
mouse  ||| S:21795 E:21801 ||| NN
astrocytes  ||| S:21801 E:21820 ||| NNS
and  ||| S:21820 E:21824 ||| CC
the  ||| S:21824 E:21828 ||| DT
ability  ||| S:21828 E:21836 ||| NN
of  ||| S:21836 E:21839 ||| IN
Tag  ||| S:21839 E:21843 ||| NNP
to  ||| S:21843 E:21846 ||| TO
decrease  ||| S:21846 E:21855 ||| VB
the  ||| S:21855 E:21859 ||| DT
cell  ||| S:21859 E:21864 ||| NN
cycle  ||| S:21864 E:21870 ||| NN
time  ||| S:21870 E:21875 ||| NN
[  ||| S:21875 E:21877 ||| -LRB-
11  ||| S:21877 E:21888 ||| CD
]  ||| S:21888 E:21890 ||| -RRB-
and  ||| S:21890 E:21894 ||| CC
increase  ||| S:21894 E:21903 ||| VB
saturation  ||| S:21903 E:21914 ||| JJ
density  ||| S:21914 E:21922 ||| NNS
[ ||| S:21922 E:21923 ||| -LRB-
e.g. ||| S:21923 E:21927 ||| NNP
,  ||| S:21927 E:21929 ||| ,
[  ||| S:21929 E:21931 ||| -LRB-
4  ||| S:21931 E:21933 ||| CD
6  ||| S:21933 E:21935 ||| CD
]  ||| S:21935 E:21937 ||| CD
] ||| S:21937 E:21938 ||| -RRB-
.  ||| S:21938 E:21940 ||| .
In  ||| S:21940 E:21943 ||| IN
this  ||| S:21943 E:21956 ||| DT
study ||| S:21956 E:21961 ||| NN
,  ||| S:21961 E:21963 ||| ,
the  ||| S:21963 E:21967 ||| DT
expression  ||| S:21967 E:21978 ||| NN
potential  ||| S:21978 E:21988 ||| NN
of  ||| S:21988 E:21991 ||| IN
cell  ||| S:21991 E:21996 ||| NN
lines  ||| S:21996 E:22002 ||| NNS
was  ||| S:22002 E:22006 ||| VBD
not  ||| S:22006 E:22018 ||| RB
related  ||| S:22018 E:22026 ||| VBN
to  ||| S:22026 E:22029 ||| TO
proliferation  ||| S:22029 E:22043 ||| VB
related  ||| S:22043 E:22051 ||| VBN
changes  ||| S:22051 E:22059 ||| NNS
in  ||| S:22059 E:22062 ||| IN
expression  ||| S:22062 E:22073 ||| NN
of  ||| S:22073 E:22084 ||| IN
Tag ||| S:22084 E:22087 ||| NNP
,  ||| S:22087 E:22089 ||| ,
emphasizing  ||| S:22089 E:22101 ||| VBG
that  ||| S:22101 E:22106 ||| IN
clonal  ||| S:22106 E:22113 ||| JJ
variation  ||| S:22113 E:22123 ||| NN
for  ||| S:22123 E:22127 ||| IN
whatever  ||| S:22127 E:22136 ||| JJ
reason  ||| S:22136 E:22151 ||| NN
( ||| S:22151 E:22152 ||| -LRB-
which  ||| S:22152 E:22158 ||| WDT
includes  ||| S:22158 E:22167 ||| VBZ
promoter  ||| S:22167 E:22176 ||| JJ
strength ||| S:22176 E:22184 ||| NN
)  ||| S:22184 E:22186 ||| -RRB-
accounts  ||| S:22186 E:22195 ||| NNS
for  ||| S:22195 E:22199 ||| IN
the  ||| S:22199 E:22203 ||| DT
large  ||| S:22203 E:22217 ||| JJ
range  ||| S:22217 E:22223 ||| NN
of  ||| S:22223 E:22226 ||| IN
htk  ||| S:22226 E:22230 ||| JJ
related  ||| S:22230 E:22238 ||| JJ
expression ||| S:22238 E:22248 ||| NN
.  ||| S:22248 E:22258 ||| .
Making  ||| S:22258 E:22265 ||| VBG
sense  ||| S:22265 E:22271 ||| NN
of  ||| S:22271 E:22274 ||| IN
a  ||| S:22274 E:22276 ||| DT
quantitative  ||| S:22276 E:22289 ||| JJ
description  ||| S:22289 E:22301 ||| NN
of  ||| S:22301 E:22304 ||| IN
the  ||| S:22304 E:22308 ||| DT
role  ||| S:22308 E:22321 ||| NN
of  ||| S:22321 E:22324 ||| IN
Tag  ||| S:22324 E:22328 ||| NNP
and  ||| S:22328 E:22332 ||| CC
other  ||| S:22332 E:22338 ||| JJ
regulatory  ||| S:22338 E:22349 ||| JJ
proteins  ||| S:22349 E:22358 ||| NNS
in  ||| S:22358 E:22361 ||| IN
cell  ||| S:22361 E:22366 ||| NN
cycle  ||| S:22366 E:22380 ||| NN
regulation  ||| S:22380 E:22391 ||| NN
and  ||| S:22391 E:22395 ||| CC
cell  ||| S:22395 E:22400 ||| NN
transformation  ||| S:22400 E:22415 ||| NN
requires  ||| S:22415 E:22424 ||| VBZ
either  ||| S:22424 E:22431 ||| RB
that  ||| S:22431 E:22436 ||| IN
all  ||| S:22436 E:22448 ||| PDT
the  ||| S:22448 E:22452 ||| DT
parameters  ||| S:22452 E:22463 ||| NN
affecting  ||| S:22463 E:22473 ||| VBG
expression  ||| S:22473 E:22484 ||| NNS
are  ||| S:22484 E:22488 ||| VBP
measured  ||| S:22488 E:22497 ||| VBN
at  ||| S:22497 E:22500 ||| IN
the  ||| S:22500 E:22512 ||| DT
same  ||| S:22512 E:22517 ||| JJ
time  ||| S:22517 E:22522 ||| NN
so  ||| S:22522 E:22525 ||| RB
that  ||| S:22525 E:22530 ||| IN
differences  ||| S:22530 E:22542 ||| NNS
can  ||| S:22542 E:22546 ||| MD
be  ||| S:22546 E:22549 ||| VB
accounted  ||| S:22549 E:22559 ||| VBN
for ||| S:22559 E:22562 ||| IN
,  ||| S:22562 E:22564 ||| ,
or  ||| S:22564 E:22567 ||| CC
an  ||| S:22567 E:22578 ||| DT
ability  ||| S:22578 E:22586 ||| NN
to  ||| S:22586 E:22589 ||| TO
compute  ||| S:22589 E:22597 ||| VB
some  ||| S:22597 E:22602 ||| DT
base  ||| S:22602 E:22607 ||| NN
line  ||| S:22607 E:22612 ||| NN
or  ||| S:22612 E:22615 ||| CC
"expression  ||| S:22615 E:22627 ||| CD
potential ||| S:22627 E:22636 ||| JJ
"  ||| S:22636 E:22646 ||| ''
statistic  ||| S:22646 E:22656 ||| NN
with  ||| S:22656 E:22661 ||| IN
which  ||| S:22661 E:22667 ||| WDT
to  ||| S:22667 E:22670 ||| TO
evaluate  ||| S:22670 E:22679 ||| VB
differences  ||| S:22679 E:22691 ||| NNS
( ||| S:22691 E:22692 ||| -LRB-
e.g. ||| S:22692 E:22696 ||| NNP
,  ||| S:22696 E:22698 ||| ,
between  ||| S:22698 E:22714 ||| IN
cell  ||| S:22714 E:22719 ||| NN
lines ||| S:22719 E:22724 ||| NNS
) ||| S:22724 E:22725 ||| -RRB-
.  ||| S:22725 E:22727 ||| .
A  ||| S:22727 E:22729 ||| DT
practical  ||| S:22729 E:22739 ||| JJ
application  ||| S:22739 E:22751 ||| NN
of  ||| S:22751 E:22754 ||| IN
this  ||| S:22754 E:22759 ||| DT
knowledge  ||| S:22759 E:22769 ||| NN
is  ||| S:22769 E:22780 ||| VBZ
the  ||| S:22780 E:22784 ||| DT
ability  ||| S:22784 E:22792 ||| NN
to  ||| S:22792 E:22795 ||| TO
create  ||| S:22795 E:22802 ||| VB
biological  ||| S:22802 E:22813 ||| JJ
standards  ||| S:22813 E:22823 ||| NNS
from  ||| S:22823 E:22828 ||| IN
cell  ||| S:22828 E:22833 ||| NN
lines  ||| S:22833 E:22847 ||| NNS
that  ||| S:22847 E:22852 ||| WDT
express  ||| S:22852 E:22860 ||| VBP
varying  ||| S:22860 E:22868 ||| VBG
levels  ||| S:22868 E:22875 ||| NNS
of  ||| S:22875 E:22878 ||| IN
a  ||| S:22878 E:22880 ||| DT
given  ||| S:22880 E:22886 ||| VBN
protein  ||| S:22886 E:22894 ||| NN
and  ||| S:22894 E:22898 ||| CC
then  ||| S:22898 E:22903 ||| RB
use  ||| S:22903 E:22915 ||| VB
these  ||| S:22915 E:22921 ||| DT
in  ||| S:22921 E:22924 ||| IN
quantitative  ||| S:22924 E:22937 ||| JJ
and ||| S:22937 E:22940 ||| CC
/ ||| S:22940 E:22941 ||| NNP
or  ||| S:22941 E:22944 ||| CC
longitudinal  ||| S:22944 E:22957 ||| JJ
experiments ||| S:22957 E:22968 ||| NNS
.  ||| S:22968 E:22978 ||| .
Clearly ||| S:22978 E:22985 ||| RB
,  ||| S:22985 E:22987 ||| ,
in  ||| S:22987 E:22990 ||| IN
cases  ||| S:22990 E:22996 ||| NNS
where  ||| S:22996 E:23002 ||| WRB
gene  ||| S:23002 E:23007 ||| NN
expression  ||| S:23007 E:23018 ||| NN
varies  ||| S:23018 E:23033 ||| VBZ
significantly  ||| S:23033 E:23047 ||| RB
with  ||| S:23047 E:23052 ||| IN
cell  ||| S:23052 E:23057 ||| NN
density  ||| S:23057 E:23065 ||| NNS
( ||| S:23065 E:23066 ||| -LRB-
e.g. ||| S:23066 E:23070 ||| NNP
,  ||| S:23070 E:23072 ||| ,
P0-3DtkT ||| S:23072 E:23080 ||| RB
# ||| S:23080 E:23081 ||| #
5 ||| S:23081 E:23082 ||| CD
) ||| S:23082 E:23083 ||| -RRB-
,  ||| S:23083 E:23085 ||| ,
use  ||| S:23085 E:23089 ||| NN
of  ||| S:23089 E:23100 ||| IN
these  ||| S:23100 E:23106 ||| DT
cells  ||| S:23106 E:23112 ||| NNS
as  ||| S:23112 E:23115 ||| IN
a  ||| S:23115 E:23117 ||| DT
standard  ||| S:23117 E:23126 ||| NN
in  ||| S:23126 E:23129 ||| IN
a  ||| S:23129 E:23131 ||| DT
longitudinal  ||| S:23131 E:23144 ||| JJ
study  ||| S:23144 E:23150 ||| NN
would  ||| S:23150 E:23164 ||| MD
require  ||| S:23164 E:23172 ||| VB
that  ||| S:23172 E:23177 ||| IN
the  ||| S:23177 E:23181 ||| DT
standard  ||| S:23181 E:23190 ||| NN
was  ||| S:23190 E:23194 ||| VBD
measured  ||| S:23194 E:23203 ||| VBN
at  ||| S:23203 E:23206 ||| IN
the  ||| S:23206 E:23210 ||| DT
same  ||| S:23210 E:23215 ||| JJ
cell  ||| S:23215 E:23228 ||| NN
density  ||| S:23228 E:23236 ||| NN
for  ||| S:23236 E:23240 ||| IN
each  ||| S:23240 E:23245 ||| DT
experimental  ||| S:23245 E:23258 ||| JJ
sampling ||| S:23258 E:23266 ||| NN
,  ||| S:23266 E:23268 ||| ,
or  ||| S:23268 E:23271 ||| CC
that  ||| S:23271 E:23276 ||| IN
a  ||| S:23276 E:23278 ||| DT
derived  ||| S:23278 E:23294 ||| JJ
statistic  ||| S:23294 E:23304 ||| NNS
( ||| S:23304 E:23305 ||| -LRB-
Expression ||| S:23305 E:23315 ||| NNP
/ ||| S:23315 E:23316 ||| NNP
Density  ||| S:23316 E:23324 ||| NNP
or  ||| S:23324 E:23327 ||| CC
Expression ||| S:23327 E:23337 ||| NNP
/ ||| S:23337 E:23338 ||| NNP
G  ||| S:23338 E:23349 ||| NNP
1  ||| S:23349 E:23351 ||| CD
intercepts ||| S:23351 E:23361 ||| CD
)  ||| S:23361 E:23363 ||| -RRB-
is  ||| S:23363 E:23366 ||| VBZ
used  ||| S:23366 E:23371 ||| VBN
to  ||| S:23371 E:23374 ||| TO
normalize  ||| S:23374 E:23384 ||| VB
the  ||| S:23384 E:23396 ||| DT
data ||| S:23396 E:23400 ||| NNS
.  ||| S:23400 E:23402 ||| .
In  ||| S:23402 E:23405 ||| IN
this  ||| S:23405 E:23410 ||| DT
regard ||| S:23410 E:23416 ||| NN
,  ||| S:23416 E:23418 ||| ,
the  ||| S:23418 E:23422 ||| DT
good  ||| S:23422 E:23427 ||| JJ
agreement  ||| S:23427 E:23437 ||| NN
between  ||| S:23437 E:23445 ||| IN
the  ||| S:23445 E:23457 ||| DT
intercepts  ||| S:23457 E:23468 ||| NN
and  ||| S:23468 E:23472 ||| CC
non-density  ||| S:23472 E:23484 ||| JJ
corrected  ||| S:23484 E:23494 ||| JJ
Western  ||| S:23494 E:23502 ||| JJ
blot  ||| S:23502 E:23507 ||| JJ
data  ||| S:23507 E:23512 ||| NNS
for  ||| S:23512 E:23524 ||| IN
cell  ||| S:23524 E:23529 ||| NN
lines  ||| S:23529 E:23535 ||| NNS
varying  ||| S:23535 E:23543 ||| VBG
over  ||| S:23543 E:23548 ||| IN
a  ||| S:23548 E:23550 ||| DT
20-fold  ||| S:23550 E:23558 ||| JJ
range  ||| S:23558 E:23564 ||| NN
is  ||| S:23564 E:23567 ||| VBZ
supportive ||| S:23567 E:23577 ||| JJ
.  ||| S:23577 E:23587 ||| .
Originally ||| S:23587 E:23597 ||| RB
,  ||| S:23597 E:23599 ||| ,
we  ||| S:23599 E:23602 ||| PRP
pursued  ||| S:23602 E:23610 ||| VBD
a  ||| S:23610 E:23612 ||| DT
strategy  ||| S:23612 E:23621 ||| NN
of  ||| S:23621 E:23624 ||| IN
reduced  ||| S:23624 E:23632 ||| JJ
Tag  ||| S:23632 E:23644 ||| JJ
expression  ||| S:23644 E:23655 ||| NN
from  ||| S:23655 E:23660 ||| IN
the  ||| S:23660 E:23664 ||| DT
htk  ||| S:23664 E:23668 ||| JJ
promoter  ||| S:23668 E:23677 ||| NN
as  ||| S:23677 E:23680 ||| IN
a  ||| S:23680 E:23682 ||| DT
means  ||| S:23682 E:23688 ||| NNS
of  ||| S:23688 E:23691 ||| IN
producing  ||| S:23691 E:23709 ||| VBG
immortalized ||| S:23709 E:23721 ||| NN
,  ||| S:23721 E:23723 ||| ,
differentiated  ||| S:23723 E:23738 ||| JJ
cells  ||| S:23738 E:23744 ||| NNS
that  ||| S:23744 E:23749 ||| WDT
may  ||| S:23749 E:23753 ||| MD
have  ||| S:23753 E:23758 ||| VB
a  ||| S:23758 E:23760 ||| DT
reduced  ||| S:23760 E:23776 ||| JJ
transformation  ||| S:23776 E:23791 ||| NN
phenotype ||| S:23791 E:23800 ||| NN
.  ||| S:23800 E:23802 ||| .
We  ||| S:23802 E:23805 ||| PRP
noticed  ||| S:23805 E:23813 ||| VBD
however ||| S:23813 E:23820 ||| RB
,  ||| S:23820 E:23822 ||| ,
that  ||| S:23822 E:23835 ||| WDT
initially  ||| S:23835 E:23845 ||| RB
slow  ||| S:23845 E:23850 ||| VB
growing  ||| S:23850 E:23858 ||| VBG
cell  ||| S:23858 E:23863 ||| NN
lines  ||| S:23863 E:23869 ||| NNS
produced  ||| S:23869 E:23878 ||| VBN
with  ||| S:23878 E:23883 ||| IN
htk  ||| S:23883 E:23887 ||| VBG
driven  ||| S:23887 E:23902 ||| VBN
gene  ||| S:23902 E:23907 ||| NN
expression  ||| S:23907 E:23918 ||| NN
needed  ||| S:23918 E:23925 ||| VBN
to  ||| S:23925 E:23928 ||| TO
be  ||| S:23928 E:23931 ||| VB
cloned  ||| S:23931 E:23938 ||| VBN
early  ||| S:23938 E:23944 ||| JJ
to  ||| S:23944 E:23947 ||| TO
prevent  ||| S:23947 E:23963 ||| VB
overgrowth  ||| S:23963 E:23974 ||| VBN
of  ||| S:23974 E:23977 ||| IN
more  ||| S:23977 E:23982 ||| RBR
rapidly  ||| S:23982 E:23990 ||| RB
growing  ||| S:23990 E:23998 ||| VBG
cells  ||| S:23998 E:24004 ||| NNS
that  ||| S:24004 E:24009 ||| WDT
expressed  ||| S:24009 E:24027 ||| VBD
high  ||| S:24027 E:24032 ||| JJ
levels  ||| S:24032 E:24039 ||| NNS
of  ||| S:24039 E:24042 ||| IN
Tag ||| S:24042 E:24045 ||| NNP
.  ||| S:24045 E:24047 ||| .
This  ||| S:24047 E:24052 ||| DT
was  ||| S:24052 E:24056 ||| VBD
not  ||| S:24056 E:24060 ||| RB
true  ||| S:24060 E:24065 ||| JJ
for  ||| S:24065 E:24069 ||| IN
clonal  ||| S:24069 E:24076 ||| NN
or  ||| S:24076 E:24087 ||| CC
polyclonal  ||| S:24087 E:24098 ||| JJ
transductants  ||| S:24098 E:24112 ||| NN
that  ||| S:24112 E:24117 ||| WDT
expressed  ||| S:24117 E:24127 ||| VBD
Tag  ||| S:24127 E:24131 ||| NNP
from  ||| S:24131 E:24136 ||| IN
the  ||| S:24136 E:24140 ||| DT
MoMuLV  ||| S:24140 E:24155 ||| JJ
LTR ||| S:24155 E:24158 ||| NNP
,  ||| S:24158 E:24160 ||| ,
which  ||| S:24160 E:24166 ||| WDT
supports  ||| S:24166 E:24175 ||| VBZ
a  ||| S:24175 E:24177 ||| DT
high  ||| S:24177 E:24182 ||| JJ
level  ||| S:24182 E:24188 ||| NN
of  ||| S:24188 E:24191 ||| IN
expression  ||| S:24191 E:24202 ||| NN
( ||| S:24202 E:24203 ||| -LRB-
unpublished  ||| S:24203 E:24223 ||| JJ
observations ||| S:24223 E:24235 ||| NNS
) ||| S:24235 E:24236 ||| -RRB-
.  ||| S:24236 E:24238 ||| .
In  ||| S:24238 E:24241 ||| IN
the  ||| S:24241 E:24245 ||| DT
context  ||| S:24245 E:24253 ||| NN
of  ||| S:24253 E:24256 ||| IN
this  ||| S:24256 E:24261 ||| DT
study ||| S:24261 E:24266 ||| NN
,  ||| S:24266 E:24268 ||| ,
we  ||| S:24268 E:24271 ||| PRP
wished  ||| S:24271 E:24278 ||| VBD
to  ||| S:24278 E:24289 ||| TO
explore  ||| S:24289 E:24297 ||| VB
density  ||| S:24297 E:24305 ||| JJ
dependent  ||| S:24305 E:24315 ||| JJ
expression  ||| S:24315 E:24326 ||| NN
as  ||| S:24326 E:24329 ||| IN
a  ||| S:24329 E:24331 ||| DT
function  ||| S:24331 E:24340 ||| NN
of  ||| S:24340 E:24343 ||| IN
these  ||| S:24343 E:24357 ||| DT
two  ||| S:24357 E:24361 ||| CD
types  ||| S:24361 E:24367 ||| NNS
of  ||| S:24367 E:24370 ||| IN
transformants ||| S:24370 E:24383 ||| NN
.  ||| S:24383 E:24385 ||| .
The  ||| S:24385 E:24389 ||| DT
data  ||| S:24389 E:24394 ||| NNS
presented  ||| S:24394 E:24404 ||| VBD
here  ||| S:24404 E:24409 ||| RB
show  ||| S:24409 E:24422 ||| VB
that  ||| S:24422 E:24427 ||| IN
LTR  ||| S:24427 E:24431 ||| NNP
driven  ||| S:24431 E:24438 ||| FW
Tag  ||| S:24438 E:24442 ||| FW
expressing  ||| S:24442 E:24453 ||| FW
cell  ||| S:24453 E:24458 ||| NN
lines  ||| S:24458 E:24464 ||| NNS
either  ||| S:24464 E:24471 ||| RB
increase  ||| S:24471 E:24488 ||| VB
Tag  ||| S:24488 E:24492 ||| NNP
during  ||| S:24492 E:24499 ||| IN
exponential  ||| S:24499 E:24511 ||| JJ
growth  ||| S:24511 E:24518 ||| NN
despite  ||| S:24518 E:24526 ||| IN
a  ||| S:24526 E:24528 ||| DT
progressively  ||| S:24528 E:24550 ||| RB
increasing  ||| S:24550 E:24561 ||| VBG
G  ||| S:24561 E:24572 ||| NNP
1  ||| S:24572 E:24574 ||| CD
phase  ||| S:24574 E:24580 ||| NN
and  ||| S:24580 E:24584 ||| CC
contact  ||| S:24584 E:24592 ||| NN
inhibition  ||| S:24592 E:24603 ||| NNS
( ||| S:24603 E:24604 ||| -LRB-
density ||| S:24604 E:24611 ||| LS
)  ||| S:24611 E:24621 ||| -RRB-
or  ||| S:24621 E:24624 ||| CC
the  ||| S:24624 E:24628 ||| DT
levels  ||| S:24628 E:24635 ||| NNS
to  ||| S:24635 E:24638 ||| TO
not  ||| S:24638 E:24642 ||| RB
change  ||| S:24642 E:24649 ||| VB
significantly ||| S:24649 E:24662 ||| RB
,  ||| S:24662 E:24664 ||| ,
whereas  ||| S:24664 E:24672 ||| IN
those  ||| S:24672 E:24686 ||| DT
created  ||| S:24686 E:24694 ||| VBN
with  ||| S:24694 E:24699 ||| IN
the  ||| S:24699 E:24703 ||| DT
htk  ||| S:24703 E:24707 ||| JJ
promoter  ||| S:24707 E:24716 ||| NNS
show  ||| S:24716 E:24721 ||| VBP
varying  ||| S:24721 E:24729 ||| VBG
degrees  ||| S:24729 E:24737 ||| NNS
of  ||| S:24737 E:24748 ||| IN
reduced  ||| S:24748 E:24756 ||| JJ
expression ||| S:24756 E:24766 ||| NN
,  ||| S:24766 E:24768 ||| ,
that  ||| S:24768 E:24773 ||| WDT
is  ||| S:24773 E:24776 ||| VBZ
consistent  ||| S:24776 E:24787 ||| JJ
in  ||| S:24787 E:24790 ||| IN
magnitude  ||| S:24790 E:24800 ||| NN
between  ||| S:24800 E:24816 ||| IN
experiments ||| S:24816 E:24827 ||| NNS
,  ||| S:24827 E:24829 ||| ,
as  ||| S:24829 E:24832 ||| IN
the  ||| S:24832 E:24836 ||| DT
cell  ||| S:24836 E:24841 ||| NN
cycle  ||| S:24841 E:24847 ||| NN
lengthens ||| S:24847 E:24856 ||| NN
.  ||| S:24856 E:24858 ||| .
This  ||| S:24858 E:24863 ||| DT
suggests  ||| S:24863 E:24880 ||| VBZ
that  ||| S:24880 E:24885 ||| IN
the  ||| S:24885 E:24889 ||| DT
LTR  ||| S:24889 E:24893 ||| NNP
is  ||| S:24893 E:24896 ||| VBZ
less  ||| S:24896 E:24901 ||| JJR
density  ||| S:24901 E:24909 ||| NNS
regulated  ||| S:24909 E:24919 ||| VBN
than  ||| S:24919 E:24924 ||| IN
the  ||| S:24924 E:24928 ||| DT
htk  ||| S:24928 E:24940 ||| JJ
promoter ||| S:24940 E:24948 ||| NN
,  ||| S:24948 E:24950 ||| ,
which  ||| S:24950 E:24956 ||| WDT
is  ||| S:24956 E:24959 ||| VBZ
subject  ||| S:24959 E:24967 ||| JJ
to  ||| S:24967 E:24970 ||| TO
down  ||| S:24970 E:24975 ||| JJ
regulation  ||| S:24975 E:24986 ||| NN
as  ||| S:24986 E:24989 ||| IN
the  ||| S:24989 E:24993 ||| DT
cell  ||| S:24993 E:25006 ||| NN
cycle  ||| S:25006 E:25012 ||| NN
lengthens  ||| S:25012 E:25022 ||| NN
during  ||| S:25022 E:25029 ||| IN
contact  ||| S:25029 E:25037 ||| NN
inhibition  ||| S:25037 E:25048 ||| NN
of  ||| S:25048 E:25051 ||| IN
growth ||| S:25051 E:25057 ||| NN
.  ||| S:25057 E:25059 ||| .
The  ||| S:25059 E:25071 ||| DT
single  ||| S:25071 E:25078 ||| JJ
exception  ||| S:25078 E:25088 ||| NN
is  ||| S:25088 E:25091 ||| VBZ
the  ||| S:25091 E:25095 ||| DT
pattern  ||| S:25095 E:25103 ||| NN
of  ||| S:25103 E:25106 ||| IN
expression  ||| S:25106 E:25117 ||| NN
observed  ||| S:25117 E:25126 ||| VBD
for  ||| S:25126 E:25138 ||| IN
an  ||| S:25138 E:25141 ||| DT
LTR  ||| S:25141 E:25145 ||| NN
driven  ||| S:25145 E:25152 ||| VBN
line  ||| S:25152 E:25157 ||| NN
expressing  ||| S:25157 E:25168 ||| VBG
a  ||| S:25168 E:25170 ||| DT
form  ||| S:25170 E:25175 ||| NN
of  ||| S:25175 E:25178 ||| IN
Tag  ||| S:25178 E:25182 ||| NNP
that  ||| S:25182 E:25187 ||| WDT
is  ||| S:25187 E:25190 ||| VBZ
mutant  ||| S:25190 E:25205 ||| VBN
in  ||| S:25205 E:25208 ||| IN
binding  ||| S:25208 E:25216 ||| VBG
the  ||| S:25216 E:25220 ||| DT
Rb  ||| S:25220 E:25223 ||| JJ
family  ||| S:25223 E:25230 ||| NN
proteins  ||| S:25230 E:25239 ||| NNS
[ ||| S:25239 E:25240 ||| -LRB-
e.g. ||| S:25240 E:25244 ||| NNP
,  ||| S:25244 E:25246 ||| ,
[  ||| S:25246 E:25248 ||| -LRB-
22  ||| S:25248 E:25251 ||| CD
]  ||| S:25251 E:25253 ||| CD
] ||| S:25253 E:25254 ||| -RRB-
.  ||| S:25254 E:25256 ||| .
This  ||| S:25256 E:25269 ||| DT
density-dependent  ||| S:25269 E:25287 ||| JJ
reduction  ||| S:25287 E:25297 ||| NN
inTag  ||| S:25297 E:25303 ||| JJ
expression  ||| S:25303 E:25314 ||| NN
was  ||| S:25314 E:25318 ||| VBD
somewhat  ||| S:25318 E:25335 ||| RB
surprising ||| S:25335 E:25345 ||| JJ
.  ||| S:25345 E:25347 ||| .
We  ||| S:25347 E:25350 ||| PRP
do  ||| S:25350 E:25353 ||| VBP
not  ||| S:25353 E:25357 ||| RB
know  ||| S:25357 E:25362 ||| VB
the  ||| S:25362 E:25366 ||| DT
half  ||| S:25366 E:25371 ||| NN
life  ||| S:25371 E:25376 ||| NN
of  ||| S:25376 E:25379 ||| IN
this  ||| S:25379 E:25384 ||| DT
mutant  ||| S:25384 E:25391 ||| JJ
T  ||| S:25391 E:25401 ||| NN
antigen  ||| S:25401 E:25409 ||| NN
( ||| S:25409 E:25410 ||| -LRB-
K1 ||| S:25410 E:25412 ||| NNP
) ||| S:25412 E:25413 ||| -RRB-
.  ||| S:25413 E:25415 ||| .
Since  ||| S:25415 E:25421 ||| IN
it  ||| S:25421 E:25424 ||| PRP
is  ||| S:25424 E:25427 ||| VBZ
expressed  ||| S:25427 E:25437 ||| VBN
at  ||| S:25437 E:25440 ||| IN
levels  ||| S:25440 E:25447 ||| NNS
that  ||| S:25447 E:25452 ||| WDT
are  ||| S:25452 E:25456 ||| VBP
1-2  ||| S:25456 E:25468 ||| RB
fold  ||| S:25468 E:25473 ||| VB
that  ||| S:25473 E:25478 ||| IN
of  ||| S:25478 E:25481 ||| IN
wild-type  ||| S:25481 E:25491 ||| NNP
Tag  ||| S:25491 E:25495 ||| NNP
in  ||| S:25495 E:25498 ||| IN
NIH  ||| S:25498 E:25502 ||| NNP
3T3  ||| S:25502 E:25506 ||| NNP
cells  ||| S:25506 E:25512 ||| NNS
[  ||| S:25512 E:25514 ||| -LRB-
23  ||| S:25514 E:25517 ||| CD
]  ||| S:25517 E:25519 ||| -RRB-
,  ||| S:25519 E:25521 ||| ,
we  ||| S:25521 E:25532 ||| PRP
would  ||| S:25532 E:25538 ||| MD
not  ||| S:25538 E:25542 ||| RB
expect  ||| S:25542 E:25549 ||| VB
that  ||| S:25549 E:25554 ||| IN
the  ||| S:25554 E:25558 ||| DT
half  ||| S:25558 E:25563 ||| NN
life  ||| S:25563 E:25568 ||| NN
was  ||| S:25568 E:25572 ||| VBD
significantly  ||| S:25572 E:25586 ||| RB
lower  ||| S:25586 E:25600 ||| JJR
than  ||| S:25600 E:25605 ||| IN
that  ||| S:25605 E:25610 ||| DT
of  ||| S:25610 E:25613 ||| IN
wild  ||| S:25613 E:25618 ||| JJ
type ||| S:25618 E:25622 ||| NN
.  ||| S:25622 E:25624 ||| .
Alternatively ||| S:25624 E:25637 ||| RB
,  ||| S:25637 E:25639 ||| ,
the  ||| S:25639 E:25643 ||| DT
cell  ||| S:25643 E:25648 ||| NN
line  ||| S:25648 E:25653 ||| NN
used  ||| S:25653 E:25666 ||| VBD
here  ||| S:25666 E:25671 ||| RB
is  ||| S:25671 E:25674 ||| VBZ
a  ||| S:25674 E:25676 ||| DT
low  ||| S:25676 E:25680 ||| JJ
expressing  ||| S:25680 E:25691 ||| JJ
cell  ||| S:25691 E:25696 ||| NN
line  ||| S:25696 E:25701 ||| NN
(  ||| S:25701 E:25702 ||| -LRB-
< ||| S:25702 E:25703 ||| SYM
2  ||| S:25703 E:25705 ||| CD
fold  ||| S:25705 E:25710 ||| NN
above  ||| S:25710 E:25716 ||| IN
the  ||| S:25716 E:25728 ||| DT
lowest  ||| S:25728 E:25735 ||| JJS
expressing  ||| S:25735 E:25746 ||| JJ
cell  ||| S:25746 E:25751 ||| NN
line ||| S:25751 E:25755 ||| NN
) ||| S:25755 E:25756 ||| -RRB-
.  ||| S:25756 E:25758 ||| .
Thus ||| S:25758 E:25762 ||| RB
,  ||| S:25762 E:25764 ||| ,
in  ||| S:25764 E:25767 ||| IN
this  ||| S:25767 E:25772 ||| DT
cell  ||| S:25772 E:25777 ||| NN
line ||| S:25777 E:25781 ||| NN
,  ||| S:25781 E:25783 ||| ,
for  ||| S:25783 E:25795 ||| IN
unknown  ||| S:25795 E:25803 ||| JJ
reasons  ||| S:25803 E:25811 ||| NNS
the  ||| S:25811 E:25815 ||| DT
protein  ||| S:25815 E:25823 ||| NN
could  ||| S:25823 E:25829 ||| MD
be  ||| S:25829 E:25832 ||| VB
less  ||| S:25832 E:25837 ||| RBR
stable ||| S:25837 E:25843 ||| JJ
.  ||| S:25843 E:25845 ||| .
If  ||| S:25845 E:25848 ||| IN
the  ||| S:25848 E:25860 ||| DT
idea  ||| S:25860 E:25865 ||| NN
that  ||| S:25865 E:25870 ||| IN
transcription  ||| S:25870 E:25884 ||| JJ
strength  ||| S:25884 E:25893 ||| NN
mainly  ||| S:25893 E:25900 ||| RB
drives  ||| S:25900 E:25907 ||| VBZ
Tag  ||| S:25907 E:25919 ||| JJ
expression  ||| S:25919 E:25930 ||| NN
is  ||| S:25930 E:25933 ||| VBZ
kept  ||| S:25933 E:25938 ||| VBN
as  ||| S:25938 E:25941 ||| IN
the  ||| S:25941 E:25945 ||| DT
working  ||| S:25945 E:25953 ||| JJ
hypothesis ||| S:25953 E:25963 ||| NN
,  ||| S:25963 E:25965 ||| ,
then  ||| S:25965 E:25970 ||| RB
there  ||| S:25970 E:25984 ||| EX
are  ||| S:25984 E:25988 ||| VBP
at  ||| S:25988 E:25991 ||| IN
least  ||| S:25991 E:25997 ||| JJS
three  ||| S:25997 E:26003 ||| CD
possibilities  ||| S:26003 E:26017 ||| NNS
to  ||| S:26017 E:26020 ||| TO
explain  ||| S:26020 E:26028 ||| VB
the  ||| S:26028 E:26032 ||| DT
K1  ||| S:26032 E:26035 ||| CD
data ||| S:26035 E:26039 ||| NNS
:  ||| S:26039 E:26041 ||| :
1 ||| S:26041 E:26042 ||| LS
)  ||| S:26042 E:26052 ||| -RRB-
the  ||| S:26052 E:26056 ||| DT
K1  ||| S:26056 E:26059 ||| JJ
protein  ||| S:26059 E:26067 ||| NN
has  ||| S:26067 E:26071 ||| VBZ
a  ||| S:26071 E:26073 ||| DT
mildly  ||| S:26073 E:26080 ||| RB
shorter  ||| S:26080 E:26088 ||| JJR
half-life  ||| S:26088 E:26098 ||| NN
and  ||| S:26098 E:26102 ||| CC
the  ||| S:26102 E:26106 ||| DT
small  ||| S:26106 E:26120 ||| JJ
difference  ||| S:26120 E:26131 ||| NN
results  ||| S:26131 E:26139 ||| NNS
in  ||| S:26139 E:26142 ||| IN
a  ||| S:26142 E:26144 ||| DT
different  ||| S:26144 E:26154 ||| JJ
phenotype  ||| S:26154 E:26164 ||| JJ
vis--vis  ||| S:26164 E:26174 ||| JJ
the  ||| S:26174 E:26186 ||| DT
density  ||| S:26186 E:26194 ||| JJ
related  ||| S:26194 E:26202 ||| JJ
expression ||| S:26202 E:26212 ||| NN
;  ||| S:26212 E:26214 ||| :
2 ||| S:26214 E:26215 ||| LS
)  ||| S:26215 E:26217 ||| -RRB-
failure  ||| S:26217 E:26225 ||| NN
to  ||| S:26225 E:26228 ||| TO
bind  ||| S:26228 E:26233 ||| VB
Rb  ||| S:26233 E:26236 ||| JJ
family  ||| S:26236 E:26251 ||| NN
members  ||| S:26251 E:26259 ||| NNS
significantly  ||| S:26259 E:26273 ||| RB
affects  ||| S:26273 E:26281 ||| VBZ
the  ||| S:26281 E:26285 ||| DT
half-life  ||| S:26285 E:26295 ||| NN
during  ||| S:26295 E:26310 ||| IN
exponential  ||| S:26310 E:26322 ||| JJ
growth ||| S:26322 E:26328 ||| NN
;  ||| S:26328 E:26330 ||| :
3 ||| S:26330 E:26331 ||| LS
)  ||| S:26331 E:26333 ||| -RRB-
the  ||| S:26333 E:26337 ||| DT
LTR  ||| S:26337 E:26341 ||| NNP
vectors  ||| S:26341 E:26349 ||| NN
can  ||| S:26349 E:26353 ||| MD
occasionally  ||| S:26353 E:26374 ||| RB
display  ||| S:26374 E:26382 ||| VB
integration  ||| S:26382 E:26394 ||| NN
position  ||| S:26394 E:26403 ||| NN
effects  ||| S:26403 E:26411 ||| NNS
that  ||| S:26411 E:26416 ||| IN
in  ||| S:26416 E:26419 ||| IN
this  ||| S:26419 E:26424 ||| DT
special  ||| S:26424 E:26440 ||| JJ
case  ||| S:26440 E:26445 ||| NN
was  ||| S:26445 E:26449 ||| VBD
subject  ||| S:26449 E:26457 ||| JJ
to  ||| S:26457 E:26460 ||| TO
density  ||| S:26460 E:26468 ||| VB
dependent  ||| S:26468 E:26478 ||| JJ
control  ||| S:26478 E:26486 ||| NN
that  ||| S:26486 E:26491 ||| WDT
is  ||| S:26491 E:26502 ||| VBZ
different  ||| S:26502 E:26512 ||| JJ
from  ||| S:26512 E:26517 ||| IN
most  ||| S:26517 E:26522 ||| JJS
LTR  ||| S:26522 E:26526 ||| NN
driven  ||| S:26526 E:26533 ||| VBN
cell  ||| S:26533 E:26538 ||| NN
populations ||| S:26538 E:26549 ||| NNS
.  ||| S:26549 E:26559 ||| .
Both  ||| S:26559 E:26564 ||| PDT
the  ||| S:26564 E:26568 ||| DT
promoters  ||| S:26568 E:26578 ||| NNS
as  ||| S:26578 E:26581 ||| IN
well  ||| S:26581 E:26586 ||| RB
as  ||| S:26586 E:26589 ||| IN
the  ||| S:26589 E:26593 ||| DT
protein  ||| S:26593 E:26601 ||| NN
investigated  ||| S:26601 E:26622 ||| VBD
here  ||| S:26622 E:26627 ||| RB
are  ||| S:26627 E:26631 ||| VBP
viral ||| S:26631 E:26636 ||| VBN
.  ||| S:26636 E:26638 ||| .
The  ||| S:26638 E:26642 ||| DT
cells  ||| S:26642 E:26648 ||| NNS
are  ||| S:26648 E:26652 ||| VBP
dependent  ||| S:26652 E:26662 ||| JJ
on  ||| S:26662 E:26665 ||| IN
Tag  ||| S:26665 E:26669 ||| NNP
expression ||| S:26669 E:26679 ||| NN
,  ||| S:26679 E:26689 ||| ,
and  ||| S:26689 E:26693 ||| CC
so  ||| S:26693 E:26696 ||| RB
there  ||| S:26696 E:26702 ||| EX
is  ||| S:26702 E:26705 ||| VBZ
significant  ||| S:26705 E:26717 ||| JJ
selective  ||| S:26717 E:26727 ||| JJ
pressure  ||| S:26727 E:26736 ||| NN
against  ||| S:26736 E:26752 ||| IN
extinction  ||| S:26752 E:26763 ||| NN
of  ||| S:26763 E:26766 ||| IN
Tag  ||| S:26766 E:26770 ||| NNP
expression ||| S:26770 E:26780 ||| NN
.  ||| S:26780 E:26782 ||| .
Effects  ||| S:26782 E:26790 ||| NNS
of  ||| S:26790 E:26793 ||| IN
viral  ||| S:26793 E:26799 ||| JJ
promoters  ||| S:26799 E:26817 ||| NNS
may  ||| S:26817 E:26821 ||| MD
reflect  ||| S:26821 E:26829 ||| VB
the  ||| S:26829 E:26833 ||| DT
evolution  ||| S:26833 E:26843 ||| NN
of  ||| S:26843 E:26846 ||| IN
the  ||| S:26846 E:26850 ||| DT
viruses  ||| S:26850 E:26858 ||| NN
and  ||| S:26858 E:26862 ||| CC
their  ||| S:26862 E:26868 ||| PRP$
hosts ||| S:26868 E:26873 ||| NNS
.  ||| S:26873 E:26883 ||| .
We  ||| S:26883 E:26886 ||| PRP
have  ||| S:26886 E:26891 ||| VBP
additional  ||| S:26891 E:26902 ||| JJ
evidence  ||| S:26902 E:26911 ||| NN
that  ||| S:26911 E:26916 ||| IN
the  ||| S:26916 E:26920 ||| DT
same  ||| S:26920 E:26925 ||| JJ
type  ||| S:26925 E:26930 ||| NN
of  ||| S:26930 E:26933 ||| IN
density  ||| S:26933 E:26949 ||| JJ
effects  ||| S:26949 E:26957 ||| NNS
( ||| S:26957 E:26958 ||| -LRB-
i.e. ||| S:26958 E:26962 ||| FW
,  ||| S:26962 E:26964 ||| ,
changes  ||| S:26964 E:26972 ||| NNS
in  ||| S:26972 E:26975 ||| IN
gene  ||| S:26975 E:26980 ||| NN
expression  ||| S:26980 E:26991 ||| NN
detected  ||| S:26991 E:27008 ||| VBD
continuously  ||| S:27008 E:27021 ||| RB
during  ||| S:27021 E:27028 ||| IN
exponential  ||| S:27028 E:27040 ||| JJ
growth ||| S:27040 E:27046 ||| NN
)  ||| S:27046 E:27048 ||| -RRB-
may  ||| S:27048 E:27052 ||| MD
operate  ||| S:27052 E:27060 ||| VB
on  ||| S:27060 E:27071 ||| IN
native  ||| S:27071 E:27078 ||| JJ
proteins ||| S:27078 E:27086 ||| NNS
.  ||| S:27086 E:27088 ||| .
Tag  ||| S:27088 E:27092 ||| FW
immortalized  ||| S:27092 E:27105 ||| FW
human  ||| S:27105 E:27111 ||| FW
tracheal  ||| S:27111 E:27120 ||| FW
epithelial  ||| S:27120 E:27139 ||| FW
( ||| S:27139 E:27140 ||| -LRB-
HTE ||| S:27140 E:27143 ||| NNP
)  ||| S:27143 E:27145 ||| -RRB-
cells  ||| S:27145 E:27151 ||| NNS
grown  ||| S:27151 E:27157 ||| VBN
at  ||| S:27157 E:27160 ||| IN
different  ||| S:27160 E:27170 ||| JJ
densities  ||| S:27170 E:27180 ||| NN
and  ||| S:27180 E:27184 ||| CC
assayed  ||| S:27184 E:27192 ||| NN
for  ||| S:27192 E:27204 ||| IN
cytokeratins  ||| S:27204 E:27217 ||| CD
6  ||| S:27217 E:27219 ||| CD
and  ||| S:27219 E:27223 ||| CC
18  ||| S:27223 E:27226 ||| CD
showed  ||| S:27226 E:27233 ||| VBD
a  ||| S:27233 E:27235 ||| DT
density  ||| S:27235 E:27243 ||| JJ
dependent  ||| S:27243 E:27253 ||| JJ
decrease  ||| S:27253 E:27270 ||| NN
in  ||| S:27270 E:27273 ||| IN
cytokeratin  ||| S:27273 E:27285 ||| JJ
immunoreactivity  ||| S:27285 E:27302 ||| NN
and  ||| S:27302 E:27306 ||| CC
a  ||| S:27306 E:27308 ||| DT
concomitant  ||| S:27308 E:27320 ||| JJ
increase  ||| S:27320 E:27337 ||| NN
in  ||| S:27337 E:27340 ||| IN
% ||| S:27340 E:27341 ||| NN
G  ||| S:27341 E:27352 ||| NNP
1  ||| S:27352 E:27354 ||| CD
both  ||| S:27354 E:27359 ||| DT
in  ||| S:27359 E:27362 ||| IN
normal  ||| S:27362 E:27369 ||| JJ
growth  ||| S:27369 E:27376 ||| NN
medium  ||| S:27376 E:27383 ||| NN
and  ||| S:27383 E:27387 ||| CC
in  ||| S:27387 E:27398 ||| IN
differentiation  ||| S:27398 E:27414 ||| JJ
medium  ||| S:27414 E:27421 ||| NN
( ||| S:27421 E:27422 ||| -LRB-
Frisa  ||| S:27422 E:27428 ||| NNP
&  ||| S:27428 E:27430 ||| CC
Jacobberger ||| S:27430 E:27441 ||| NNP
,  ||| S:27441 E:27451 ||| ,
unpublished ||| S:27451 E:27462 ||| JJ
) ||| S:27462 E:27463 ||| -RRB-
.  ||| S:27463 E:27465 ||| .
Additionally ||| S:27465 E:27477 ||| RB
,  ||| S:27477 E:27479 ||| ,
the  ||| S:27479 E:27483 ||| DT
expression  ||| S:27483 E:27494 ||| NN
levels  ||| S:27494 E:27501 ||| NNS
of  ||| S:27501 E:27504 ||| IN
cyclin  ||| S:27504 E:27519 ||| JJ
B1  ||| S:27519 E:27522 ||| NN
are  ||| S:27522 E:27526 ||| VBP
lower  ||| S:27526 E:27532 ||| JJR
in  ||| S:27532 E:27535 ||| IN
replicating  ||| S:27535 E:27547 ||| VBG
Hela  ||| S:27547 E:27552 ||| JJ
cells  ||| S:27552 E:27558 ||| NNS
at  ||| S:27558 E:27561 ||| IN
high  ||| S:27561 E:27566 ||| JJ
cell  ||| S:27566 E:27571 ||| NN
density  ||| S:27571 E:27587 ||| NNS
( ||| S:27587 E:27588 ||| -LRB-
Soni  ||| S:27588 E:27593 ||| NNP
&  ||| S:27593 E:27595 ||| CC
Jacobberger ||| S:27595 E:27606 ||| NNP
,  ||| S:27606 E:27608 ||| ,
unpublished  ||| S:27608 E:27620 ||| JJ
results ||| S:27620 E:27627 ||| NNS
) ||| S:27627 E:27628 ||| -RRB-
.  ||| S:27628 E:27630 ||| .
It  ||| S:27630 E:27633 ||| PRP
is  ||| S:27633 E:27644 ||| VBZ
conceivable  ||| S:27644 E:27656 ||| VBN
that  ||| S:27656 E:27661 ||| IN
other  ||| S:27661 E:27667 ||| JJ
proteins  ||| S:27667 E:27676 ||| NNS
that  ||| S:27676 E:27681 ||| WDT
are  ||| S:27681 E:27685 ||| VBP
at  ||| S:27685 E:27688 ||| IN
high  ||| S:27688 E:27693 ||| JJ
levels  ||| S:27693 E:27700 ||| NNS
in  ||| S:27700 E:27711 ||| IN
density-arrested  ||| S:27711 E:27728 ||| JJ
cells  ||| S:27728 E:27734 ||| NNS
may  ||| S:27734 E:27738 ||| MD
be  ||| S:27738 E:27741 ||| VB
positively  ||| S:27741 E:27752 ||| RB
regulated  ||| S:27752 E:27762 ||| VBN
by  ||| S:27762 E:27773 ||| IN
density  ||| S:27773 E:27781 ||| NN
during  ||| S:27781 E:27788 ||| IN
exponential  ||| S:27788 E:27800 ||| JJ
growth ||| S:27800 E:27806 ||| NN
.  ||| S:27806 E:27808 ||| .
There  ||| S:27808 E:27814 ||| EX
are  ||| S:27814 E:27818 ||| VBP
many  ||| S:27818 E:27823 ||| JJ
papers  ||| S:27823 E:27838 ||| NNS
that  ||| S:27838 E:27843 ||| WDT
describe  ||| S:27843 E:27852 ||| VBP
genes  ||| S:27852 E:27858 ||| NNS
that  ||| S:27858 E:27863 ||| WDT
are  ||| S:27863 E:27867 ||| VBP
up  ||| S:27867 E:27870 ||| RP
or  ||| S:27870 E:27873 ||| CC
down  ||| S:27873 E:27878 ||| RB
regulated  ||| S:27878 E:27888 ||| VBN
at  ||| S:27888 E:27899 ||| IN
confluence ||| S:27899 E:27909 ||| NN
.  ||| S:27909 E:27911 ||| .
Several  ||| S:27911 E:27919 ||| JJ
recent  ||| S:27919 E:27926 ||| JJ
papers  ||| S:27926 E:27933 ||| NNS
identify  ||| S:27933 E:27942 ||| VBP
genes  ||| S:27942 E:27948 ||| NNS
that  ||| S:27948 E:27953 ||| WDT
are  ||| S:27953 E:27965 ||| VBP
up-regulated  ||| S:27965 E:27978 ||| JJ
by  ||| S:27978 E:27981 ||| IN
cell  ||| S:27981 E:27986 ||| NN
density ||| S:27986 E:27993 ||| NN
.  ||| S:27993 E:27995 ||| .
These  ||| S:27995 E:28001 ||| DT
include  ||| S:28001 E:28017 ||| VBP
TEM1 ||| S:28017 E:28021 ||| CD
/ ||| S:28021 E:28022 ||| CD
endosialin ||| S:28022 E:28032 ||| NN
,  ||| S:28032 E:28034 ||| ,
IGF-1 ||| S:28034 E:28039 ||| NNP
,  ||| S:28039 E:28041 ||| ,
IGF-1R ||| S:28041 E:28047 ||| NNP
,  ||| S:28047 E:28049 ||| ,
IGFBP-2 ||| S:28049 E:28056 ||| NNP
,  ||| S:28056 E:28058 ||| ,
Bak ||| S:28058 E:28061 ||| NNP
,  ||| S:28061 E:28063 ||| ,
drp ||| S:28063 E:28066 ||| NN
,  ||| S:28066 E:28068 ||| ,
SP1 ||| S:28068 E:28071 ||| NNP
,  ||| S:28071 E:28073 ||| ,
p27  ||| S:28073 E:28085 ||| NNP
Kip1  ||| S:28085 E:28090 ||| NNP
[  ||| S:28090 E:28092 ||| -LRB-
24  ||| S:28092 E:28095 ||| CD
25  ||| S:28095 E:28098 ||| CD
26  ||| S:28098 E:28101 ||| CD
27  ||| S:28101 E:28104 ||| CD
28  ||| S:28104 E:28107 ||| CD
]  ||| S:28107 E:28109 ||| -RRB-
.  ||| S:28109 E:28111 ||| .
However ||| S:28111 E:28118 ||| RB
,  ||| S:28118 E:28120 ||| ,
cell  ||| S:28120 E:28125 ||| NN
context  ||| S:28125 E:28133 ||| NN
differences  ||| S:28133 E:28153 ||| NNS
are  ||| S:28153 E:28157 ||| VBP
apparent  ||| S:28157 E:28166 ||| JJ
[ ||| S:28166 E:28167 ||| -LRB-
e.g.  ||| S:28167 E:28172 ||| NNP
IGFR ||| S:28172 E:28176 ||| NNP
,  ||| S:28176 E:28178 ||| ,
[  ||| S:28178 E:28180 ||| -LRB-
29  ||| S:28180 E:28183 ||| CD
]  ||| S:28183 E:28185 ||| CD
] ||| S:28185 E:28186 ||| -RRB-
,  ||| S:28186 E:28188 ||| ,
and  ||| S:28188 E:28192 ||| CC
one  ||| S:28192 E:28196 ||| CD
study  ||| S:28196 E:28202 ||| NN
used  ||| S:28202 E:28215 ||| VBD
several  ||| S:28215 E:28223 ||| JJ
cell  ||| S:28223 E:28228 ||| NN
lines  ||| S:28228 E:28234 ||| NNS
and  ||| S:28234 E:28238 ||| CC
demonstrated  ||| S:28238 E:28251 ||| VBD
distinct  ||| S:28251 E:28260 ||| JJ
effects  ||| S:28260 E:28268 ||| NNS
of  ||| S:28268 E:28271 ||| IN
the  ||| S:28271 E:28283 ||| DT
cell  ||| S:28283 E:28288 ||| NN
genetic  ||| S:28288 E:28296 ||| JJ
background  ||| S:28296 E:28307 ||| NN
[  ||| S:28307 E:28309 ||| -LRB-
25  ||| S:28309 E:28312 ||| CD
]  ||| S:28312 E:28314 ||| -RRB-
.  ||| S:28314 E:28316 ||| .
Down-regulated  ||| S:28316 E:28331 ||| JJ
genes  ||| S:28331 E:28345 ||| NNS
include  ||| S:28345 E:28353 ||| VBP
bFGF ||| S:28353 E:28357 ||| JJ
,  ||| S:28357 E:28359 ||| ,
FGF-2 ||| S:28359 E:28364 ||| NNP
,  ||| S:28364 E:28366 ||| ,
Topoisomerase  ||| S:28366 E:28380 ||| NNP
II- ||| S:28380 E:28384 ||| NNP
,  ||| S:28384 E:28386 ||| ,
EGFR ||| S:28386 E:28390 ||| NNP
, ||| S:28390 E:28391 ||| NNP
,  ||| S:28391 E:28393 ||| ,
human  ||| S:28393 E:28407 ||| JJ
HDAC1 ||| S:28407 E:28412 ||| NN
,  ||| S:28412 E:28414 ||| ,
as  ||| S:28414 E:28417 ||| RB
well  ||| S:28417 E:28422 ||| RB
as  ||| S:28422 E:28425 ||| IN
cell  ||| S:28425 E:28430 ||| NN
cycle  ||| S:28430 E:28436 ||| NN
regulatory  ||| S:28436 E:28447 ||| JJ
genes  ||| S:28447 E:28453 ||| NNS
among  ||| S:28453 E:28459 ||| IN
others  ||| S:28459 E:28474 ||| NNS
[  ||| S:28474 E:28476 ||| -LRB-
30  ||| S:28476 E:28479 ||| CD
31  ||| S:28479 E:28482 ||| CD
32  ||| S:28482 E:28485 ||| CD
33  ||| S:28485 E:28488 ||| CD
34  ||| S:28488 E:28491 ||| CD
35  ||| S:28491 E:28494 ||| CD
36  ||| S:28494 E:28497 ||| CD
37  ||| S:28497 E:28500 ||| CD
]  ||| S:28500 E:28502 ||| -RRB-
.  ||| S:28502 E:28504 ||| .
Regions  ||| S:28504 E:28512 ||| NNS
in  ||| S:28512 E:28515 ||| IN
the  ||| S:28515 E:28519 ||| DT
bFGF  ||| S:28519 E:28524 ||| JJ
promoter  ||| S:28524 E:28541 ||| NNS
have  ||| S:28541 E:28546 ||| VBP
been  ||| S:28546 E:28551 ||| VBN
identified  ||| S:28551 E:28562 ||| VBN
as  ||| S:28562 E:28565 ||| RB
associated  ||| S:28565 E:28576 ||| VBN
with  ||| S:28576 E:28581 ||| IN
density-dependent  ||| S:28581 E:28607 ||| JJ
down-regulation  ||| S:28607 E:28623 ||| NN
of  ||| S:28623 E:28626 ||| IN
bFGF  ||| S:28626 E:28631 ||| NNP
[  ||| S:28631 E:28633 ||| -LRB-
31  ||| S:28633 E:28636 ||| CD
]  ||| S:28636 E:28638 ||| -RRB-
.  ||| S:28638 E:28640 ||| .
The  ||| S:28640 E:28644 ||| DT
IGF-II  ||| S:28644 E:28651 ||| JJ
P3  ||| S:28651 E:28654 ||| CD
promoter  ||| S:28654 E:28663 ||| NN
is  ||| S:28663 E:28674 ||| VBZ
down-regulated  ||| S:28674 E:28689 ||| JJ
as  ||| S:28689 E:28692 ||| IN
a  ||| S:28692 E:28694 ||| DT
function  ||| S:28694 E:28703 ||| NN
of  ||| S:28703 E:28706 ||| IN
cell  ||| S:28706 E:28711 ||| NN
density ||| S:28711 E:28718 ||| NN
,  ||| S:28718 E:28720 ||| ,
and  ||| S:28720 E:28724 ||| CC
a  ||| S:28724 E:28726 ||| DT
7-base  ||| S:28726 E:28741 ||| JJ
pair  ||| S:28741 E:28746 ||| NN
sequence  ||| S:28746 E:28755 ||| NN
has  ||| S:28755 E:28759 ||| VBZ
been  ||| S:28759 E:28764 ||| VBN
identified  ||| S:28764 E:28775 ||| VBN
that  ||| S:28775 E:28780 ||| WDT
plays  ||| S:28780 E:28786 ||| VBZ
a  ||| S:28786 E:28788 ||| DT
critical  ||| S:28788 E:28805 ||| JJ
role  ||| S:28805 E:28810 ||| NN
in  ||| S:28810 E:28813 ||| IN
this  ||| S:28813 E:28818 ||| DT
down-regulation  ||| S:28818 E:28834 ||| JJ
[  ||| S:28834 E:28836 ||| -LRB-
32  ||| S:28836 E:28839 ||| CD
]  ||| S:28839 E:28841 ||| -RRB-
.  ||| S:28841 E:28843 ||| .
Neither  ||| S:28843 E:28851 ||| CC
the  ||| S:28851 E:28855 ||| DT
MoMuLV  ||| S:28855 E:28870 ||| JJ
LTR  ||| S:28870 E:28874 ||| NNP
or  ||| S:28874 E:28877 ||| CC
the  ||| S:28877 E:28881 ||| DT
htk  ||| S:28881 E:28885 ||| JJ
promoters  ||| S:28885 E:28895 ||| NNS
encode  ||| S:28895 E:28902 ||| VBP
this  ||| S:28902 E:28907 ||| DT
sequence ||| S:28907 E:28915 ||| NN
,  ||| S:28915 E:28917 ||| ,
although  ||| S:28917 E:28934 ||| IN
both  ||| S:28934 E:28939 ||| DT
encode  ||| S:28939 E:28946 ||| NN
a  ||| S:28946 E:28948 ||| DT
10-base  ||| S:28948 E:28956 ||| JJ
pair  ||| S:28956 E:28961 ||| NN
sequence  ||| S:28961 E:28970 ||| NN
that  ||| S:28970 E:28975 ||| WDT
is  ||| S:28975 E:28978 ||| VBZ
identical  ||| S:28978 E:28988 ||| JJ
to  ||| S:28988 E:28999 ||| TO
the  ||| S:28999 E:29003 ||| DT
P3  ||| S:29003 E:29006 ||| JJ
sequence  ||| S:29006 E:29015 ||| NN
with  ||| S:29015 E:29020 ||| IN
an  ||| S:29020 E:29023 ||| DT
insertion  ||| S:29023 E:29033 ||| NN
of  ||| S:29033 E:29036 ||| IN
3  ||| S:29036 E:29038 ||| CD
base  ||| S:29038 E:29043 ||| NN
pairs  ||| S:29043 E:29049 ||| NNS
at  ||| S:29049 E:29060 ||| IN
position  ||| S:29060 E:29069 ||| NN
-1081 ||| S:29069 E:29074 ||| NN
.  ||| S:29074 E:29076 ||| .
Most  ||| S:29076 E:29081 ||| JJS
studies  ||| S:29081 E:29089 ||| NNS
focus  ||| S:29089 E:29095 ||| VBP
on  ||| S:29095 E:29098 ||| IN
transcription  ||| S:29098 E:29112 ||| NN
and ||| S:29112 E:29115 ||| CC
/ ||| S:29115 E:29116 ||| NNP
or  ||| S:29116 E:29127 ||| CC
protein  ||| S:29127 E:29135 ||| NN
levels ||| S:29135 E:29141 ||| NNS
.  ||| S:29141 E:29143 ||| .
Fewer  ||| S:29143 E:29149 ||| JJR
studies  ||| S:29149 E:29157 ||| NNS
have  ||| S:29157 E:29162 ||| VBP
addressed  ||| S:29162 E:29172 ||| VBN
translation ||| S:29172 E:29183 ||| NN
,  ||| S:29183 E:29193 ||| ,
however ||| S:29193 E:29200 ||| RB
,  ||| S:29200 E:29202 ||| ,
iso-forms  ||| S:29202 E:29212 ||| JJ
of  ||| S:29212 E:29215 ||| IN
c-myc  ||| S:29215 E:29221 ||| JJ
and  ||| S:29221 E:29225 ||| CC
FGF-2  ||| S:29225 E:29231 ||| NNP
are  ||| S:29231 E:29235 ||| VBP
translationally  ||| S:29235 E:29259 ||| VBN
regulated  ||| S:29259 E:29269 ||| VBN
by  ||| S:29269 E:29272 ||| IN
cell  ||| S:29272 E:29277 ||| NN
density  ||| S:29277 E:29285 ||| NNS
[  ||| S:29285 E:29287 ||| -LRB-
34  ||| S:29287 E:29290 ||| CD
]  ||| S:29290 E:29292 ||| -RRB-
.  ||| S:29292 E:29294 ||| .
For  ||| S:29294 E:29298 ||| IN
many  ||| S:29298 E:29303 ||| JJ
of  ||| S:29303 E:29306 ||| IN
these  ||| S:29306 E:29312 ||| DT
genes ||| S:29312 E:29317 ||| NNS
,  ||| S:29317 E:29327 ||| ,
down  ||| S:29327 E:29332 ||| IN
regulation  ||| S:29332 E:29343 ||| NN
at  ||| S:29343 E:29346 ||| IN
confluence  ||| S:29346 E:29357 ||| NN
is  ||| S:29357 E:29360 ||| VBZ
not  ||| S:29360 E:29364 ||| RB
surprising  ||| S:29364 E:29375 ||| JJ
( ||| S:29375 E:29376 ||| -LRB-
e.g. ||| S:29376 E:29380 ||| NNP
,  ||| S:29380 E:29382 ||| ,
cell  ||| S:29382 E:29395 ||| NN
proliferation  ||| S:29395 E:29409 ||| NN
associated  ||| S:29409 E:29420 ||| VBN
genes ||| S:29420 E:29425 ||| NNS
) ||| S:29425 E:29426 ||| -RRB-
,  ||| S:29426 E:29428 ||| ,
and  ||| S:29428 E:29432 ||| CC
upregulation  ||| S:29432 E:29445 ||| NN
of  ||| S:29445 E:29456 ||| IN
differentiation  ||| S:29456 E:29472 ||| JJ
specific  ||| S:29472 E:29481 ||| JJ
genes  ||| S:29481 E:29487 ||| NNS
at  ||| S:29487 E:29490 ||| IN
confluence  ||| S:29490 E:29501 ||| NN
is  ||| S:29501 E:29504 ||| VBZ
equally  ||| S:29504 E:29520 ||| RB
unsurprising ||| S:29520 E:29532 ||| JJ
.  ||| S:29532 E:29534 ||| .
However ||| S:29534 E:29541 ||| RB
,  ||| S:29541 E:29543 ||| ,
a  ||| S:29543 E:29545 ||| DT
glance  ||| S:29545 E:29552 ||| NN
at  ||| S:29552 E:29555 ||| IN
the  ||| S:29555 E:29559 ||| DT
literature  ||| S:29559 E:29570 ||| NN
does  ||| S:29570 E:29575 ||| VBZ
not  ||| S:29575 E:29587 ||| RB
suggest  ||| S:29587 E:29595 ||| VB
that  ||| S:29595 E:29600 ||| IN
any  ||| S:29600 E:29604 ||| DT
quick  ||| S:29604 E:29610 ||| JJ
classification  ||| S:29610 E:29625 ||| NN
or  ||| S:29625 E:29628 ||| CC
generalizations  ||| S:29628 E:29652 ||| NNS
should  ||| S:29652 E:29659 ||| MD
be  ||| S:29659 E:29662 ||| VB
made ||| S:29662 E:29666 ||| VBN
.  ||| S:29666 E:29676 ||| .
Regulation  ||| S:29676 E:29687 ||| NN
of  ||| S:29687 E:29690 ||| IN
protein  ||| S:29690 E:29698 ||| NN
levels  ||| S:29698 E:29705 ||| NNS
is  ||| S:29705 E:29708 ||| VBZ
multi-factorial ||| S:29708 E:29723 ||| JJ
.  ||| S:29723 E:29733 ||| .
Transcription ||| S:29733 E:29746 ||| NNP
,  ||| S:29746 E:29748 ||| ,
translation ||| S:29748 E:29759 ||| NN
,  ||| S:29759 E:29761 ||| ,
protein  ||| S:29761 E:29769 ||| NN
stability  ||| S:29769 E:29779 ||| NN
and  ||| S:29779 E:29791 ||| CC
degradation  ||| S:29791 E:29803 ||| NNS
are  ||| S:29803 E:29807 ||| VBP
involved ||| S:29807 E:29815 ||| VBN
.  ||| S:29815 E:29817 ||| .
Tag  ||| S:29817 E:29821 ||| NN
levels  ||| S:29821 E:29828 ||| NNS
in  ||| S:29828 E:29831 ||| IN
rapidly  ||| S:29831 E:29839 ||| RB
growing  ||| S:29839 E:29855 ||| VBG
polyclonal  ||| S:29855 E:29866 ||| JJ
cell  ||| S:29866 E:29871 ||| NN
lines  ||| S:29871 E:29877 ||| NNS
appear  ||| S:29877 E:29884 ||| VBP
to  ||| S:29884 E:29887 ||| TO
be  ||| S:29887 E:29890 ||| VB
set  ||| S:29890 E:29894 ||| VBN
primarily  ||| S:29894 E:29904 ||| RB
by  ||| S:29904 E:29915 ||| IN
transcription  ||| S:29915 E:29929 ||| NNS
[  ||| S:29929 E:29931 ||| -LRB-
11  ||| S:29931 E:29934 ||| CD
12  ||| S:29934 E:29937 ||| CD
]  ||| S:29937 E:29939 ||| -RRB-
.  ||| S:29939 E:29941 ||| .
However ||| S:29941 E:29948 ||| RB
,  ||| S:29948 E:29950 ||| ,
as  ||| S:29950 E:29953 ||| RB
discussed  ||| S:29953 E:29963 ||| VBN
above ||| S:29963 E:29968 ||| IN
,  ||| S:29968 E:29970 ||| ,
Tag  ||| S:29970 E:29982 ||| NNP
levels  ||| S:29982 E:29989 ||| NNS
in  ||| S:29989 E:29992 ||| IN
clonal  ||| S:29992 E:29999 ||| JJ
cell  ||| S:29999 E:30004 ||| NN
lines  ||| S:30004 E:30010 ||| NNS
produced  ||| S:30010 E:30019 ||| VBN
with  ||| S:30019 E:30024 ||| IN
the  ||| S:30024 E:30028 ||| DT
weak  ||| S:30028 E:30033 ||| JJ
htk  ||| S:30033 E:30045 ||| JJ
promoter  ||| S:30045 E:30054 ||| NN
and  ||| S:30054 E:30058 ||| CC
generated  ||| S:30058 E:30068 ||| VBN
from  ||| S:30068 E:30073 ||| IN
slowly  ||| S:30073 E:30080 ||| RB
growing  ||| S:30080 E:30088 ||| VBG
primary  ||| S:30088 E:30096 ||| JJ
cells  ||| S:30096 E:30110 ||| NNS
are  ||| S:30110 E:30114 ||| VBP
related  ||| S:30114 E:30122 ||| VBN
to  ||| S:30122 E:30125 ||| TO
clonality ||| S:30125 E:30134 ||| VB
.  ||| S:30134 E:30136 ||| .
SV40  ||| S:30136 E:30141 ||| NNP
Tag  ||| S:30141 E:30145 ||| NNP
is  ||| S:30145 E:30148 ||| VBZ
a  ||| S:30148 E:30150 ||| DT
long-lived  ||| S:30150 E:30161 ||| JJ
protein  ||| S:30161 E:30177 ||| NN
with  ||| S:30177 E:30182 ||| IN
a  ||| S:30182 E:30184 ||| DT
half-life  ||| S:30184 E:30194 ||| NN
variously  ||| S:30194 E:30204 ||| RB
measured  ||| S:30204 E:30213 ||| VBN
at  ||| S:30213 E:30216 ||| IN
48-90  ||| S:30216 E:30222 ||| CD
hrs ||| S:30222 E:30225 ||| NNS
.  ||| S:30225 E:30227 ||| .
The  ||| S:30227 E:30231 ||| DT
long  ||| S:30231 E:30244 ||| JJ
half-life  ||| S:30244 E:30254 ||| NN
of  ||| S:30254 E:30257 ||| IN
Tag  ||| S:30257 E:30261 ||| NNP
would  ||| S:30261 E:30267 ||| MD
not  ||| S:30267 E:30271 ||| RB
normally  ||| S:30271 E:30280 ||| RB
implicate  ||| S:30280 E:30290 ||| JJ
protein  ||| S:30290 E:30306 ||| NN
stability ||| S:30306 E:30315 ||| NN
,  ||| S:30315 E:30317 ||| ,
however ||| S:30317 E:30324 ||| RB
,  ||| S:30324 E:30326 ||| ,
the  ||| S:30326 E:30330 ||| DT
magnitude  ||| S:30330 E:30340 ||| NN
of  ||| S:30340 E:30343 ||| IN
changes  ||| S:30343 E:30351 ||| NNS
that  ||| S:30351 E:30356 ||| IN
we  ||| S:30356 E:30367 ||| PRP
discuss  ||| S:30367 E:30375 ||| VB
here ||| S:30375 E:30379 ||| RB
,  ||| S:30379 E:30381 ||| ,
although  ||| S:30381 E:30390 ||| IN
biologically  ||| S:30390 E:30403 ||| JJ
relevant ||| S:30403 E:30411 ||| JJ
,  ||| S:30411 E:30413 ||| ,
are  ||| S:30413 E:30417 ||| VBP
within  ||| S:30417 E:30432 ||| IN
two  ||| S:30432 E:30436 ||| CD
fold  ||| S:30436 E:30441 ||| NNS
and  ||| S:30441 E:30445 ||| CC
might  ||| S:30445 E:30451 ||| MD
be  ||| S:30451 E:30454 ||| VB
affected  ||| S:30454 E:30463 ||| VBN
by  ||| S:30463 E:30466 ||| IN
small  ||| S:30466 E:30472 ||| JJ
differences  ||| S:30472 E:30484 ||| NNS
in  ||| S:30484 E:30495 ||| IN
protein  ||| S:30495 E:30503 ||| NN
stability ||| S:30503 E:30512 ||| NN
.  ||| S:30512 E:30514 ||| .
Given  ||| S:30514 E:30520 ||| VBN
this  ||| S:30520 E:30525 ||| DT
line  ||| S:30525 E:30530 ||| NN
of  ||| S:30530 E:30533 ||| IN
reasoning ||| S:30533 E:30542 ||| NN
,  ||| S:30542 E:30544 ||| ,
the  ||| S:30544 E:30548 ||| DT
data  ||| S:30548 E:30561 ||| NNS
presented  ||| S:30561 E:30571 ||| VBD
here  ||| S:30571 E:30576 ||| RB
can  ||| S:30576 E:30580 ||| MD
be  ||| S:30580 E:30583 ||| VB
interpreted  ||| S:30583 E:30595 ||| VBN
as  ||| S:30595 E:30598 ||| IN
evidence  ||| S:30598 E:30607 ||| NN
for  ||| S:30607 E:30611 ||| IN
a  ||| S:30611 E:30613 ||| DT
cell  ||| S:30613 E:30626 ||| NN
contact  ||| S:30626 E:30634 ||| NN
( ||| S:30634 E:30635 ||| -LRB-
density ||| S:30635 E:30642 ||| LS
)  ||| S:30642 E:30644 ||| -RRB-
/  ||| S:30644 E:30646 ||| CD
cell  ||| S:30646 E:30651 ||| NN
cycle  ||| S:30651 E:30657 ||| NN
length  ||| S:30657 E:30664 ||| NN
related  ||| S:30664 E:30672 ||| VBN
effect  ||| S:30672 E:30679 ||| NN
on  ||| S:30679 E:30690 ||| IN
transcription  ||| S:30690 E:30704 ||| NNS
that  ||| S:30704 E:30709 ||| WDT
does  ||| S:30709 E:30714 ||| VBZ
not  ||| S:30714 E:30718 ||| RB
affect  ||| S:30718 E:30725 ||| VB
the  ||| S:30725 E:30729 ||| DT
retroviral  ||| S:30729 E:30740 ||| JJ
LTR  ||| S:30740 E:30744 ||| NN
to  ||| S:30744 E:30755 ||| TO
the  ||| S:30755 E:30759 ||| DT
extent  ||| S:30759 E:30766 ||| NN
that  ||| S:30766 E:30771 ||| IN
it  ||| S:30771 E:30774 ||| PRP
does  ||| S:30774 E:30779 ||| VBZ
the  ||| S:30779 E:30783 ||| DT
htk  ||| S:30783 E:30787 ||| JJ
promoter ||| S:30787 E:30795 ||| NN
.  ||| S:30795 E:30797 ||| .
This  ||| S:30797 E:30802 ||| DT
effect  ||| S:30802 E:30809 ||| NN
is  ||| S:30809 E:30820 ||| VBZ
predictive  ||| S:30820 E:30831 ||| VBN
of  ||| S:30831 E:30834 ||| IN
the  ||| S:30834 E:30838 ||| DT
plateau  ||| S:30838 E:30846 ||| NN
growth  ||| S:30846 E:30853 ||| NN
phase  ||| S:30853 E:30859 ||| NN
levels  ||| S:30859 E:30866 ||| NNS
of  ||| S:30866 E:30869 ||| IN
Tag  ||| S:30869 E:30873 ||| NNP
and  ||| S:30873 E:30885 ||| CC
thus ||| S:30885 E:30889 ||| RB
,  ||| S:30889 E:30891 ||| ,
ultimately  ||| S:30891 E:30902 ||| RB
should  ||| S:30902 E:30909 ||| MD
affect ||| S:30909 E:30915 ||| VB
,  ||| S:30915 E:30917 ||| ,
in  ||| S:30917 E:30920 ||| IN
the  ||| S:30920 E:30924 ||| DT
case  ||| S:30924 E:30929 ||| NN
of  ||| S:30929 E:30932 ||| IN
Tag  ||| S:30932 E:30936 ||| NNP
or  ||| S:30936 E:30947 ||| CC
similar  ||| S:30947 E:30955 ||| JJ
oncogenes ||| S:30955 E:30964 ||| NNS
,  ||| S:30964 E:30966 ||| ,
the  ||| S:30966 E:30970 ||| DT
fate  ||| S:30970 E:30975 ||| NN
of  ||| S:30975 E:30978 ||| IN
clones  ||| S:30978 E:30985 ||| NNS
in  ||| S:30985 E:30988 ||| IN
polyclonal  ||| S:30988 E:31007 ||| JJ
populations ||| S:31007 E:31018 ||| NNS
.  ||| S:31018 E:31020 ||| .
For  ||| S:31020 E:31024 ||| IN
example  ||| S:31024 E:31032 ||| NN
if  ||| S:31032 E:31035 ||| IN
an  ||| S:31035 E:31038 ||| DT
LTR  ||| S:31038 E:31042 ||| NNP
Tag  ||| S:31042 E:31046 ||| NNP
line  ||| S:31046 E:31051 ||| NN
and  ||| S:31051 E:31055 ||| CC
htk  ||| S:31055 E:31059 ||| JJ
Tag  ||| S:31059 E:31071 ||| JJ
line  ||| S:31071 E:31076 ||| NN
with  ||| S:31076 E:31081 ||| IN
equal  ||| S:31081 E:31087 ||| JJ
expression  ||| S:31087 E:31098 ||| NN
potential  ||| S:31098 E:31108 ||| NN
were  ||| S:31108 E:31113 ||| VBD
co-cultured ||| S:31113 E:31124 ||| JJ
,  ||| S:31124 E:31126 ||| ,
over  ||| S:31126 E:31139 ||| IN
time ||| S:31139 E:31143 ||| NN
,  ||| S:31143 E:31145 ||| ,
one  ||| S:31145 E:31149 ||| PRP
would  ||| S:31149 E:31155 ||| MD
expect  ||| S:31155 E:31162 ||| VB
the  ||| S:31162 E:31166 ||| DT
LTR  ||| S:31166 E:31170 ||| NN
driven  ||| S:31170 E:31177 ||| VBN
line  ||| S:31177 E:31182 ||| NN
to  ||| S:31182 E:31185 ||| TO
dominate ||| S:31185 E:31193 ||| VB
.  ||| S:31193 E:31203 ||| .
Finally ||| S:31203 E:31210 ||| RB
,  ||| S:31210 E:31212 ||| ,
the  ||| S:31212 E:31216 ||| DT
htk  ||| S:31216 E:31220 ||| JJ
lines  ||| S:31220 E:31226 ||| NNS
here  ||| S:31226 E:31231 ||| RB
varied  ||| S:31231 E:31238 ||| VBN
significantly  ||| S:31238 E:31252 ||| RB
in  ||| S:31252 E:31263 ||| IN
terms  ||| S:31263 E:31269 ||| NNS
of  ||| S:31269 E:31272 ||| IN
Tag  ||| S:31272 E:31276 ||| NNP
expression  ||| S:31276 E:31287 ||| NN
potential ||| S:31287 E:31296 ||| NN
,  ||| S:31296 E:31298 ||| ,
and  ||| S:31298 E:31302 ||| CC
in  ||| S:31302 E:31305 ||| IN
terms  ||| S:31305 E:31311 ||| NNS
of  ||| S:31311 E:31314 ||| IN
the  ||| S:31314 E:31318 ||| DT
rate  ||| S:31318 E:31331 ||| NN
at  ||| S:31331 E:31334 ||| IN
which  ||| S:31334 E:31340 ||| WDT
expression  ||| S:31340 E:31351 ||| VBZ
decreased  ||| S:31351 E:31361 ||| VBN
as  ||| S:31361 E:31364 ||| IN
a  ||| S:31364 E:31366 ||| DT
function  ||| S:31366 E:31375 ||| NN
of  ||| S:31375 E:31378 ||| IN
cell  ||| S:31378 E:31391 ||| NN
density ||| S:31391 E:31398 ||| NN
.  ||| S:31398 E:31400 ||| .
There  ||| S:31400 E:31406 ||| EX
was  ||| S:31406 E:31410 ||| VBD
no  ||| S:31410 E:31413 ||| DT
correlation  ||| S:31413 E:31425 ||| NN
in  ||| S:31425 E:31428 ||| IN
the  ||| S:31428 E:31432 ||| DT
rate  ||| S:31432 E:31437 ||| NN
of  ||| S:31437 E:31440 ||| IN
change  ||| S:31440 E:31447 ||| NN
in  ||| S:31447 E:31458 ||| IN
density  ||| S:31458 E:31466 ||| JJ
related  ||| S:31466 E:31474 ||| JJ
expression  ||| S:31474 E:31485 ||| NN
and  ||| S:31485 E:31489 ||| CC
the  ||| S:31489 E:31493 ||| DT
density  ||| S:31493 E:31501 ||| JJ
independent  ||| S:31501 E:31521 ||| JJ
expression  ||| S:31521 E:31532 ||| NN
( ||| S:31532 E:31533 ||| -LRB-
here  ||| S:31533 E:31538 ||| RB
referred  ||| S:31538 E:31547 ||| VBN
to  ||| S:31547 E:31550 ||| TO
as  ||| S:31550 E:31553 ||| RB
intrinsic  ||| S:31553 E:31563 ||| JJ
expression  ||| S:31563 E:31582 ||| NN
potential ||| S:31582 E:31591 ||| NN
) ||| S:31591 E:31592 ||| -RRB-
.  ||| S:31592 E:31594 ||| .
This  ||| S:31594 E:31599 ||| DT
supports  ||| S:31599 E:31608 ||| VBZ
the  ||| S:31608 E:31612 ||| DT
idea  ||| S:31612 E:31617 ||| NN
that  ||| S:31617 E:31622 ||| IN
the  ||| S:31622 E:31626 ||| DT
density  ||| S:31626 E:31642 ||| JJ
independent  ||| S:31642 E:31654 ||| JJ
expression  ||| S:31654 E:31665 ||| NN
in  ||| S:31665 E:31668 ||| IN
the  ||| S:31668 E:31672 ||| DT
htk  ||| S:31672 E:31676 ||| JJ
lines  ||| S:31676 E:31682 ||| NNS
is  ||| S:31682 E:31685 ||| VBZ
set  ||| S:31685 E:31689 ||| VBN
by  ||| S:31689 E:31692 ||| IN
the  ||| S:31692 E:31696 ||| DT
clone  ||| S:31696 E:31710 ||| JJ
specific  ||| S:31710 E:31719 ||| JJ
effects  ||| S:31719 E:31727 ||| NNS
( ||| S:31727 E:31728 ||| -LRB-
e.g. ||| S:31728 E:31732 ||| NNP
,  ||| S:31732 E:31734 ||| ,
integration  ||| S:31734 E:31746 ||| NN
position ||| S:31746 E:31754 ||| NN
)  ||| S:31754 E:31756 ||| -RRB-
and  ||| S:31756 E:31760 ||| CC
the  ||| S:31760 E:31772 ||| DT
density ||| S:31772 E:31779 ||| JJ
/ ||| S:31779 E:31780 ||| CD
cell  ||| S:31780 E:31785 ||| NN
cycle  ||| S:31785 E:31791 ||| NN
related  ||| S:31791 E:31799 ||| VBN
expression  ||| S:31799 E:31810 ||| NN
is  ||| S:31810 E:31813 ||| VBZ
set  ||| S:31813 E:31817 ||| VBN
in  ||| S:31817 E:31820 ||| IN
these  ||| S:31820 E:31826 ||| DT
cases  ||| S:31826 E:31840 ||| NNS
by  ||| S:31840 E:31843 ||| IN
the  ||| S:31843 E:31847 ||| DT
promoter ||| S:31847 E:31855 ||| NN
.  ||| S:31855 E:31879 ||| .
Conclusions  ||| S:31879 E:31899 ||| NNS
These  ||| S:31899 E:31905 ||| DT
data  ||| S:31905 E:31910 ||| NNS
show  ||| S:31910 E:31915 ||| VBP
quantitatively  ||| S:31915 E:31930 ||| VBN
that  ||| S:31930 E:31935 ||| IN
the  ||| S:31935 E:31939 ||| DT
Tag  ||| S:31939 E:31943 ||| JJ
expression  ||| S:31943 E:31962 ||| NN
potential  ||| S:31962 E:31972 ||| NN
of  ||| S:31972 E:31975 ||| IN
introduced  ||| S:31975 E:31986 ||| VBN
Tag  ||| S:31986 E:31990 ||| NNP
varies  ||| S:31990 E:31997 ||| VBZ
over  ||| S:31997 E:32002 ||| IN
a  ||| S:32002 E:32004 ||| DT
wide  ||| S:32004 E:32009 ||| JJ
range  ||| S:32009 E:32023 ||| NN
depending  ||| S:32023 E:32033 ||| VBG
on  ||| S:32033 E:32036 ||| IN
the  ||| S:32036 E:32040 ||| DT
vector  ||| S:32040 E:32047 ||| NN
used  ||| S:32047 E:32052 ||| VBN
and  ||| S:32052 E:32056 ||| CC
clonal  ||| S:32056 E:32063 ||| JJ
variation ||| S:32063 E:32072 ||| NN
.  ||| S:32072 E:32074 ||| .
The  ||| S:32074 E:32086 ||| DT
expression  ||| S:32086 E:32097 ||| NN
level  ||| S:32097 E:32103 ||| NN
is  ||| S:32103 E:32106 ||| VBZ
a  ||| S:32106 E:32108 ||| DT
complex  ||| S:32108 E:32116 ||| JJ
measurement  ||| S:32116 E:32128 ||| NN
that  ||| S:32128 E:32133 ||| WDT
can  ||| S:32133 E:32137 ||| MD
be  ||| S:32137 E:32148 ||| VB
partially  ||| S:32148 E:32158 ||| RB
simplified  ||| S:32158 E:32169 ||| VBN
by  ||| S:32169 E:32172 ||| IN
accounting  ||| S:32172 E:32183 ||| NN
for  ||| S:32183 E:32187 ||| IN
the  ||| S:32187 E:32191 ||| DT
cell  ||| S:32191 E:32196 ||| NN
cycle  ||| S:32196 E:32210 ||| NN
transit  ||| S:32210 E:32218 ||| NN
time  ||| S:32218 E:32223 ||| NN
and  ||| S:32223 E:32227 ||| CC
cell  ||| S:32227 E:32232 ||| NN
density ||| S:32232 E:32239 ||| NN
.  ||| S:32239 E:32249 ||| .
The  ||| S:32249 E:32253 ||| DT
hypothetical  ||| S:32253 E:32266 ||| JJ
terms ||| S:32266 E:32271 ||| NNS
,  ||| S:32271 E:32273 ||| ,
expression  ||| S:32273 E:32284 ||| NN
at  ||| S:32284 E:32287 ||| IN
zero  ||| S:32287 E:32292 ||| CD
cell  ||| S:32292 E:32297 ||| NN
density  ||| S:32297 E:32313 ||| NN
and  ||| S:32313 E:32317 ||| CC
expression  ||| S:32317 E:32328 ||| NN
at  ||| S:32328 E:32331 ||| IN
minimum  ||| S:32331 E:32339 ||| JJ
G  ||| S:32339 E:32350 ||| NNP
1  ||| S:32350 E:32352 ||| CD
phase  ||| S:32352 E:32358 ||| NN
fraction ||| S:32358 E:32366 ||| NN
,  ||| S:32366 E:32368 ||| ,
were  ||| S:32368 E:32373 ||| VBD
introduced  ||| S:32373 E:32384 ||| VBN
to  ||| S:32384 E:32395 ||| TO
simplify  ||| S:32395 E:32404 ||| VB
measures  ||| S:32404 E:32413 ||| NNS
of  ||| S:32413 E:32416 ||| IN
expression  ||| S:32416 E:32427 ||| NN
potential ||| S:32427 E:32436 ||| NN
.  ||| S:32436 E:32446 ||| .
Accounting  ||| S:32446 E:32457 ||| NN
for  ||| S:32457 E:32461 ||| IN
both  ||| S:32461 E:32466 ||| DT
cell  ||| S:32466 E:32471 ||| NN
cycle  ||| S:32471 E:32477 ||| NN
transit  ||| S:32477 E:32485 ||| NN
time  ||| S:32485 E:32490 ||| NN
and  ||| S:32490 E:32494 ||| CC
cell  ||| S:32494 E:32507 ||| NN
density  ||| S:32507 E:32515 ||| NN
should  ||| S:32515 E:32522 ||| MD
increase  ||| S:32522 E:32531 ||| VB
the  ||| S:32531 E:32535 ||| DT
precision  ||| S:32535 E:32545 ||| NN
and  ||| S:32545 E:32549 ||| CC
accuracy  ||| S:32549 E:32558 ||| NN
with  ||| S:32558 E:32571 ||| IN
which  ||| S:32571 E:32577 ||| WDT
gene  ||| S:32577 E:32582 ||| NN
expression  ||| S:32582 E:32593 ||| NN
can  ||| S:32593 E:32597 ||| MD
be  ||| S:32597 E:32600 ||| VB
measured ||| S:32600 E:32608 ||| VBN
.  ||| S:32608 E:32610 ||| .
This  ||| S:32610 E:32615 ||| DT
is  ||| S:32615 E:32618 ||| VBZ
important  ||| S:32618 E:32636 ||| JJ
for  ||| S:32636 E:32640 ||| IN
the  ||| S:32640 E:32644 ||| DT
use  ||| S:32644 E:32648 ||| NN
of  ||| S:32648 E:32651 ||| IN
cell  ||| S:32651 E:32656 ||| NN
lines  ||| S:32656 E:32662 ||| NNS
as  ||| S:32662 E:32665 ||| IN
quantitative  ||| S:32665 E:32678 ||| JJ
standards  ||| S:32678 E:32688 ||| NNS
for  ||| S:32688 E:32700 ||| IN
gene  ||| S:32700 E:32705 ||| NN
expression  ||| S:32705 E:32716 ||| NN
studies ||| S:32716 E:32723 ||| NNS
,  ||| S:32723 E:32725 ||| ,
for  ||| S:32725 E:32729 ||| IN
relating  ||| S:32729 E:32738 ||| VBG
expression  ||| S:32738 E:32749 ||| NN
to  ||| S:32749 E:32760 ||| TO
phenotype ||| S:32760 E:32769 ||| VB
,  ||| S:32769 E:32771 ||| ,
and  ||| S:32771 E:32775 ||| CC
for  ||| S:32775 E:32779 ||| IN
an  ||| S:32779 E:32782 ||| DT
understanding  ||| S:32782 E:32796 ||| NN
of  ||| S:32796 E:32799 ||| IN
gene  ||| S:32799 E:32804 ||| NN
expression  ||| S:32804 E:32815 ||| NN
in  ||| S:32815 E:32826 ||| IN
general ||| S:32826 E:32833 ||| JJ
,  ||| S:32833 E:32835 ||| ,
and  ||| S:32835 E:32839 ||| CC
affects  ||| S:32839 E:32847 ||| JJ
ideas  ||| S:32847 E:32853 ||| NNS
on  ||| S:32853 E:32856 ||| IN
cell  ||| S:32856 E:32861 ||| NN
engineering ||| S:32861 E:32872 ||| NN
.  ||| S:32872 E:32896 ||| .
Materials  ||| S:32896 E:32906 ||| NNS
and  ||| S:32906 E:32910 ||| CC
Methods  ||| S:32910 E:32937 ||| NNP
Generation  ||| S:32937 E:32948 ||| NNP
of  ||| S:32948 E:32951 ||| IN
astrocyte  ||| S:32951 E:32961 ||| JJ
cell  ||| S:32961 E:32966 ||| NN
lines  ||| S:32966 E:32982 ||| NNS
Cortical  ||| S:32982 E:32991 ||| JJ
astrocytes  ||| S:32991 E:33002 ||| NN
were  ||| S:33002 E:33007 ||| VBD
harvested  ||| S:33007 E:33017 ||| VBN
from  ||| S:33017 E:33022 ||| IN
neonatal  ||| S:33022 E:33041 ||| CD
C57BL ||| S:33041 E:33046 ||| CD
/ ||| S:33046 E:33047 ||| CD
6  ||| S:33047 E:33049 ||| CD
mice  ||| S:33049 E:33054 ||| NNS
and  ||| S:33054 E:33058 ||| CC
infected  ||| S:33058 E:33067 ||| VBN
with  ||| S:33067 E:33072 ||| IN
a  ||| S:33072 E:33074 ||| DT
replication-defective  ||| S:33074 E:33106 ||| JJ
retrovirus  ||| S:33106 E:33117 ||| NN
encoding  ||| S:33117 E:33126 ||| VBD
Tag  ||| S:33126 E:33130 ||| NNP
and  ||| S:33130 E:33134 ||| CC
neomycin  ||| S:33134 E:33143 ||| JJ
resistance  ||| S:33143 E:33154 ||| NN
as  ||| S:33154 E:33167 ||| IN
previously  ||| S:33167 E:33178 ||| RB
described  ||| S:33178 E:33188 ||| VBN
[  ||| S:33188 E:33190 ||| -LRB-
13  ||| S:33190 E:33193 ||| CD
]  ||| S:33193 E:33195 ||| -RRB-
.  ||| S:33195 E:33197 ||| .
The  ||| S:33197 E:33201 ||| DT
transferred  ||| S:33201 E:33213 ||| JJ
viruses  ||| S:33213 E:33231 ||| NN
were  ||| S:33231 E:33236 ||| VBD
SV40-6  ||| S:33236 E:33243 ||| CD
[  ||| S:33243 E:33245 ||| -LRB-
5  ||| S:33245 E:33247 ||| LS
]  ||| S:33247 E:33249 ||| -RRB-
,  ||| S:33249 E:33251 ||| ,
in  ||| S:33251 E:33254 ||| IN
which  ||| S:33254 E:33260 ||| WDT
wild  ||| S:33260 E:33265 ||| JJ
type  ||| S:33265 E:33270 ||| NN
Tag  ||| S:33270 E:33274 ||| NNP
is  ||| S:33274 E:33277 ||| VBZ
expressed  ||| S:33277 E:33297 ||| VBN
from  ||| S:33297 E:33302 ||| IN
the  ||| S:33302 E:33306 ||| DT
M-MuLV  ||| S:33306 E:33313 ||| JJ
LTR  ||| S:33313 E:33317 ||| NNP
promoter ||| S:33317 E:33325 ||| NN
;  ||| S:33325 E:33327 ||| :
SV ||| S:33327 E:33329 ||| NNP
( ||| S:33329 E:33330 ||| -LRB-
X ||| S:33330 E:33331 ||| NNP
) ||| S:33331 E:33332 ||| -RRB-
T  ||| S:33332 E:33334 ||| NNP
K1 ||| S:33334 E:33336 ||| NNP
,  ||| S:33336 E:33338 ||| ,
which  ||| S:33338 E:33344 ||| WDT
is  ||| S:33344 E:33357 ||| VBZ
constructed  ||| S:33357 E:33369 ||| VBN
the  ||| S:33369 E:33373 ||| DT
same  ||| S:33373 E:33378 ||| JJ
as  ||| S:33378 E:33381 ||| IN
SV40-6  ||| S:33381 E:33388 ||| CD
except  ||| S:33388 E:33395 ||| IN
that  ||| S:33395 E:33400 ||| IN
the  ||| S:33400 E:33404 ||| DT
Tag  ||| S:33404 E:33408 ||| NNP
is  ||| S:33408 E:33421 ||| VBZ
mutant  ||| S:33421 E:33428 ||| JJ
[  ||| S:33428 E:33430 ||| -LRB-
38  ||| S:33430 E:33433 ||| CD
]  ||| S:33433 E:33435 ||| -RRB-
and  ||| S:33435 E:33439 ||| CC
defective  ||| S:33439 E:33449 ||| JJ
for  ||| S:33449 E:33453 ||| IN
binding  ||| S:33453 E:33461 ||| VBG
the  ||| S:33461 E:33475 ||| DT
retinoblastoma  ||| S:33475 E:33490 ||| NN
protein  ||| S:33490 E:33498 ||| NN
family  ||| S:33498 E:33505 ||| NN
[  ||| S:33505 E:33507 ||| -LRB-
39  ||| S:33507 E:33510 ||| CD
]  ||| S:33510 E:33512 ||| -RRB-
;  ||| S:33512 E:33514 ||| :
Linker-tkT ||| S:33514 E:33524 ||| NNP
,  ||| S:33524 E:33526 ||| ,
in  ||| S:33526 E:33539 ||| IN
which  ||| S:33539 E:33545 ||| WDT
the  ||| S:33545 E:33549 ||| DT
cDNA  ||| S:33549 E:33554 ||| JJ
for  ||| S:33554 E:33558 ||| IN
Tag  ||| S:33558 E:33562 ||| NNP
is  ||| S:33562 E:33565 ||| VBZ
expressed  ||| S:33565 E:33575 ||| VBN
from  ||| S:33575 E:33580 ||| IN
the  ||| S:33580 E:33584 ||| DT
herpes  ||| S:33584 E:33601 ||| JJ
simplex  ||| S:33601 E:33609 ||| NN
1  ||| S:33609 E:33611 ||| CD
tk  ||| S:33611 E:33614 ||| JJ
promoter  ||| S:33614 E:33623 ||| NN
[  ||| S:33623 E:33625 ||| -LRB-
11  ||| S:33625 E:33628 ||| CD
]  ||| S:33628 E:33630 ||| -RRB-
.  ||| S:33630 E:33632 ||| .
The  ||| S:33632 E:33636 ||| DT
differentiation  ||| S:33636 E:33652 ||| NN
and  ||| S:33652 E:33666 ||| CC
transformation  ||| S:33666 E:33681 ||| JJ
phenotypes  ||| S:33681 E:33692 ||| NN
of  ||| S:33692 E:33695 ||| IN
the  ||| S:33695 E:33699 ||| DT
cell  ||| S:33699 E:33704 ||| NN
lines  ||| S:33704 E:33710 ||| NNS
utilizing  ||| S:33710 E:33720 ||| VBP
the  ||| S:33720 E:33734 ||| DT
M-MuLV  ||| S:33734 E:33741 ||| JJ
LTR  ||| S:33741 E:33745 ||| NN
promoter  ||| S:33745 E:33754 ||| NNS
have  ||| S:33754 E:33759 ||| VBP
been  ||| S:33759 E:33764 ||| VBN
described  ||| S:33764 E:33774 ||| VBN
[  ||| S:33774 E:33776 ||| -LRB-
6  ||| S:33776 E:33778 ||| CD
13  ||| S:33778 E:33781 ||| CD
]  ||| S:33781 E:33783 ||| -RRB-
.  ||| S:33783 E:33785 ||| .
The  ||| S:33785 E:33799 ||| DT
Linker-tkT  ||| S:33799 E:33810 ||| JJ
lines  ||| S:33810 E:33816 ||| NNS
( ||| S:33816 E:33817 ||| -LRB-
tkT ||| S:33817 E:33820 ||| NNP
)  ||| S:33820 E:33822 ||| -RRB-
were  ||| S:33822 E:33827 ||| VBD
either  ||| S:33827 E:33834 ||| RB
isolated  ||| S:33834 E:33843 ||| VBN
as  ||| S:33843 E:33846 ||| IN
clones  ||| S:33846 E:33863 ||| NNS
after  ||| S:33863 E:33869 ||| IN
G418  ||| S:33869 E:33874 ||| CD
selection  ||| S:33874 E:33884 ||| NN
( ||| S:33884 E:33885 ||| -LRB-
as  ||| S:33885 E:33888 ||| RB
previously  ||| S:33888 E:33899 ||| RB
described ||| S:33899 E:33908 ||| VBN
)  ||| S:33908 E:33910 ||| -RRB-
[  ||| S:33910 E:33912 ||| -LRB-
6  ||| S:33912 E:33914 ||| CD
]  ||| S:33914 E:33916 ||| -RRB-
or  ||| S:33916 E:33929 ||| CC
frozen  ||| S:33929 E:33936 ||| VBN
immediately  ||| S:33936 E:33948 ||| RB
after  ||| S:33948 E:33954 ||| IN
selection  ||| S:33954 E:33964 ||| NN
( ||| S:33964 E:33965 ||| -LRB-
pooled  ||| S:33965 E:33972 ||| FW
clones ||| S:33972 E:33978 ||| FW
)  ||| S:33978 E:33980 ||| -RRB-
and  ||| S:33980 E:33994 ||| CC
clonally  ||| S:33994 E:34003 ||| VB
selected  ||| S:34003 E:34012 ||| VBN
at  ||| S:34012 E:34015 ||| IN
a  ||| S:34015 E:34017 ||| DT
later  ||| S:34017 E:34023 ||| JJ
time ||| S:34023 E:34027 ||| NN
.  ||| S:34027 E:34029 ||| .
Typically ||| S:34029 E:34038 ||| RB
,  ||| S:34038 E:34040 ||| ,
it  ||| S:34040 E:34043 ||| PRP
took  ||| S:34043 E:34048 ||| VBD
40  ||| S:34048 E:34061 ||| CD
days  ||| S:34061 E:34066 ||| NNS
after  ||| S:34066 E:34072 ||| IN
infection  ||| S:34072 E:34082 ||| NN
to  ||| S:34082 E:34085 ||| TO
obtain  ||| S:34085 E:34092 ||| VB
colonies  ||| S:34092 E:34101 ||| NNS
and  ||| S:34101 E:34105 ||| CC
60  ||| S:34105 E:34108 ||| CD
more  ||| S:34108 E:34113 ||| JJR
days  ||| S:34113 E:34128 ||| NNS
to  ||| S:34128 E:34131 ||| TO
generate  ||| S:34131 E:34140 ||| VB
a  ||| S:34140 E:34142 ||| DT
rapidly  ||| S:34142 E:34150 ||| RB
growing  ||| S:34150 E:34158 ||| VBG
line  ||| S:34158 E:34163 ||| NN
that  ||| S:34163 E:34168 ||| WDT
could  ||| S:34168 E:34174 ||| MD
be  ||| S:34174 E:34177 ||| VB
serially  ||| S:34177 E:34196 ||| JJ
cultured  ||| S:34196 E:34205 ||| NNS
( ||| S:34205 E:34206 ||| -LRB-
split  ||| S:34206 E:34212 ||| VBN
1 ||| S:34212 E:34213 ||| CD
: ||| S:34213 E:34214 ||| :
80  ||| S:34214 E:34217 ||| CD
at  ||| S:34217 E:34220 ||| IN
weekly  ||| S:34220 E:34227 ||| JJ
intervals ||| S:34227 E:34236 ||| NNS
) ||| S:34236 E:34237 ||| -RRB-
.  ||| S:34237 E:34239 ||| .
The  ||| S:34239 E:34243 ||| DT
lines  ||| S:34243 E:34259 ||| NNS
termed  ||| S:34259 E:34266 ||| VBD
early  ||| S:34266 E:34272 ||| JJ
passage  ||| S:34272 E:34280 ||| NN
in  ||| S:34280 E:34283 ||| IN
this  ||| S:34283 E:34288 ||| DT
paper  ||| S:34288 E:34294 ||| NN
were  ||| S:34294 E:34299 ||| VBD
140-200  ||| S:34299 E:34307 ||| CD
days  ||| S:34307 E:34312 ||| NNS
post  ||| S:34312 E:34327 ||| NN
infection ||| S:34327 E:34336 ||| NN
,  ||| S:34336 E:34338 ||| ,
and  ||| S:34338 E:34342 ||| CC
all  ||| S:34342 E:34346 ||| DT
others  ||| S:34346 E:34353 ||| NNS
were  ||| S:34353 E:34358 ||| VBD
340-860  ||| S:34358 E:34366 ||| CD
days  ||| S:34366 E:34371 ||| NNS
post  ||| S:34371 E:34386 ||| NN
infection ||| S:34386 E:34395 ||| NN
.  ||| S:34395 E:34397 ||| .
The  ||| S:34397 E:34401 ||| DT
names  ||| S:34401 E:34407 ||| NNS
of  ||| S:34407 E:34410 ||| IN
the  ||| S:34410 E:34414 ||| DT
cell  ||| S:34414 E:34419 ||| NN
lines  ||| S:34419 E:34425 ||| NNS
designate  ||| S:34425 E:34435 ||| VBP
the  ||| S:34435 E:34449 ||| DT
number  ||| S:34449 E:34456 ||| NN
of  ||| S:34456 E:34459 ||| IN
days  ||| S:34459 E:34464 ||| NNS
the  ||| S:34464 E:34468 ||| DT
primary  ||| S:34468 E:34476 ||| JJ
neonatal  ||| S:34476 E:34485 ||| JJ
astrocytes  ||| S:34485 E:34496 ||| NN
were  ||| S:34496 E:34511 ||| VBD
cultured  ||| S:34511 E:34520 ||| VBN
prior  ||| S:34520 E:34526 ||| RB
to  ||| S:34526 E:34529 ||| TO
infection ||| S:34529 E:34538 ||| NN
.  ||| S:34538 E:34540 ||| .
For  ||| S:34540 E:34544 ||| IN
example ||| S:34544 E:34551 ||| NN
,  ||| S:34551 E:34553 ||| ,
P0-17D ||| S:34553 E:34559 ||| RB
# ||| S:34559 E:34560 ||| #
8  ||| S:34560 E:34562 ||| CD
is  ||| S:34562 E:34565 ||| VBZ
the  ||| S:34565 E:34579 ||| DT
eighth  ||| S:34579 E:34586 ||| JJ
clone  ||| S:34586 E:34592 ||| NNS
derived  ||| S:34592 E:34600 ||| VBN
from  ||| S:34600 E:34605 ||| IN
cortical  ||| S:34605 E:34614 ||| NNS
astrocytes  ||| S:34614 E:34625 ||| VBP
isolated  ||| S:34625 E:34634 ||| VBN
on  ||| S:34634 E:34647 ||| IN
the  ||| S:34647 E:34651 ||| DT
day  ||| S:34651 E:34655 ||| NN
of  ||| S:34655 E:34658 ||| IN
birth  ||| S:34658 E:34664 ||| NN
and  ||| S:34664 E:34668 ||| CC
infected  ||| S:34668 E:34677 ||| JJ
17  ||| S:34677 E:34680 ||| CD
days  ||| S:34680 E:34685 ||| NNS
later ||| S:34685 E:34690 ||| RB
.  ||| S:34690 E:34692 ||| .
Immortalized  ||| S:34692 E:34715 ||| JJ
cells  ||| S:34715 E:34721 ||| NNS
were  ||| S:34721 E:34726 ||| VBD
maintained  ||| S:34726 E:34737 ||| VBN
in  ||| S:34737 E:34740 ||| IN
Dulbecco ||| S:34740 E:34748 ||| NNP
's  ||| S:34748 E:34751 ||| POS
modified  ||| S:34751 E:34760 ||| JJ
Eagle  ||| S:34760 E:34766 ||| NNP
medium  ||| S:34766 E:34783 ||| NN
( ||| S:34783 E:34784 ||| -LRB-
DMEM ||| S:34784 E:34788 ||| NNP
,  ||| S:34788 E:34790 ||| ,
Sigma ||| S:34790 E:34795 ||| NNP
,  ||| S:34795 E:34797 ||| ,
St.  ||| S:34797 E:34801 ||| NNP
Louis ||| S:34801 E:34806 ||| NNP
,  ||| S:34806 E:34808 ||| ,
MO ||| S:34808 E:34810 ||| NNP
)  ||| S:34810 E:34812 ||| -RRB-
with  ||| S:34812 E:34817 ||| IN
5 ||| S:34817 E:34818 ||| CD
%  ||| S:34818 E:34820 ||| NN
fetal  ||| S:34820 E:34826 ||| JJ
bovine  ||| S:34826 E:34833 ||| JJ
serum  ||| S:34833 E:34849 ||| NNS
( ||| S:34849 E:34850 ||| -LRB-
FBS ||| S:34850 E:34853 ||| NNP
)  ||| S:34853 E:34855 ||| -RRB-
and  ||| S:34855 E:34859 ||| CC
5 ||| S:34859 E:34860 ||| CD
%  ||| S:34860 E:34862 ||| NN
calf  ||| S:34862 E:34867 ||| NN
serum  ||| S:34867 E:34873 ||| NN
in  ||| S:34873 E:34876 ||| IN
5 ||| S:34876 E:34877 ||| CD
%  ||| S:34877 E:34879 ||| NN
CO  ||| S:34879 E:34893 ||| NNP
2  ||| S:34893 E:34895 ||| CD
at  ||| S:34895 E:34898 ||| IN
37C ||| S:34898 E:34902 ||| CD
.  ||| S:34902 E:34932 ||| .
Cell  ||| S:34932 E:34937 ||| NN
density  ||| S:34937 E:34945 ||| NN
experiments  ||| S:34945 E:34967 ||| NNS
To  ||| S:34967 E:34970 ||| TO
test  ||| S:34970 E:34975 ||| VB
density  ||| S:34975 E:34983 ||| JJ
effects ||| S:34983 E:34990 ||| NNS
,  ||| S:34990 E:34992 ||| ,
cells  ||| S:34992 E:34998 ||| NNS
were  ||| S:34998 E:35003 ||| VBD
plated  ||| S:35003 E:35010 ||| VBN
in  ||| S:35010 E:35023 ||| IN
duplicate  ||| S:35023 E:35033 ||| NN
at  ||| S:35033 E:35036 ||| IN
initial  ||| S:35036 E:35044 ||| JJ
numbers  ||| S:35044 E:35052 ||| NNS
of  ||| S:35052 E:35055 ||| IN
1 ||| S:35055 E:35056 ||| CD
,  ||| S:35056 E:35058 ||| ,
2 ||| S:35058 E:35059 ||| CD
,  ||| S:35059 E:35061 ||| ,
5 ||| S:35061 E:35062 ||| CD
,  ||| S:35062 E:35064 ||| ,
10 ||| S:35064 E:35066 ||| CD
,  ||| S:35066 E:35068 ||| ,
20  ||| S:35068 E:35071 ||| CD
and  ||| S:35071 E:35075 ||| CC
40  ||| S:35075 E:35078 ||| CD
  ||| S:35078 E:35090 ||| CD
10  ||| S:35090 E:35093 ||| CD
5per  ||| S:35093 E:35098 ||| CD
100  ||| S:35098 E:35102 ||| CD
mm  ||| S:35102 E:35105 ||| JJ
cell  ||| S:35105 E:35110 ||| NN
culture  ||| S:35110 E:35118 ||| NN
dish  ||| S:35118 E:35123 ||| NN
with  ||| S:35123 E:35128 ||| IN
DMEM  ||| S:35128 E:35133 ||| NNP
containing  ||| S:35133 E:35144 ||| VBG
5 ||| S:35144 E:35145 ||| CD
%  ||| S:35145 E:35157 ||| NN
FBS  ||| S:35157 E:35161 ||| NNP
and  ||| S:35161 E:35165 ||| CC
5 ||| S:35165 E:35166 ||| CD
%  ||| S:35166 E:35168 ||| NN
calf  ||| S:35168 E:35173 ||| NN
serum ||| S:35173 E:35178 ||| NN
.  ||| S:35178 E:35180 ||| .
After  ||| S:35180 E:35186 ||| IN
2  ||| S:35186 E:35188 ||| CD
to  ||| S:35188 E:35191 ||| TO
3  ||| S:35191 E:35193 ||| CD
days  ||| S:35193 E:35198 ||| NNS
of  ||| S:35198 E:35201 ||| IN
culture ||| S:35201 E:35208 ||| NN
,  ||| S:35208 E:35220 ||| ,
cells  ||| S:35220 E:35226 ||| NNS
were  ||| S:35226 E:35231 ||| VBD
harvested  ||| S:35231 E:35241 ||| VBN
with  ||| S:35241 E:35246 ||| IN
trypsin  ||| S:35246 E:35254 ||| NN
and  ||| S:35254 E:35258 ||| CC
counted  ||| S:35258 E:35266 ||| VBN
on  ||| S:35266 E:35269 ||| IN
a  ||| S:35269 E:35281 ||| DT
Coulter  ||| S:35281 E:35289 ||| NNP
Counter  ||| S:35289 E:35297 ||| NNP
( ||| S:35297 E:35298 ||| -LRB-
Coulter  ||| S:35298 E:35306 ||| NNP
Electronics ||| S:35306 E:35317 ||| NNP
,  ||| S:35317 E:35319 ||| ,
Hialeah ||| S:35319 E:35326 ||| NNP
,  ||| S:35326 E:35328 ||| ,
FL ||| S:35328 E:35330 ||| NNP
) ||| S:35330 E:35331 ||| -RRB-
,  ||| S:35331 E:35333 ||| ,
then  ||| S:35333 E:35348 ||| RB
fixed  ||| S:35348 E:35354 ||| VBN
for  ||| S:35354 E:35358 ||| IN
cytometry  ||| S:35358 E:35368 ||| NN
in  ||| S:35368 E:35371 ||| IN
0.5 ||| S:35371 E:35374 ||| CD
%  ||| S:35374 E:35376 ||| NN
formaldehyde  ||| S:35376 E:35389 ||| NN
at  ||| S:35389 E:35392 ||| IN
37C  ||| S:35392 E:35397 ||| NNP
followed  ||| S:35397 E:35416 ||| VBD
by  ||| S:35416 E:35419 ||| IN
95 ||| S:35419 E:35421 ||| CD
%  ||| S:35421 E:35423 ||| NN
methanol  ||| S:35423 E:35432 ||| NN
at  ||| S:35432 E:35435 ||| IN
-20C ||| S:35435 E:35440 ||| CD
.  ||| S:35440 E:35470 ||| .
Cytometry  ||| S:35470 E:35490 ||| NNP
Fixed  ||| S:35490 E:35496 ||| NNP
samples  ||| S:35496 E:35504 ||| NNS
were  ||| S:35504 E:35509 ||| VBD
immunostained  ||| S:35509 E:35523 ||| VBN
with  ||| S:35523 E:35528 ||| IN
anti-Tag ||| S:35528 E:35536 ||| NNP
,  ||| S:35536 E:35538 ||| ,
PAb416  ||| S:35538 E:35555 ||| NNP
( ||| S:35555 E:35556 ||| -LRB-
Ab2 ||| S:35556 E:35559 ||| NNP
,  ||| S:35559 E:35561 ||| ,
Oncogene  ||| S:35561 E:35570 ||| NNP
Sciences ||| S:35570 E:35578 ||| NNPS
,  ||| S:35578 E:35580 ||| ,
Mineola ||| S:35580 E:35587 ||| NNP
,  ||| S:35587 E:35589 ||| ,
NY ||| S:35589 E:35591 ||| NNP
) ||| S:35591 E:35592 ||| -RRB-
,  ||| S:35592 E:35594 ||| ,
and  ||| S:35594 E:35598 ||| CC
fluorescein  ||| S:35598 E:35620 ||| JJ
isothiocyanate  ||| S:35620 E:35635 ||| NNS
( ||| S:35635 E:35636 ||| -LRB-
FITC ||| S:35636 E:35640 ||| NNP
)  ||| S:35640 E:35642 ||| -RRB-
conjugated  ||| S:35642 E:35653 ||| JJ
secondary  ||| S:35653 E:35663 ||| JJ
antibody  ||| S:35663 E:35682 ||| NN
followed  ||| S:35682 E:35691 ||| VBN
by  ||| S:35691 E:35694 ||| IN
RNase  ||| S:35694 E:35700 ||| JJ
treatment  ||| S:35700 E:35710 ||| NN
and  ||| S:35710 E:35714 ||| CC
propidium  ||| S:35714 E:35724 ||| JJ
staining  ||| S:35724 E:35733 ||| NN
at  ||| S:35733 E:35736 ||| IN
50  ||| S:35736 E:35749 ||| CD
g ||| S:35749 E:35751 ||| CD
/ ||| S:35751 E:35752 ||| CD
ml ||| S:35752 E:35754 ||| NN
,  ||| S:35754 E:35756 ||| ,
as  ||| S:35756 E:35759 ||| RB
previously  ||| S:35759 E:35770 ||| RB
described  ||| S:35770 E:35780 ||| VBN
[  ||| S:35780 E:35782 ||| -LRB-
13  ||| S:35782 E:35785 ||| CD
]  ||| S:35785 E:35787 ||| -RRB-
.  ||| S:35787 E:35789 ||| .
Cells  ||| S:35789 E:35795 ||| NNS
were  ||| S:35795 E:35810 ||| VBD
excited  ||| S:35810 E:35818 ||| VBN
with  ||| S:35818 E:35823 ||| IN
the  ||| S:35823 E:35827 ||| DT
488  ||| S:35827 E:35831 ||| CD
nm  ||| S:35831 E:35834 ||| JJ
line  ||| S:35834 E:35839 ||| NN
of  ||| S:35839 E:35842 ||| IN
the  ||| S:35842 E:35846 ||| DT
argon  ||| S:35846 E:35852 ||| JJ
laser  ||| S:35852 E:35858 ||| NN
of  ||| S:35858 E:35861 ||| IN
a  ||| S:35861 E:35873 ||| DT
Coulter  ||| S:35873 E:35881 ||| NNP
ESP  ||| S:35881 E:35885 ||| NNP
Elite  ||| S:35885 E:35891 ||| NNP
Cytometer  ||| S:35891 E:35901 ||| NNP
( ||| S:35901 E:35902 ||| -LRB-
Coulter  ||| S:35902 E:35910 ||| NNP
Electronics ||| S:35910 E:35921 ||| NNP
,  ||| S:35921 E:35923 ||| ,
Miami ||| S:35923 E:35928 ||| NNP
,  ||| S:35928 E:35940 ||| ,
FL ||| S:35940 E:35942 ||| NNP
) ||| S:35942 E:35943 ||| -RRB-
.  ||| S:35943 E:35945 ||| .
Final  ||| S:35945 E:35951 ||| JJ
filters  ||| S:35951 E:35959 ||| NNS
were  ||| S:35959 E:35964 ||| VBD
525  ||| S:35964 E:35968 ||| CD
nm  ||| S:35968 E:35971 ||| CD
bandpass  ||| S:35971 E:35980 ||| NNS
( ||| S:35980 E:35981 ||| -LRB-
FITC ||| S:35981 E:35985 ||| NNP
)  ||| S:35985 E:35987 ||| -RRB-
and  ||| S:35987 E:35991 ||| CC
640  ||| S:35991 E:35995 ||| CD
nm  ||| S:35995 E:36008 ||| NNS
long  ||| S:36008 E:36013 ||| RB
pass  ||| S:36013 E:36018 ||| VB
( ||| S:36018 E:36019 ||| -LRB-
propidium ||| S:36019 E:36028 ||| LS
) ||| S:36028 E:36029 ||| -RRB-
.  ||| S:36029 E:36031 ||| .
A  ||| S:36031 E:36033 ||| DT
sample  ||| S:36033 E:36040 ||| NN
from  ||| S:36040 E:36045 ||| IN
a  ||| S:36045 E:36047 ||| DT
large  ||| S:36047 E:36053 ||| JJ
batch  ||| S:36053 E:36059 ||| NN
of  ||| S:36059 E:36072 ||| IN
fixed  ||| S:36072 E:36078 ||| JJ
cells  ||| S:36078 E:36084 ||| NNS
was  ||| S:36084 E:36088 ||| VBD
used  ||| S:36088 E:36093 ||| VBN
to  ||| S:36093 E:36096 ||| TO
standardize  ||| S:36096 E:36108 ||| VB
assays  ||| S:36108 E:36115 ||| VBN
in  ||| S:36115 E:36118 ||| IN
time ||| S:36118 E:36122 ||| NN
.  ||| S:36122 E:36124 ||| .
This  ||| S:36124 E:36139 ||| DT
sample  ||| S:36139 E:36146 ||| NN
was  ||| S:36146 E:36150 ||| VBD
stained  ||| S:36150 E:36158 ||| JJ
concurrently  ||| S:36158 E:36171 ||| NN
in  ||| S:36171 E:36174 ||| IN
each  ||| S:36174 E:36179 ||| DT
experiment  ||| S:36179 E:36190 ||| NN
and  ||| S:36190 E:36204 ||| CC
used  ||| S:36204 E:36209 ||| VBN
to  ||| S:36209 E:36212 ||| TO
adjust  ||| S:36212 E:36219 ||| VB
the  ||| S:36219 E:36223 ||| DT
PMT ||| S:36223 E:36226 ||| NNP
's  ||| S:36226 E:36229 ||| VBZ
to  ||| S:36229 E:36232 ||| TO
the  ||| S:36232 E:36236 ||| DT
same  ||| S:36236 E:36241 ||| JJ
FITC  ||| S:36241 E:36246 ||| NNP
and  ||| S:36246 E:36250 ||| CC
PI  ||| S:36250 E:36263 ||| NNP
fluorescences  ||| S:36263 E:36277 ||| NN
in  ||| S:36277 E:36280 ||| IN
all  ||| S:36280 E:36284 ||| DT
experiments ||| S:36284 E:36295 ||| NNS
.  ||| S:36295 E:36297 ||| .
This  ||| S:36297 E:36302 ||| DT
corrected  ||| S:36302 E:36312 ||| VBN
for  ||| S:36312 E:36326 ||| IN
differences  ||| S:36326 E:36338 ||| NNS
in  ||| S:36338 E:36341 ||| IN
staining  ||| S:36341 E:36350 ||| NN
and  ||| S:36350 E:36354 ||| CC
cytometer  ||| S:36354 E:36364 ||| VB
set  ||| S:36364 E:36368 ||| VBN
up ||| S:36368 E:36370 ||| RP
.  ||| S:36370 E:36400 ||| .
Analysis  ||| S:36400 E:36419 ||| NNP
Mean  ||| S:36419 E:36424 ||| NNP
FITC-fluorescence  ||| S:36424 E:36442 ||| NNP
of  ||| S:36442 E:36445 ||| IN
the  ||| S:36445 E:36449 ||| DT
G  ||| S:36449 E:36462 ||| NNP
1  ||| S:36462 E:36464 ||| CD
cell  ||| S:36464 E:36469 ||| NN
cycle  ||| S:36469 E:36475 ||| NN
phase  ||| S:36475 E:36481 ||| NN
population  ||| S:36481 E:36492 ||| NN
was  ||| S:36492 E:36506 ||| VBD
measured  ||| S:36506 E:36515 ||| VBN
by  ||| S:36515 E:36518 ||| IN
gating  ||| S:36518 E:36525 ||| VBG
to  ||| S:36525 E:36528 ||| TO
generate  ||| S:36528 E:36537 ||| VB
a  ||| S:36537 E:36539 ||| DT
statistic  ||| S:36539 E:36549 ||| NN
that  ||| S:36549 E:36554 ||| WDT
would  ||| S:36554 E:36560 ||| MD
be  ||| S:36560 E:36573 ||| VB
independent  ||| S:36573 E:36585 ||| JJ
of  ||| S:36585 E:36588 ||| IN
changes  ||| S:36588 E:36596 ||| NNS
in  ||| S:36596 E:36599 ||| IN
cell  ||| S:36599 E:36604 ||| NN
cycle  ||| S:36604 E:36610 ||| NN
fractions ||| S:36610 E:36619 ||| NNS
.  ||| S:36619 E:36621 ||| .
Mean  ||| S:36621 E:36626 ||| NNP
G  ||| S:36626 E:36639 ||| NNP
1  ||| S:36639 E:36641 ||| CD
fluorescence  ||| S:36641 E:36654 ||| NN
of  ||| S:36654 E:36657 ||| IN
samples  ||| S:36657 E:36665 ||| JJ
stained  ||| S:36665 E:36673 ||| NN
with  ||| S:36673 E:36688 ||| IN
the  ||| S:36688 E:36692 ||| DT
anti-Tag  ||| S:36692 E:36701 ||| JJ
isotype ||| S:36701 E:36708 ||| NN
,  ||| S:36708 E:36710 ||| ,
IgG2a ||| S:36710 E:36715 ||| NNP
,  ||| S:36715 E:36717 ||| ,
and  ||| S:36717 E:36721 ||| CC
FITC-conjugated  ||| S:36721 E:36747 ||| JJ
secondary  ||| S:36747 E:36757 ||| JJ
antibody  ||| S:36757 E:36766 ||| NN
served  ||| S:36766 E:36773 ||| VBN
as  ||| S:36773 E:36776 ||| IN
a  ||| S:36776 E:36778 ||| DT
control  ||| S:36778 E:36786 ||| NN
for  ||| S:36786 E:36790 ||| IN
non-specific  ||| S:36790 E:36813 ||| JJ
fluorescence  ||| S:36813 E:36826 ||| NN
and  ||| S:36826 E:36830 ||| CC
was  ||| S:36830 E:36834 ||| VBD
subtracted  ||| S:36834 E:36845 ||| VBN
from  ||| S:36845 E:36850 ||| IN
the  ||| S:36850 E:36854 ||| DT
G  ||| S:36854 E:36867 ||| NNP
1  ||| S:36867 E:36869 ||| CD
fluorescence  ||| S:36869 E:36882 ||| NN
of  ||| S:36882 E:36885 ||| IN
corresponding  ||| S:36885 E:36909 ||| JJ
Tag-stained  ||| S:36909 E:36921 ||| JJ
samples  ||| S:36921 E:36929 ||| NNS
( ||| S:36929 E:36930 ||| -LRB-
Figure  ||| S:36930 E:36937 ||| NNP
4 ||| S:36937 E:36938 ||| CD
) ||| S:36938 E:36939 ||| -RRB-
.  ||| S:36939 E:36941 ||| .
The  ||| S:36941 E:36945 ||| DT
result  ||| S:36945 E:36952 ||| NN
of  ||| S:36952 E:36955 ||| IN
the  ||| S:36955 E:36969 ||| DT
subtraction  ||| S:36969 E:36981 ||| NN
is  ||| S:36981 E:36984 ||| VBZ
the  ||| S:36984 E:36988 ||| DT
Tag  ||| S:36988 E:36992 ||| JJ
specific  ||| S:36992 E:37001 ||| JJ
fluorescence  ||| S:37001 E:37014 ||| NN
and  ||| S:37014 E:37028 ||| CC
corresponds  ||| S:37028 E:37040 ||| JJ
to  ||| S:37040 E:37043 ||| TO
the  ||| S:37043 E:37047 ||| DT
amount  ||| S:37047 E:37054 ||| NN
of  ||| S:37054 E:37057 ||| IN
Tag  ||| S:37057 E:37061 ||| NNP
in  ||| S:37061 E:37064 ||| IN
the  ||| S:37064 E:37068 ||| DT
average  ||| S:37068 E:37076 ||| JJ
G  ||| S:37076 E:37089 ||| NNP
1  ||| S:37089 E:37091 ||| CD
cell  ||| S:37091 E:37096 ||| NN
for  ||| S:37096 E:37100 ||| IN
a  ||| S:37100 E:37102 ||| DT
specific  ||| S:37102 E:37111 ||| JJ
population ||| S:37111 E:37121 ||| NN
.  ||| S:37121 E:37133 ||| .
Forward  ||| S:37133 E:37141 ||| RB
and  ||| S:37141 E:37145 ||| CC
right  ||| S:37145 E:37151 ||| JJ
angle  ||| S:37151 E:37157 ||| NN
light  ||| S:37157 E:37163 ||| NN
scatter  ||| S:37163 E:37171 ||| NNS
were  ||| S:37171 E:37176 ||| VBD
used  ||| S:37176 E:37181 ||| VBN
to  ||| S:37181 E:37184 ||| TO
gate  ||| S:37184 E:37199 ||| VB
debris ||| S:37199 E:37205 ||| NN
.  ||| S:37205 E:37207 ||| .
Modeling  ||| S:37207 E:37216 ||| JJ
software  ||| S:37216 E:37225 ||| NN
( ||| S:37225 E:37226 ||| -LRB-
ModFit ||| S:37226 E:37232 ||| NNP
,  ||| S:37232 E:37234 ||| ,
Verity  ||| S:37234 E:37241 ||| NNP
Software  ||| S:37241 E:37250 ||| NNP
House ||| S:37250 E:37255 ||| NNP
,  ||| S:37255 E:37267 ||| ,
Topsham ||| S:37267 E:37274 ||| NNP
,  ||| S:37274 E:37276 ||| ,
ME ||| S:37276 E:37278 ||| NNP
)  ||| S:37278 E:37280 ||| -RRB-
was  ||| S:37280 E:37284 ||| VBD
used  ||| S:37284 E:37289 ||| VBN
to  ||| S:37289 E:37292 ||| TO
determine  ||| S:37292 E:37302 ||| VB
the  ||| S:37302 E:37306 ||| DT
phase  ||| S:37306 E:37312 ||| NN
fractions  ||| S:37312 E:37332 ||| NNS
from  ||| S:37332 E:37337 ||| IN
analysis  ||| S:37337 E:37346 ||| NN
of  ||| S:37346 E:37349 ||| IN
single  ||| S:37349 E:37356 ||| JJ
parameter  ||| S:37356 E:37366 ||| JJ
DNA  ||| S:37366 E:37370 ||| NN
data ||| S:37370 E:37374 ||| NNS
.  ||| S:37374 E:37376 ||| .
Linear  ||| S:37376 E:37393 ||| NNP
regression ||| S:37393 E:37403 ||| NN
,  ||| S:37403 E:37405 ||| ,
using  ||| S:37405 E:37411 ||| VBG
GraphPad  ||| S:37411 E:37420 ||| JJ
Prism  ||| S:37420 E:37426 ||| JJ
version  ||| S:37426 E:37434 ||| NN
3.00  ||| S:37434 E:37439 ||| NN
for  ||| S:37439 E:37443 ||| IN
Windows  ||| S:37443 E:37461 ||| NNP
( ||| S:37461 E:37462 ||| -LRB-
GraphPad  ||| S:37462 E:37471 ||| NNP
Software ||| S:37471 E:37479 ||| NNP
,  ||| S:37479 E:37481 ||| ,
San  ||| S:37481 E:37485 ||| NNP
Diego  ||| S:37485 E:37491 ||| NNP
California  ||| S:37491 E:37502 ||| NNP
USA ||| S:37502 E:37505 ||| NNP
,  ||| S:37505 E:37517 ||| ,
www.graphpad.com ||| S:37517 E:37533 ||| CD
) ||| S:37533 E:37534 ||| -RRB-
,  ||| S:37534 E:37536 ||| ,
was  ||| S:37536 E:37540 ||| VBD
used  ||| S:37540 E:37545 ||| VBN
to  ||| S:37545 E:37548 ||| TO
determine  ||| S:37548 E:37558 ||| VB
the  ||| S:37558 E:37562 ||| DT
slope ||| S:37562 E:37567 ||| NN
,  ||| S:37567 E:37579 ||| ,
standard  ||| S:37579 E:37588 ||| JJ
error  ||| S:37588 E:37594 ||| NN
( ||| S:37594 E:37595 ||| -LRB-
SE ||| S:37595 E:37597 ||| NNP
) ||| S:37597 E:37598 ||| -RRB-
,  ||| S:37598 E:37600 ||| ,
and  ||| S:37600 E:37604 ||| CC
p-value  ||| S:37604 E:37612 ||| JJ
for  ||| S:37612 E:37616 ||| IN
Tag  ||| S:37616 E:37620 ||| NNP
expression  ||| S:37620 E:37631 ||| NN
as  ||| S:37631 E:37634 ||| IN
a  ||| S:37634 E:37646 ||| DT
function  ||| S:37646 E:37655 ||| NN
of  ||| S:37655 E:37658 ||| IN
cell  ||| S:37658 E:37663 ||| NN
density  ||| S:37663 E:37671 ||| NN
or  ||| S:37671 E:37674 ||| CC
the  ||| S:37674 E:37678 ||| DT
frequency  ||| S:37678 E:37688 ||| NN
of  ||| S:37688 E:37691 ||| IN
G  ||| S:37691 E:37704 ||| NNP
1  ||| S:37704 E:37706 ||| CD
cells ||| S:37706 E:37711 ||| NNS
.  ||| S:37711 E:37741 ||| .
Electrophoresis  ||| S:37741 E:37757 ||| NNP
and  ||| S:37757 E:37761 ||| CC
western  ||| S:37761 E:37769 ||| JJ
blotting  ||| S:37769 E:37788 ||| JJ
Cell  ||| S:37788 E:37793 ||| JJ
extracts  ||| S:37793 E:37802 ||| NN
were  ||| S:37802 E:37807 ||| VBD
prepared  ||| S:37807 E:37816 ||| VBN
in  ||| S:37816 E:37819 ||| IN
10 ||| S:37819 E:37821 ||| CD
%  ||| S:37821 E:37823 ||| NN
SDS  ||| S:37823 E:37827 ||| FW
lysis  ||| S:37827 E:37833 ||| FW
buffer  ||| S:37833 E:37850 ||| FW
( ||| S:37850 E:37851 ||| -LRB-
0.137  ||| S:37851 E:37857 ||| NNP
M  ||| S:37857 E:37859 ||| NNP
NaCl ||| S:37859 E:37863 ||| NNP
,  ||| S:37863 E:37865 ||| ,
2 ||| S:37865 E:37866 ||| CD
%  ||| S:37866 E:37868 ||| NN
Nonidet  ||| S:37868 E:37876 ||| NNP
P-40 ||| S:37876 E:37880 ||| NNP
,  ||| S:37880 E:37882 ||| ,
10 ||| S:37882 E:37884 ||| CD
%  ||| S:37884 E:37886 ||| NN
SDS ||| S:37886 E:37889 ||| NNP
,  ||| S:37889 E:37891 ||| ,
1 ||| S:37891 E:37892 ||| CD
%  ||| S:37892 E:37894 ||| NN
sodium  ||| S:37894 E:37911 ||| NN
deoxycholate ||| S:37911 E:37923 ||| NN
,  ||| S:37923 E:37925 ||| ,
20  ||| S:37925 E:37928 ||| CD
mM  ||| S:37928 E:37931 ||| JJ
Tris ||| S:37931 E:37935 ||| NNP
,  ||| S:37935 E:37937 ||| ,
pH  ||| S:37937 E:37940 ||| NNP
8.0 ||| S:37940 E:37943 ||| NNP
,  ||| S:37943 E:37945 ||| ,
2  ||| S:37945 E:37947 ||| CD
mM  ||| S:37947 E:37950 ||| JJ
PMSF ||| S:37950 E:37954 ||| NNP
,  ||| S:37954 E:37956 ||| ,
10  ||| S:37956 E:37959 ||| CD
l ||| S:37959 E:37961 ||| FW
/ ||| S:37961 E:37962 ||| FW
ml  ||| S:37962 E:37975 ||| FW
protease  ||| S:37975 E:37984 ||| FW
inhibitor  ||| S:37984 E:37994 ||| FW
cocktail ||| S:37994 E:38002 ||| FW
) ||| S:38002 E:38003 ||| -RRB-
,  ||| S:38003 E:38005 ||| ,
which  ||| S:38005 E:38011 ||| WDT
solubilizes  ||| S:38011 E:38033 ||| VBZ
cytoskeletal  ||| S:38033 E:38046 ||| VBN
and  ||| S:38046 E:38050 ||| CC
nuclear  ||| S:38050 E:38058 ||| JJ
matrices ||| S:38058 E:38066 ||| NN
.  ||| S:38066 E:38068 ||| .
Samples  ||| S:38068 E:38076 ||| NNS
of  ||| S:38076 E:38079 ||| IN
known  ||| S:38079 E:38095 ||| JJ
numbers  ||| S:38095 E:38103 ||| NNS
of  ||| S:38103 E:38106 ||| IN
cells  ||| S:38106 E:38112 ||| NNS
from  ||| S:38112 E:38117 ||| IN
the  ||| S:38117 E:38121 ||| DT
cell  ||| S:38121 E:38126 ||| NN
lines  ||| S:38126 E:38132 ||| NNS
and  ||| S:38132 E:38136 ||| CC
recombinant ||| S:38136 E:38147 ||| JJ
,  ||| S:38147 E:38159 ||| ,
purified  ||| S:38159 E:38168 ||| JJ
Tag  ||| S:38168 E:38172 ||| NNS
prepared  ||| S:38172 E:38181 ||| VBN
from  ||| S:38181 E:38186 ||| IN
a  ||| S:38186 E:38188 ||| DT
baculovirus  ||| S:38188 E:38200 ||| JJ
lysate  ||| S:38200 E:38207 ||| NNS
[  ||| S:38207 E:38209 ||| -LRB-
40  ||| S:38209 E:38212 ||| CD
]  ||| S:38212 E:38224 ||| -RRB-
were  ||| S:38224 E:38229 ||| VBD
loaded  ||| S:38229 E:38236 ||| VBN
on  ||| S:38236 E:38239 ||| IN
10 ||| S:38239 E:38241 ||| CD
%  ||| S:38241 E:38243 ||| NN
polyacrylamide  ||| S:38243 E:38258 ||| FW
discontinuous  ||| S:38258 E:38272 ||| FW
mini-gels  ||| S:38272 E:38292 ||| FW
( ||| S:38292 E:38293 ||| -LRB-
Bio-Rad ||| S:38293 E:38300 ||| NNP
,  ||| S:38300 E:38302 ||| ,
Hercules ||| S:38302 E:38310 ||| NNP
,  ||| S:38310 E:38312 ||| ,
CA ||| S:38312 E:38314 ||| NNP
)  ||| S:38314 E:38316 ||| -RRB-
and  ||| S:38316 E:38320 ||| CC
electrophoresed  ||| S:38320 E:38346 ||| JJ
conventionally  ||| S:38346 E:38361 ||| NNS
[  ||| S:38361 E:38363 ||| -LRB-
41  ||| S:38363 E:38366 ||| CD
]  ||| S:38366 E:38368 ||| -RRB-
.  ||| S:38368 E:38370 ||| .
Gels  ||| S:38370 E:38375 ||| NNP
were  ||| S:38375 E:38380 ||| VBD
then  ||| S:38380 E:38395 ||| RB
electrophoretically  ||| S:38395 E:38415 ||| JJ
blotted  ||| S:38415 E:38423 ||| NNS
[  ||| S:38423 E:38425 ||| -LRB-
42  ||| S:38425 E:38428 ||| CD
]  ||| S:38428 E:38430 ||| -RRB-
onto  ||| S:38430 E:38435 ||| IN
PVDF  ||| S:38435 E:38440 ||| NNP
membrane  ||| S:38440 E:38459 ||| NNS
( ||| S:38459 E:38460 ||| -LRB-
Bio-Rad ||| S:38460 E:38467 ||| NNP
)  ||| S:38467 E:38469 ||| -RRB-
without  ||| S:38469 E:38477 ||| IN
methanol  ||| S:38477 E:38486 ||| NN
for  ||| S:38486 E:38490 ||| IN
15  ||| S:38490 E:38493 ||| CD
min  ||| S:38493 E:38497 ||| NN
at  ||| S:38497 E:38500 ||| IN
100  ||| S:38500 E:38504 ||| CD
V.  ||| S:38504 E:38507 ||| NNP
Tag  ||| S:38507 E:38511 ||| NNP
was  ||| S:38511 E:38525 ||| VBD
visualized  ||| S:38525 E:38536 ||| VBN
by  ||| S:38536 E:38539 ||| IN
immunostaining  ||| S:38539 E:38554 ||| NN
with  ||| S:38554 E:38559 ||| IN
PAb416  ||| S:38559 E:38566 ||| NNP
and  ||| S:38566 E:38570 ||| CC
alkaline  ||| S:38570 E:38589 ||| JJ
phosphatase  ||| S:38589 E:38601 ||| NNS
conjugated  ||| S:38601 E:38612 ||| VBP
secondary  ||| S:38612 E:38622 ||| JJ
antibody  ||| S:38622 E:38631 ||| NN
( ||| S:38631 E:38632 ||| -LRB-
Sigma ||| S:38632 E:38637 ||| NNP
)  ||| S:38637 E:38639 ||| -RRB-
using  ||| S:38639 E:38655 ||| VBG
chemiluminescent  ||| S:38655 E:38672 ||| JJ
detection  ||| S:38672 E:38682 ||| NN
with  ||| S:38682 E:38687 ||| IN
CDP-Star  ||| S:38687 E:38696 ||| JJ
substrate  ||| S:38696 E:38716 ||| NNS
according  ||| S:38716 E:38726 ||| VBG
to  ||| S:38726 E:38729 ||| TO
the  ||| S:38729 E:38733 ||| DT
manufacturers  ||| S:38733 E:38747 ||| NNS
directions  ||| S:38747 E:38758 ||| NNS
( ||| S:38758 E:38759 ||| -LRB-
Tropix ||| S:38759 E:38765 ||| NNP
,  ||| S:38765 E:38777 ||| ,
Bedford ||| S:38777 E:38784 ||| NNP
,  ||| S:38784 E:38786 ||| ,
MA ||| S:38786 E:38788 ||| NNP
) ||| S:38788 E:38789 ||| -RRB-
.  ||| S:38789 E:38791 ||| .
Images  ||| S:38791 E:38798 ||| NNS
were  ||| S:38798 E:38803 ||| VBD
developed  ||| S:38803 E:38813 ||| VBN
on  ||| S:38813 E:38816 ||| IN
X-ray  ||| S:38816 E:38822 ||| NN
film  ||| S:38822 E:38827 ||| NN
( ||| S:38827 E:38828 ||| -LRB-
Kodak ||| S:38828 E:38833 ||| NNP
,  ||| S:38833 E:38845 ||| ,
X-Omat ||| S:38845 E:38851 ||| NNP
,  ||| S:38851 E:38853 ||| ,
Rochester ||| S:38853 E:38862 ||| NNP
,  ||| S:38862 E:38864 ||| ,
NY ||| S:38864 E:38866 ||| NNP
) ||| S:38866 E:38867 ||| -RRB-
.  ||| S:38867 E:38869 ||| .
Quantification  ||| S:38869 E:38884 ||| NNP
was  ||| S:38884 E:38888 ||| VBD
performed  ||| S:38888 E:38898 ||| VBN
by  ||| S:38898 E:38911 ||| IN
densitometry  ||| S:38911 E:38924 ||| NN
on  ||| S:38924 E:38927 ||| IN
the  ||| S:38927 E:38931 ||| DT
Sci  ||| S:38931 E:38935 ||| NNP
Scan  ||| S:38935 E:38940 ||| NNP
5000  ||| S:38940 E:38945 ||| CD
automated  ||| S:38945 E:38955 ||| JJ
scanning  ||| S:38955 E:38974 ||| JJ
system  ||| S:38974 E:38981 ||| NN
( ||| S:38981 E:38982 ||| -LRB-
US  ||| S:38982 E:38985 ||| NNP
Biochemicals ||| S:38985 E:38997 ||| NNP
,  ||| S:38997 E:38999 ||| ,
Cleveland ||| S:38999 E:39008 ||| NNP
,  ||| S:39008 E:39010 ||| ,
OH ||| S:39010 E:39012 ||| NNP
) ||| S:39012 E:39013 ||| -RRB-
.  ||| S:39013 E:39025 ||| .
To  ||| S:39025 E:39028 ||| TO
test  ||| S:39028 E:39033 ||| VB
for  ||| S:39033 E:39037 ||| IN
astrocyte  ||| S:39037 E:39047 ||| JJ
lineage ||| S:39047 E:39054 ||| NN
,  ||| S:39054 E:39056 ||| ,
early  ||| S:39056 E:39062 ||| JJ
passage  ||| S:39062 E:39070 ||| NN
cells  ||| S:39070 E:39086 ||| NNS
were  ||| S:39086 E:39091 ||| VBD
grown  ||| S:39091 E:39097 ||| VBN
in  ||| S:39097 E:39100 ||| IN
dibutyryl  ||| S:39100 E:39110 ||| JJ
cAMP  ||| S:39110 E:39115 ||| NN
( ||| S:39115 E:39116 ||| -LRB-
Sigma ||| S:39116 E:39121 ||| NNP
)  ||| S:39121 E:39123 ||| -RRB-
to  ||| S:39123 E:39126 ||| TO
enhance  ||| S:39126 E:39134 ||| VB
GFAP  ||| S:39134 E:39149 ||| JJ
expression ||| S:39149 E:39159 ||| NN
.  ||| S:39159 E:39161 ||| .
Intermediate  ||| S:39161 E:39174 ||| JJ
filament  ||| S:39174 E:39183 ||| JJ
extracts  ||| S:39183 E:39192 ||| NN
of  ||| S:39192 E:39195 ||| IN
the  ||| S:39195 E:39199 ||| DT
cell  ||| S:39199 E:39214 ||| NN
lines  ||| S:39214 E:39220 ||| NNS
[  ||| S:39220 E:39222 ||| -LRB-
43  ||| S:39222 E:39225 ||| CD
44  ||| S:39225 E:39228 ||| CD
]  ||| S:39228 E:39230 ||| -RRB-
were  ||| S:39230 E:39235 ||| VBD
electrophoretically  ||| S:39235 E:39255 ||| JJ
blotted  ||| S:39255 E:39263 ||| NN
and  ||| S:39263 E:39277 ||| CC
detected  ||| S:39277 E:39286 ||| VBN
with  ||| S:39286 E:39291 ||| IN
polyclonal  ||| S:39291 E:39302 ||| FW
anti  ||| S:39302 E:39307 ||| FW
GFAP  ||| S:39307 E:39312 ||| FW
( ||| S:39312 E:39313 ||| -LRB-
DAKO ||| S:39313 E:39317 ||| NNP
,  ||| S:39317 E:39319 ||| ,
Carpenteria ||| S:39319 E:39330 ||| NNP
,  ||| S:39330 E:39342 ||| ,
CA ||| S:39342 E:39344 ||| NNP
)  ||| S:39344 E:39346 ||| -RRB-
and  ||| S:39346 E:39350 ||| CC
secondary  ||| S:39350 E:39360 ||| JJ
reagents  ||| S:39360 E:39369 ||| NN
as  ||| S:39369 E:39372 ||| IN
above ||| S:39372 E:39377 ||| JJ
.  ||| S:39377 E:39403 ||| .
